T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDPOTS
44 sources
- T1REGISTERED-ONLY NCT07597902 ↗ — SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
- T6INDIRECT 36219278 ↗ — Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies
- T6INDIRECT 34659109 ↗ — COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic Review
- T6INDIRECT 35893864 ↗ — The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musc
- T6INDIRECT 37091856 ↗ — Subacute thyroiditis following COVID-19: A systematic review
- T6INDIRECT 35395090 ↗ — The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the
- T6INDIRECT 40597703 ↗ — Subacute thyroiditis as a post-COVID-19 complication: a systematic review
- T1 37660680 ↗ — Efficacy and safety of celecoxib monotherapy for treatment of moderate depressive symptoms following
- T6INDIRECT 41562079 ↗ — Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid<sup>®</sup>
- T6 35039676 ↗ — Immune targets for therapeutic development in depression: towards precision medicine
- T6 23988267 ↗ — Molecular mechanisms underlying chronic inflammation-associated cancers
- T6 33733315 ↗ — COVID-19 and the clinical course of rheumatic manifestations
- T6 32840756 ↗ — Pain Management During the COVID-19 Pandemic
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 29694674 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 24683057 ↗ — Pharmacological interventions for prevention or treatment of postoperative pain in people undergoing
- T6INDIRECT 33179245 ↗ — Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults
- T6INDIRECT 36269595 ↗ — Antidepressants for hip and knee osteoarthritis
- T6INDIRECT 31207169 ↗ — The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Do
- T6INDIRECT 31680610 ↗ — Outpatient total hip or knee arthroplasty in ambulatory surgery center versus arthroplasty ward: a r
- T6INDIRECT 24954491 ↗ — Role of preoperative pain, muscle function, and activity level in discharge readiness after fast-tra
- T6 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 33409010 ↗ — Reactive Arthritis After COVID-19 Infection
- T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
- T6INDIRECT 33421734 ↗ — The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacol
- T6INDIRECT 34015983 ↗ — SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives
- T6INDIRECT 36736220 ↗ — Lung fibrosis: Post-COVID-19 complications and evidences
- T6 38868666 ↗ — Alzheimer's disease and its treatment-yesterday, today, and tomorrow
- T6 39861782 ↗ — Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques
- T6 37759498 ↗ — A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Ava
- T6 37251376 ↗ — The chemokine landscape: one system multiple shades
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 20357277 ↗ — Pain management in the cirrhotic patient: the clinical challenge
- T6INDIRECT 27973405 ↗ — Chronic Pain in Children and Adolescents: Diagnosis and Treatment of Primary Pain Disorders in Head,
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 21445724 ↗ — European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological
- T6INDIRECT 23227356 ↗ — Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder
- T6 20696139 ↗ — Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic dise
- T6 23588782 ↗ — Applications of CYP450 testing in the clinical setting
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 30712918 ↗ — Type 2 diabetes mellitus and osteoarthritis
- T6 30578418 ↗ — Trans-ethnic association study of blood pressure determinants in over 750,000 individuals
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 22066560 ↗ — Why still in hospital after fast-track hip and knee arthroplasty?
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDPOTS
57 sources
- T1 NCT06404086 ↗ — RECOVER-SLEEP: Platform Protocol
- T1 NCT06404099 ↗ — RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T2REGISTERED-ONLY NCT01988883 ↗ — Modafinil and Cognitive Function in POTS
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 38228914 ↗ — Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for
- T6INDIRECT 39207396 ↗ — Undervaluing nondrug rewards or overvaluing cocaine? Cocaine demand relates to cocaine use severity
- T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
- T6 34390682 ↗ — Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6 33755344 ↗ — Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers"
- T6 34346558 ↗ — Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fati
- T6 35577469 ↗ — Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled t
- T6 38384879 ↗ — Self-managing symptoms of Long COVID: an education and strategies research protocol
- T6HARM 35277411 ↗ — Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systemati
- T6INDIRECT 27153153 ↗ — Pharmacological treatment for Kleine-Levin syndrome
- T6INDIRECT 35651342 ↗ — Sleep Disturbances in Pediatric Craniopharyngioma: A Systematic Review
- T6INDIRECT 40653179 ↗ — The evidence for treatments for postural orthostatic tachycardia syndrome: a systematic review of ra
- T6INDIRECT 41225175 ↗ — Systematic literature review: treatment of postural orthostatic tachycardia syndrome (POTS)
- T2 25222185 ↗ — Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome
- T6INDIRECT 37447210 ↗ — Combination of Chemically Characterized Pomegranate Extract and Hydrophilic Vitamins against Prolong
- T6 22519513 ↗ — The solute carrier 6 family of transporters
- T6INDIRECT 23753844 ↗ — Postural tachycardia syndrome (POTS)
- T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 26447539 ↗ — Interventions for fatigue in Parkinson's disease
- T6INDIRECT 36190739 ↗ — Pharmacological interventions for prevention of weight gain in people with schizophrenia
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 32402075 ↗ — Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
- T6INDIRECT 36138129 ↗ — The impact of pharmacological and non-pharmacological interventions on physical health outcomes in p
- T6INDIRECT 36971690 ↗ — Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- T6INDIRECT 20679638 ↗ — Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- T6INDIRECT 17134849 ↗ — Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
- T6INDIRECT 33421734 ↗ — The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacol
- T6INDIRECT 36946625 ↗ — An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing m
- T6INDIRECT 36002784 ↗ — Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with cas
- T6INDIRECT 33681293 ↗ — Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiat
- T6INDIRECT 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
- T6 39125722 ↗ — Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detectio
- T6 34646278 ↗ — Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
- T6 35454890 ↗ — A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk P
- T6 35883527 ↗ — Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Ther
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 25200111 ↗ — Drooling in Parkinson's disease: a review
- T6INDIRECT 29101940 ↗ — REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions
- T6 26595642 ↗ — Lewy body dementias
- T6 28837986 ↗ — Sleep Disturbance, Cognitive Decline, and Dementia: A Review
- T6 24699931 ↗ — Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 19603170 ↗ — Primary biliary cirrhosis
- T6 23065655 ↗ — A practical guide to the therapy of narcolepsy and hypersomnia syndromes
- T6 20815187 ↗ — Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDPOTS
48 sources
- T1 NCT06305806 ↗ — RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
- T1 NCT06305780 ↗ — RECOVER-AUTONOMIC Platform Protocol
- T2REGISTERED-ONLY NCT04186286 ↗ — Crossover Study of Propranolol vs Ivabradine in POTS
- T2 NCT05481177 ↗ — Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
- T2 NCT03182725 ↗ — Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome
- T6 NCT01761825 ↗ — The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome
- T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
- T6INDIRECT 38673384 ↗ — Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
- T6INDIRECT 36237182 ↗ — Graves' disease following vaccination against SARS-CoV-2: A systematic review of the reported cases
- T6INDIRECT 37094584 ↗ — Postural Orthostatic Tachycardia Syndrome After COVID-19: A Systematic Review of Therapeutic Interve
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 39538129 ↗ — Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review
- T6INDIRECT 36549786 ↗ — Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarge
- T6INDIRECT 39859026 ↗ — The Role of Omega-3 Polyunsaturated Fatty Acids in Patients with Metabolic Syndrome and Endothelial
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
- T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
- T6INDIRECT 29759520 ↗ — Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature
- T2 29330767 ↗ — Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review
- T6INDIRECT 36723919 ↗ — Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrilla
- T2 33602468 ↗ — Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syn
- T6INDIRECT 37999672 ↗ — Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
- T6INDIRECT 37598401 ↗ — Semi-supervised exercise training program more effective for individuals with postural orthostatic t
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 31841279 ↗ — Central blood pressure for the management of hypertension: Is it a practical clinical tool in curren
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 33262898 ↗ — New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease 2019 Infection
- T6INDIRECT 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
- T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
- T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
- T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
- T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
- T6 39125722 ↗ — Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detectio
- T6 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
- T6 34909198 ↗ — How COVID-19 can cause autonomic dysfunctions and postural orthostatic syndrome? A Review of mechani
- T6 36113768 ↗ — Three-dimensional functional anatomy of the human sinoatrial node for epicardial and endocardial map
- T6 39536116 ↗ — Translating insights into therapies for Long Covid
- T6 34390682 ↗ — Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
- T6 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6INDIRECT 32117030 ↗ — Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome
- T6INDIRECT 26198889 ↗ — Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 29359025 ↗ — Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
- T6 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6 33999297 ↗ — The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrativ
- T6 28428055 ↗ — Sex differences in cardiovascular disease - Impact on care and outcomes
- T6 29222399 ↗ — Pediatric Disorders of Orthostatic Intolerance
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFSPOTS
81 sources
- T1 NCT06404112 ↗ — RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)
- T1 NCT06404086 ↗ — RECOVER-SLEEP: Platform Protocol
- T2 NCT05454683 ↗ — Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue
- T2 NCT03000777 ↗ — Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 36235869 ↗ — Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
- T6INDIRECT 38732592 ↗ — The Efficacy of Multivitamin, Vitamin A, Vitamin B, Vitamin C, and Vitamin D Supplements in the Prev
- T6INDIRECT 38105461 ↗ — Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and me
- T6INDIRECT 33205450 ↗ — Case report and systematic review suggest that children may experience similar long-term effects to
- T6INDIRECT 33584506 ↗ — COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exceptio
- T6INDIRECT 35893864 ↗ — The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musc
- T6INDIRECT 37397709 ↗ — A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharm
- T6INDIRECT 36334288 ↗ — Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a system
- T6INDIRECT 34837648 ↗ — Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a th
- T6INDIRECT 38908733 ↗ — Fecal Microbiota Transplantation for Sleep Disturbance in Post-acute COVID-19 Syndrome
- T6 39174535 ↗ — Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strateg
- T6 37117704 ↗ — Wearable chemical sensors for biomarker discovery in the omics era
- T6INDIRECT 27664125 ↗ — Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review
- T6INDIRECT 34902819 ↗ — Sleep, cerebrospinal fluid, and the glymphatic system: A systematic review
- T6INDIRECT 34770209 ↗ — Sleep Disorders in Cancer-A Systematic Review
- T6INDIRECT 17021301 ↗ — Interventions for the treatment, management and rehabilitation of patients with chronic fatigue synd
- T6INDIRECT 19856109 ↗ — Biofield therapies: helpful or full of hype? A best evidence synthesis
- T6INDIRECT 31478755 ↗ — Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot T
- T6INDIRECT 22728166 ↗ — Antioxidant supplementation reduces endometriosis-related pelvic pain in humans
- T6INDIRECT 25002497 ↗ — Effect of sleep deprivation on the human metabolome
- T6INDIRECT 17081700 ↗ — Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis func
- T6 30920354 ↗ — The Sleep-Immune Crosstalk in Health and Disease
- T6 24370461 ↗ — The role of microbiome in central nervous system disorders
- T6 29936690 ↗ — The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critica
- T6INDIRECT 22328094 ↗ — REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative n
- T6INDIRECT 33224097 ↗ — Cyclic Vomiting Syndrome in Children
- T6INDIRECT 33173517 ↗ — Perioperative Sleep Disturbances and Postoperative Delirium in Adult Patients: A Systematic Review a
- T6INDIRECT 36268467 ↗ — Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review
- T6INDIRECT 34472659 ↗ — Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated cl
- T2 21729284 ↗ — The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a ra
- T2 24495468 ↗ — Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial
- T6INDIRECT 32986682 ↗ — The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility
- T6INDIRECT 36751940 ↗ — Baseline characteristics of the North American prodromal Synucleinopathy cohort
- T6 23672628 ↗ — Understanding the somatic consequences of depression: biological mechanisms and the role of depressi
- T6 33856918 ↗ — COVID-19 and Cardiovascular Disease: From Bench to Bedside
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 32244523 ↗ — Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioact
- T6INDIRECT 23233021 ↗ — A randomised controlled trial of bumetanide in the treatment of autism in children
- T6INDIRECT 22549286 ↗ — Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial
- T2 22348451 ↗ — Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adult
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 25731881 ↗ — Assessment and management of behavioral and psychological symptoms of dementia
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6INDIRECT 35727534 ↗ — Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
- T6INDIRECT 33519510 ↗ — SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
- T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
- T6INDIRECT 36713204 ↗ — The role of oxidative stress in the pathogenesis of infections with coronaviruses
- T6INDIRECT 32637987 ↗ — The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
- T6INDIRECT 35589549 ↗ — Identifying who has long COVID in the USA: a machine learning approach using N3C data
- T6 36253560 ↗ — Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential t
- T6 36899952 ↗ — Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutic
- T6 34997196 ↗ — Mechanisms of action of fluvoxamine for COVID-19: a historical review
- T6 35029046 ↗ — "LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strat
- T6 34400495 ↗ — Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
- T6 37080828 ↗ — Long COVID: pathophysiological factors and abnormalities of coagulation
- T6INDIRECT 20471738 ↗ — Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms
- T6INDIRECT 23939821 ↗ — Key role of CRF in the skin stress response system
- T6INDIRECT 37760929 ↗ — Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Op
- T6INDIRECT 31885788 ↗ — Oxidative Stress Indexes for Diagnosis of Health or Disease in Humans
- T6INDIRECT 23227356 ↗ — Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder
- T6 27749086 ↗ — The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
- T6 38185705 ↗ — Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
- T6 33918736 ↗ — Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update
- T6 30525268 ↗ — Role of pyroptosis in cardiovascular disease
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 34741573 ↗ — Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considera
- T6INDIRECT 28781611 ↗ — Best practice in the management of behavioural and psychological symptoms of dementia
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 26595642 ↗ — Lewy body dementias
- T6 21034217 ↗ — Orexin receptors: pharmacology and therapeutic opportunities
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
T1 — RCT in LC/PASC/PACVS
RegisteredWithdrawnLong COVIDME/CFSPOTS
65 sources
- T1REGISTERED-ONLY NCT06366724 ↗ — LIFT: Life Improvement Trial
- T2REGISTERED-ONLY NCT07285473 ↗ — Low-Dose Naltrexone For ME/CFS: Dose-Finding
- T2WITHDRAWN NCT02965768 ↗ — Immune Effects of Low-dose Naltrexone in ME/CFS
- T2REGISTERED-ONLY NCT05363514 ↗ — Low Dose Naltrexone Use in Patients With POTS
- T6INDIRECT 39483457 ↗ — Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndr
- T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
- T6INDIRECT 34658014 ↗ — Colchicine for the treatment of COVID-19
- T6INDIRECT 36409650 ↗ — A systematic review of the biological mediators of fat taste and smell
- T6INDIRECT 39940333 ↗ — Dietary Supplementation for Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (
- T6INDIRECT 38554565 ↗ — Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian O
- T6INDIRECT 38360929 ↗ — Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a
- T6INDIRECT 36196533 ↗ — Enhancing Use of Medications for Opioid Use Disorder Through External Coaching
- T6INDIRECT 38012333 ↗ — A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T2HARM 30642329 ↗ — Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a system
- T6INDIRECT 36690401 ↗ — Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-anal
- T6INDIRECT 27894343 ↗ — Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a sy
- T6INDIRECT 34352116 ↗ — Primary-level worker interventions for the care of people living with mental disorders and distress
- T6INDIRECT 34601272 ↗ — Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine
- T6INDIRECT 25879513 ↗ — Excessive Sugar Consumption May Be a Difficult Habit to Break: A View From the Brain and Body
- T6INDIRECT 34014691 ↗ — Applying methods for personalized medicine to the treatment of alcohol use disorder
- T2 19453963 ↗ — Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study
- T6INDIRECT 15834216 ↗ — Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent m
- T2 31736966 ↗ — Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natur
- T6 2683611 ↗ — Biology of natural killer cells
- T6INDIRECT 33687070 ↗ — Smoking cessation for improving mental health
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 31702122 ↗ — Autonomic dysfunction and sudden death in patients with Rett syndrome: a systematic review
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 39042627 ↗ — Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgi
- T6 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6 34067776 ↗ — Post-COVID-19 Syndrome and the Potential Benefits of Exercise
- T6 35172971 ↗ — Risks of mental health outcomes in people with covid-19: cohort study
- T6INDIRECT 28922704 ↗ — Direct-acting antivirals for chronic hepatitis C
- T6INDIRECT 23450540 ↗ — Methadone at tapered doses for the management of opioid withdrawal
- T6INDIRECT 20680369 ↗ — A systematic review on the effectiveness of pharmacological interventions for chronic non-specific l
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 18161012 ↗ — Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse
- T6INDIRECT 25827659 ↗ — A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and pos
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 36100326 ↗ — Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue s
- T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
- T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
- T6 36899952 ↗ — Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutic
- T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
- T6 33240091 ↗ — Challenges for Drug Repurposing in the COVID-19 Pandemic Era
- T5 31911410 ↗ — Low-dose naltrexone as a treatment for chronic fatigue syndrome
- T6INDIRECT 37445634 ↗ — Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology
- T6INDIRECT 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
- T6 29462012 ↗ — Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
- T6 29867317 ↗ — Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
- T6 37069462 ↗ — Microglia polarization in nociplastic pain: mechanisms and perspectives
- T6 30146050 ↗ — Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and
- T6 33062901 ↗ — Exercise-induced hypoalgesia after acute and regular exercise: experimental and clinical manifestati
- T6 30223011 ↗ — Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 24433463 ↗ — Review of pharmacological therapies in fibromyalgia syndrome
- T6 19345246 ↗ — Opioid receptors in the gastrointestinal tract
- T6 31387301 ↗ — Mechanisms of Botulinum Toxin Type A Action on Pain
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
T1 — RCT in LC/PASC/PACVS
Harm signalRegisteredLong COVIDPOTS
57 sources
- T1REGISTERED-ONLY NCT06366724 ↗ — LIFT: Life Improvement Trial
- T2REGISTERED-ONLY NCT03124355 ↗ — Vagal Stimulation in POTS
- T2 NCT03261570 ↗ — Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
- T2HARM NCT03674541 ↗ — The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chroni
- T6REGISTERED-ONLY NCT00409435 ↗ — A Study of Pyridostigmine in Postural Tachycardia Syndrome
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 39538129 ↗ — Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review
- T6INDIRECT 40426137 ↗ — Inspiratory muscle training and aerobic exercise for respiratory muscle strength in myasthenia gravi
- T6INDIRECT 33460984 ↗ — Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6 33595463 ↗ — COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19
- T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 15911704 ↗ — Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
- T6INDIRECT 22677718 ↗ — A randomised controlled study of the effect of cholinesterase inhibition on colon function in patien
- T6INDIRECT 23978222 ↗ — A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropath
- T2 18240245 ↗ — A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyal
- T2 29500811 ↗ — Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomi
- T6INDIRECT 19506222 ↗ — Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopa
- T6INDIRECT 26387781 ↗ — Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motilit
- T6INDIRECT 17016160 ↗ — Acetylcholinesterase inhibition in patients with orthostatic intolerance
- T6INDIRECT 23116538 ↗ — Treatment of multiple system atrophy using intravenous immunoglobulin
- T6HARM 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 34752479 ↗ — Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled
- T6INDIRECT 22591985 ↗ — Efficacy of treatments for orthostatic hypotension: a systematic review
- T6INDIRECT 31214762 ↗ — Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
- T2 16476804 ↗ — Pyridostigmine treatment trial in neurogenic orthostatic hypotension
- T2 20837887 ↗ — Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotensio
- T6INDIRECT 12933939 ↗ — Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypoten
- T6INDIRECT 33262898 ↗ — New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease 2019 Infection
- T6INDIRECT 33047223 ↗ — New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature
- T6INDIRECT 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
- T6INDIRECT 34216297 ↗ — COVID-19 and Myositis: What We Know So Far
- T6 33240091 ↗ — Challenges for Drug Repurposing in the COVID-19 Pandemic Era
- T6 36174571 ↗ — Bioelectronic medicine: Preclinical insights and clinical advances
- T6 38534355 ↗ — Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
- T6 38887284 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
- T6 37028776 ↗ — Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: Role of α7 nicotinic
- T6 39444797 ↗ — Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long
- T6 34390682 ↗ — Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 26493934 ↗ — Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effe
- T6 28303218 ↗ — The modification of natural products for medical use
- T6 29717928 ↗ — Impact of the Autonomic Nervous System on the Skeleton
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 29359025 ↗ — Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
- T6 21962754 ↗ — Multiple system atrophy: a clinical and neuropathological perspective
- T6 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6 20103559 ↗ — Cardiac autonomic neuropathy in diabetes: a clinical perspective
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 23122672 ↗ — Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
Abdominal Compression Garments
T2
T2 — RCT in related condition
RegisteredPOTS
3 sources
- T2REGISTERED-ONLY NCT04881318 ↗ — Compression Garments in the Community With POTS
- T2 41338488 ↗ — Abdominal-only Compression Garments Reduce Orthostatic Tachycardia and Improve Symptoms in Patients
- T6 39685762 ↗ — Current Landscape of Compression Products for Treatment of Postural Orthostatic Tachycardia Syndrome
T2 — RCT in related condition
RegisteredPOTS
30 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 19406310 ↗ — A systematic review of the management of orthostatic hypotension after spinal cord injury
- T6INDIRECT 37930742 ↗ — Thermal stability and storage of human insulin
- T6INDIRECT 20552588 ↗ — Clinostatic hypertension and orthostatic hypotension
- T6INDIRECT 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 23616163 ↗ — Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study
- T2 25448247 ↗ — Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults wi
- T6INDIRECT 34657222 ↗ — Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 tr
- T6INDIRECT 32673517 ↗ — Splanchnic Venous Compression Enhances the Effects of ß-Blockade in the Treatment of Postural Tachyc
- T6INDIRECT 39294522 ↗ — Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled cr
- T2 41483109 ↗ — A Portable, Active Abdominal Compression Binder for Orthostatic Intolerance: Design and Evaluation i
- T6 23122672 ↗ — Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
- T6INDIRECT 27271310 ↗ — Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotensi
- T6INDIRECT 37045845 ↗ — A case study of percutaneous epidural stimulation to enable motor control in two men after spinal co
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 30001836 ↗ — Exercise and non-pharmacological treatment of POTS
- T6INDIRECT 34295184 ↗ — The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Intervent
- T6INDIRECT 29058089 ↗ — Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms
- T6INDIRECT 21664375 ↗ — Pharmacotherapy of autonomic failure
- T6INDIRECT 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6INDIRECT 28713844 ↗ — Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension
- T6 26595642 ↗ — Lewy body dementias
- T6 27495201 ↗ — Diagnostic Approach to Atypical Parkinsonian Syndromes
- T6 23472781 ↗ — Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hyp
- T6 24265239 ↗ — Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecho
- T6 32767032 ↗ — Current Management and Emerging Therapies in Multiple System Atrophy
- T6 38390594 ↗ — Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 18420158 ↗ — Management of neurogenic orthostatic hypotension: an update
T2 — RCT in related condition
POTS
27 sources
- T6INDIRECT 32773495 ↗ — Effectiveness of non-pharmacological interventions to treat orthostatic hypotension in elderly peopl
- T6INDIRECT 24659590 ↗ — Compression therapy in patients with orthostatic hypotension: a systematic review
- T2 17010806 ↗ — Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly
- T6INDIRECT 9430805 ↗ — Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension
- T6INDIRECT 27271310 ↗ — Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotensi
- T6INDIRECT 33478652 ↗ — Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostat
- T2 25448247 ↗ — Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults wi
- T2 15241645 ↗ — Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysf
- T6INDIRECT 16096819 ↗ — Effect of physical countermaneuvers on orthostatic hypotension in familial dysautonomia
- T6 10432334 ↗ — Pathophysiological basis of orthostatic hypotension in autonomic failure
- T6INDIRECT 36981522 ↗ — A Case Study of Successful Application of the Principles of ME/CFS Care to an Individual with Long C
- T6INDIRECT 26198889 ↗ — Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance
- T6INDIRECT 30001836 ↗ — Exercise and non-pharmacological treatment of POTS
- T6INDIRECT 29058089 ↗ — Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms
- T6INDIRECT 25323828 ↗ — Current treatments in familial dysautonomia
- T6INDIRECT 36074973 ↗ — Sinus Tachycardia: a Multidisciplinary Expert Focused Review
- T6INDIRECT 34321060 ↗ — Improving lung compliance by external compression of the chest wall
- T6 39827884 ↗ — Radiotherapy toxicities: mechanisms, management, and future directions
- T6 39130717 ↗ — Clinical Applications of Pressure-Volume Assessment in Congenital Heart Disease
- T6 25824068 ↗ — Drug therapies in older adults (part 2)
- T6 40843281 ↗ — Orthostatic hypotension in Parkinson's disease: therapeutic considerations
- T6 37303338 ↗ — Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review
- T6 35591450 ↗ — Assessment of Abdominal Constrictor's Forces for Informing Computational Models of Orthostatic Hypot
- T6 20439562 ↗ — Preventing and treating orthostatic hypotension: As easy as A, B, C
- T6 26174784 ↗ — Orthostatic Hypotension: Mechanisms, Causes, Management
- T6 35212554 ↗ — Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem
- T6 25538626 ↗ — Syncope: epidemiology, etiology, and prognosis
T2 — RCT in related condition
RegisteredPOTS
31 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 37147116 ↗ — Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial h
- T6INDIRECT 33224097 ↗ — Cyclic Vomiting Syndrome in Children
- T6INDIRECT 34671311 ↗ — Visual Snow Syndrome as a Network Disorder: A Systematic Review
- T6INDIRECT 30053970 ↗ — Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations
- T6INDIRECT 31832265 ↗ — Slow Orthostatic Tremor: Review of the Current Evidence
- T6INDIRECT 40299270 ↗ — Spinocerebellar ataxia 27B (SCA27B)-a systematic review and a case report of a Polish family
- T6INDIRECT 39756820 ↗ — Right ventricular strain impairment due to hypoxia in patients with COPD: a post hoc analysis of two
- T6 32792490 ↗ — Podocytopathies
- T6 37230968 ↗ — Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
- T6 30177711 ↗ — Carboxysome encapsulation of the CO<sub>2</sub>-fixing enzyme Rubisco in tobacco chloroplasts
- T6 31695035 ↗ — A combination of chitooligosaccharide and lipochitooligosaccharide recognition promotes arbuscular m
- T6 26846157 ↗ — The NIH Undiagnosed Diseases Program and Network: Applications to modern medicine
- T6INDIRECT 31794067 ↗ — Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in pe
- T6INDIRECT 36827524 ↗ — Systemic pharmacological interventions for Ménière's disease
- T6INDIRECT 35897016 ↗ — Neurological vertigo in the emergency room in pediatric and adult age: systematic literature review
- T6INDIRECT 29440005 ↗ — Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diu
- T6INDIRECT 31841279 ↗ — Central blood pressure for the management of hypertension: Is it a practical clinical tool in curren
- T6INDIRECT 10219753 ↗ — Neurotrophic factors in peripheral neuropathies: therapeutic implications
- T6INDIRECT 30961531 ↗ — Primary headaches during lifespan
- T6INDIRECT 24381726 ↗ — Glaucoma management: relative value and place in therapy of available drug treatments
- T6INDIRECT 26132530 ↗ — Primary and secondary ataxias
- T6INDIRECT 28031858 ↗ — Medical treatment of dystonia
- T6INDIRECT 32443735 ↗ — Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias
- T6INDIRECT 36787124 ↗ — Cardiorenal Syndrome in the Hospital
- T6INDIRECT 19730409 ↗ — Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-in
- T6 20978471 ↗ — The relationship between blood pressure and cognitive function
- T6 31141884 ↗ — Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Fo
- T6 36152050 ↗ — The inherited cerebellar ataxias: an update
- T6 27403447 ↗ — Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
Acoustic vagal nerve stimulation treatment
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT05212129 ↗ — Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
T2 — RCT in related condition
POTS
32 sources
- T2 NCT05404672 ↗ — Breathing Exercises With And Without Aerobic Training In Patients With Postural Orthostatic Tachycar
- T6INDIRECT 37725376 ↗ — Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19
- T6INDIRECT 31651868 ↗ — Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndro
- T6INDIRECT 34579012 ↗ — Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related C
- T6INDIRECT 36032234 ↗ — Post-COVID-19 fatigue: A systematic review
- T6INDIRECT 31076938 ↗ — Physical activity and dietary interventions in diabetic neuropathy: a systematic review
- T6INDIRECT 35893864 ↗ — The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musc
- T6INDIRECT 23531226 ↗ — Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial
- T6INDIRECT 33652910 ↗ — The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metaboli
- T6INDIRECT 32198423 ↗ — Effects of exergames on heart rate variability of women with fibromyalgia: A randomized controlled t
- T6INDIRECT 37717560 ↗ — Impact of 14 Days of Bed Rest in Older Adults and an Exercise Countermeasure on Body Composition, Mu
- T6 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6 30018614 ↗ — Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 24018704 ↗ — Physiotherapy versus placebo or no intervention in Parkinson's disease
- T6INDIRECT 24748784 ↗ — Physical activity and cognitive function in individuals over 60 years of age: a systematic review
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 25229735 ↗ — A randomized trial of functional electrical stimulation for walking in incomplete spinal cord injury
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 35679471 ↗ — Human temperature regulation under heat stress in health, disease, and injury
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 26715466 ↗ — The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease
- T6INDIRECT 25274845 ↗ — Cerebrovascular regulation, exercise, and mild traumatic brain injury
- T6 29785098 ↗ — Sarcopenia: assessment of disease burden and strategies to improve outcomes
- T6 27366343 ↗ — Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 25514304 ↗ — The diagnosis and management of mild cognitive impairment: a clinical review
- T6 21115758 ↗ — Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Asso
- T6 34409961 ↗ — International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
T2 — RCT in related condition
POTS
33 sources
- T2 NCT03919773 ↗ — IVIG (Gamunex-C) Treatment Study for POTS Subjects
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 23013600 ↗ — Associations of kidney disease measures with mortality and end-stage renal disease in individuals wi
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 25233067 ↗ — Systematic review of potential health risks posed by pharmaceutical, occupational and consumer expos
- T6INDIRECT 34017846 ↗ — Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic
- T6INDIRECT 32855289 ↗ — Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six month
- T6INDIRECT 28893208 ↗ — Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients
- T6 6326753 ↗ — Oxygen toxicity, oxygen radicals, transition metals and disease
- T6 28585944 ↗ — Cellular uptake of nanoparticles: journey inside the cell
- T6INDIRECT 26551272 ↗ — A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- T6INDIRECT 20228401 ↗ — Effects of intensive blood-pressure control in type 2 diabetes mellitus
- T6INDIRECT 27195814 ↗ — Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75
- T6INDIRECT 32409561 ↗ — Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, ra
- T6INDIRECT 20566676 ↗ — Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and e
- T6INDIRECT 24067431 ↗ — Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflo
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 23464594 ↗ — Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
- T6INDIRECT 28642330 ↗ — Effects of Intensive BP Control in CKD
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 36148880 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes As
- T6 21092187 ↗ — Fabry disease
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
T2 — RCT in related condition
WithdrawnPOTS
1 source
- T2WITHDRAWN NCT03365414 ↗ — A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe
T2 — RCT in related condition
POTS
28 sources
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 30480768 ↗ — First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive dr
- T6INDIRECT 31167038 ↗ — Pharmacotherapy for hypertension in adults 60 years or older
- T2 21236483 ↗ — Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy fo
- T6INDIRECT 27113485 ↗ — Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
- T2 23999456 ↗ — Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized
- T2 19527323 ↗ — Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hy
- T2 17118124 ↗ — Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacod
- T6 23552514 ↗ — Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of mo
- T6INDIRECT 32103487 ↗ — Pharmacological interventions for heart failure in people with chronic kidney disease
- T6INDIRECT 25565857 ↗ — Safety and effectiveness of a fixed-dose combination of olmesartan, amlodipine, and hydrochlorothiaz
- T6INDIRECT 24093037 ↗ — Reducing pill burden and helping with medication awareness to improve adherence
- T6INDIRECT 32925078 ↗ — COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
- T6INDIRECT 32880078 ↗ — Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to
- T6INDIRECT 33086572 ↗ — Age-Related Diseases and Driving Safety
- T6INDIRECT 34094953 ↗ — The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
- T6 34948113 ↗ — Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
- T6 33708784 ↗ — Therapeutic Insights in Chronic Kidney Disease Progression
- T6 26569322 ↗ — Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences
- T6 37022667 ↗ — Sparsentan: First Approval
- T6 34327491 ↗ — Ten things to know about ten cardiovascular disease risk factors
- T6 28056987 ↗ — Blood pressure control in type 2 diabetic patients
- T6 30425103 ↗ — Clinical Pharmacology of Antihypertensive Therapy for the Treatment of Hypertension in CKD
- T6 35517870 ↗ — Ten things to know about ten cardiovascular disease risk factors - 2022
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 31388453 ↗ — 2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis
T2 — RCT in related condition
WithdrawnPOTS
1 source
- T2WITHDRAWN NCT02341300 ↗ — Use of Cast Iron Pots to Improve Maternal Anemia
T2 — RCT in related condition
POTS
20 sources
- T2 34657222 ↗ — Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 tr
- T6INDIRECT 39294522 ↗ — Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled cr
- T6INDIRECT 41134458 ↗ — Establishing minimally clinically important differences for the orthostatic hypotension questionnair
- T6 32741777 ↗ — Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020
- T6 31733702 ↗ — Orthostatic Hypotension in Parkinson Disease
- T6 36467081 ↗ — Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as
- T6INDIRECT 31996627 ↗ — Management of Orthostatic Hypotension
- T6 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
- T6 PMC10056828 ↗ — Interventions for orthostatic hypotension in Parkinson's disease: a systematic review and network me
- T6INDIRECT 32767032 ↗ — Current Management and Emerging Therapies in Multiple System Atrophy
- T6INDIRECT 32316335 ↗ — Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
- T6INDIRECT 36376534 ↗ — Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies
- T6INDIRECT 32906173 ↗ — Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfall
- T6INDIRECT 38766862 ↗ — Norepinephrine Reuptake Inhibition, an Emergent Treatment for Neurogenic Orthostatic Hypotension
- T6INDIRECT 39027973 ↗ — Treating Lows: Management of Orthostatic Hypotension
- T4 37303338 ↗ — Ampreloxetine Versus Droxidopa in Neurogenic Orthostatic Hypotension: A Comparative Review
- T6 39120318 ↗ — The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy
- T6 34564798 ↗ — 32nd International Symposium on the Autonomic Nervous System
- T6 35293295 ↗ — Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinso
- T6 35614479 ↗ — The role of basket trials in drug development for neurodegenerative disorders
T2 — RCT in related condition
POTS
29 sources
- T2 NCT00962949 ↗ — The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 34509649 ↗ — Post-COVID syndrome. A case series and comprehensive review
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 39774607 ↗ — Mucosal immune response in biology, disease prevention and treatment
- T2 23266540 ↗ — Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic f
- T6INDIRECT 26607249 ↗ — Effects of sodium nitrite supplementation on vascular function and related small metabolite signatur
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6 34248921 ↗ — Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Con
- T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 28816346 ↗ — Homocysteine-lowering interventions for preventing cardiovascular events
- T6INDIRECT 34352984 ↗ — 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
- T6INDIRECT 27195814 ↗ — Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75
- T6INDIRECT 29499873 ↗ — Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihype
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T6INDIRECT 21993710 ↗ — Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy
- T6INDIRECT 17923654 ↗ — Effect of perindopril on physical function in elderly people with functional impairment: a randomize
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 29565029 ↗ — Hypertension
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Aquatic Occupational Therapy
T2
T2 — RCT in related condition
POTS
1 source
Assessment of splanchnic capacitance
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT02725060 ↗ — Autoimmune Basis for Postural Tachycardia Syndrome
T2 — RCT in related condition
WithdrawnPOTS
32 sources
- T2WITHDRAWN NCT03070730 ↗ — Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And
- T6INDIRECT 34307254 ↗ — Hypertension in Children and Adolescents: A Position Statement From a Panel of Multidisciplinary Exp
- T6INDIRECT 31788462 ↗ — Efficacy of β-Blockers on Postural Tachycardia Syndrome in Children and Adolescents: A Systematic Re
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 25267802 ↗ — Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension
- T6INDIRECT 8098220 ↗ — Beta adrenoreceptor subtype cross regulation in the human heart
- T6INDIRECT 34414903 ↗ — Comparative effectiveness of metoprolol, ivabradine, and its combination in the management of inappr
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 7437237 ↗ — Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertensi
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
- T6HARM 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6INDIRECT 19821318 ↗ — Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitiv
- T6INDIRECT 24158454 ↗ — Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data a
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 34739197 ↗ — Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- T6INDIRECT 11435337 ↗ — Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope:
- T2 11216978 ↗ — Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic
- T2 7484777 ↗ — Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained sync
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 31954495 ↗ — Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- T6INDIRECT 24636754 ↗ — Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T2 — RCT in related condition
RegisteredPOTS
34 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 32151742 ↗ — Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in you
- T6INDIRECT 34000076 ↗ — Fludrocortisone for orthostatic hypotension
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 31853557 ↗ — Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide
- T2 34919634 ↗ — A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
- T6INDIRECT 24002370 ↗ — Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome
- T2 31856425 ↗ — Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension
- T2 22803597 ↗ — Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers
- T2 39294522 ↗ — Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled cr
- T6INDIRECT 21484416 ↗ — Still Struggling: characteristics of youth with OCD who are partial responders to medication treatme
- T6 37230968 ↗ — Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
- T6 31333129 ↗ — Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 22071859 ↗ — Antidepressants for pain management in rheumatoid arthritis
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T2 20679638 ↗ — Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- T2 25185131 ↗ — Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic f
- T6INDIRECT 22311903 ↗ — Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in au
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 35841911 ↗ — Diagnosis and treatment of orthostatic hypotension
- T6INDIRECT 31031694 ↗ — Autonomic Dysfunction in α-Synucleinopathies
- T6INDIRECT 21445724 ↗ — European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological
- T6 28837986 ↗ — Sleep Disturbance, Cognitive Decline, and Dementia: A Review
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 21956442 ↗ — Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa
- T6 16554257 ↗ — Contemporary assessment and pharmacotherapy of Tourette syndrome
- T6 29523389 ↗ — Postural tachycardia syndrome - Diagnosis, physiology, and prognosis
- T6 23753844 ↗ — Postural tachycardia syndrome (POTS)
- T6 22519513 ↗ — The solute carrier 6 family of transporters
Atomoxetine & Propranolol
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
Autonomic Function Testing
T2
T2 — RCT in related condition
RegisteredPOTS
31 sources
- T2 NCT00580619 ↗ — Autonomic Nervous System and Chronic Fatigue Syndrome
- T6REGISTERED-ONLY NCT01783288 ↗ — Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening
- T6INDIRECT 32801135 ↗ — Epidermal Neurite Density in Skin Biopsies From Patients With Juvenile Fibromyalgia
- T2 31447757 ↗ — Autonomic Dysfunction in Preeclampsia: A Systematic Review
- T2 23266540 ↗ — Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic f
- T6INDIRECT 23616163 ↗ — Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study
- T6INDIRECT 31802596 ↗ — Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying
- T6INDIRECT 8988490 ↗ — Postural tachycardia syndrome: time frequency mapping
- T5 33860871 ↗ — Autonomic dysfunction following COVID-19 infection: an early experience
- T6 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6 21279414 ↗ — Low frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic
- T6 28655059 ↗ — Association of Autonomic Dysfunction With Disease Progression and Survival in Parkinson Disease
- T6 31152011 ↗ — Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy
- T2 22311903 ↗ — Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in au
- T2 26644241 ↗ — Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure
- T2 9727818 ↗ — Contrasting actions of pressor agents in severe autonomic failure
- T2 15548493 ↗ — The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 28093795 ↗ — Natural history of pure autonomic failure: A United States prospective cohort
- T4 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 35841911 ↗ — Diagnosis and treatment of orthostatic hypotension
- T6INDIRECT 36071155 ↗ — Long Covid: where we stand and challenges ahead
- T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
- T6INDIRECT 33316414 ↗ — The possible association between COVID-19 and postural tachycardia syndrome
- T6 28984582 ↗ — Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1
- T6 29523389 ↗ — Postural tachycardia syndrome - Diagnosis, physiology, and prognosis
- T6 29111419 ↗ — Diagnosis of multiple system atrophy
- T6 18194747 ↗ — The spectrum of diabetic neuropathies
- T6 37494945 ↗ — The 2023 wearable photoplethysmography roadmap
- T6 26306801 ↗ — Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA dupl
T2 — RCT in related condition
RegisteredPOTS
5 sources
- T2REGISTERED-ONLY NCT05633693 ↗ — Postural Sway and Counterpressure Maneuvers for Pediatric Syncope
- T6 29988521 ↗ — Comparison of Autonomic Control of Blood Pressure During Standing and Artificial Gravity Induced via
- T6 36873416 ↗ — Exaggerated postural sway improves orthostatic cardiovascular and cerebrovascular control
- T6 37227184 ↗ — Anticipatory central command on standing decreases cerebral blood velocity causing hypocapnia in hyp
- T6 36205820 ↗ — 33RD International Symposium on the Autonomic Nervous System
Best clinical practice
T2
T2 — RCT in related condition
RegisteredPOTS
20 sources
- T2REGISTERED-ONLY NCT06936319 ↗ — Counterpressure Maneuvers in Postural Orthostatic Tachycardia Syndrome
- T6INDIRECT 25233067 ↗ — Systematic review of potential health risks posed by pharmaceutical, occupational and consumer expos
- T6 28821991 ↗ — Transcranial Doppler in autonomic testing: standards and clinical applications
- T6 35676796 ↗ — Prognostic value of 24-hour ambulatory blood pressure patterns in diabetes: A 21-year longitudinal s
- T6 40697073 ↗ — Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteri
- T6 37072581 ↗ — Assessment of the psychometric properties of the Italian version of the New Freezing of Gait Questio
- T6INDIRECT 36971690 ↗ — Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- T2 40526204 ↗ — Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Ben
- T2 37658155 ↗ — Practical use of apomorphine infusion in Parkinson's disease: lessons from the TOLEDO study and clin
- T6 19436724 ↗ — Incidence and prediction of falls in dementia: a prospective study in older people
- T6 35963508 ↗ — American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Me
- T6 36787983 ↗ — Glomerular Hyperfiltration Predicts Kidney Function Decline and Mortality in Type 1 and Type 2 Diabe
- T6INDIRECT 21536160 ↗ — New wine in old bottle: late-life psychosis
- T6INDIRECT 31526331 ↗ — American Academy of Spinal Cord Injury Professionals ASCIP 2019 Educational Conference & Expo Septem
- T6INDIRECT 34585268 ↗ — The false myth of "iodine allergy" also in nuclear medicine
- T6INDIRECT 32218879 ↗ — Abstracts of the 14th International Congress of the European Geriatric Medicine Society: 10-12 Octob
- T4 PMC4212304 ↗ — UEG Week 2014 Oral Presentations
- T6 41969957 ↗ — Therapeutic Spectrum of Intermittent Apomorphine in Parkinson's Disease: Neuropsychiatric, Behaviora
- T6 39847311 ↗ — Pathophysiology, symptoms, outcomes, and evaluation of hyponatremia: comprehension and best clinical
- T6 34595836 ↗ — Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective
Best clinical practice plus CPM-biofeedback training
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT06936319 ↗ — Counterpressure Maneuvers in Postural Orthostatic Tachycardia Syndrome
T2 — RCT in related condition
POTS
36 sources
- T2 NCT02171988 ↗ — Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
- T6INDIRECT 27388039 ↗ — Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy
- T6INDIRECT 36525900 ↗ — Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 41225175 ↗ — Systematic literature review: treatment of postural orthostatic tachycardia syndrome (POTS)
- T6INDIRECT 24650926 ↗ — A randomized pilot study of aortic waveform guided therapy in chronic heart failure
- T2 29500811 ↗ — Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomi
- T6INDIRECT 8098220 ↗ — Beta adrenoreceptor subtype cross regulation in the human heart
- T6INDIRECT 39987007 ↗ — Exercise rehabilitation for people with postural tachycardia syndrome at two secondary care centres
- T2 11198485 ↗ — Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fl
- T6 28428055 ↗ — Sex differences in cardiovascular disease - Impact on care and outcomes
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 29059199 ↗ — Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-anal
- T6INDIRECT 23796325 ↗ — Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using pl
- T6INDIRECT 31167038 ↗ — Pharmacotherapy for hypertension in adults 60 years or older
- T6INDIRECT 23730991 ↗ — Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years
- T6INDIRECT 28655357 ↗ — Drug-related problems and medication reviews among old people with dementia
- T6INDIRECT 17786067 ↗ — A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safet
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 38441582 ↗ — Cardiac Amyloidosis Due to Transthyretin Protein: A Review
- T6INDIRECT 35830976 ↗ — Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditi
- T6INDIRECT 28261151 ↗ — The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice
- T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 11129673 ↗ — Chagas' heart disease
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
Bisoprolol+pyridostgmine
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT02171988 ↗ — Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
Blood Pressure Self-Monitoring
T2
T2 — RCT in related condition
POTS
15 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 33769555 ↗ — Mobile phone-based interventions for improving adherence to medication prescribed for the primary pr
- T2 29499873 ↗ — Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihype
- T2 28193176 ↗ — Telemonitoring and/or self-monitoring of blood pressure in hypertension (TASMINH4): protocol for a r
- T6 22187469 ↗ — Standards of medical care in diabetes--2012
- T6 23264422 ↗ — Standards of medical care in diabetes--2013
- T6 20042772 ↗ — Standards of medical care in diabetes--2010
- T6 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 30249203 ↗ — Rationale and design of a pragmatic clinical trial to assess the impact of self-monitoring blood pre
- T4 30023362 ↗ — Blood pressure targets for hypertension in patients with type 2 diabetes
- T6 36507632 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 39651970 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025
- T6 34327491 ↗ — Ten things to know about ten cardiovascular disease risk factors
Blood Sample Collection
T2
T2 — RCT in related condition
RegisteredPOTS
27 sources
- T2REGISTERED-ONLY NCT07405515 ↗ — Pathophysiology of Dysautonomia and Postural Tachycardia Syndrome (POTS) in Post-viral Syndromes and
- T6INDIRECT 25689743 ↗ — Effects of two dietary fibers as part of ready-to-eat cereal (RTEC) breakfasts on perceived appetite
- T6INDIRECT 23271912 ↗ — Microencapsulated conjugated linoleic acid associated with hypocaloric diet reduces body fat in sede
- T6INDIRECT 33176826 ↗ — Assessing the impact of a mushroom-derived food ingredient on vitamin D levels in healthy volunteers
- T6INDIRECT 29370744 ↗ — Protocol for a cluster randomised controlled trial on information technology-enabled nutrition inter
- T6INDIRECT 39064619 ↗ — Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses: A Randomize
- T6 33188616 ↗ — Hereditary transthyretin amyloidosis overview
- T6 34425843 ↗ — Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accomp
- T6 35933347 ↗ — Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individua
- T6 10737392 ↗ — The United Kingdom Childhood Cancer Study: objectives, materials and methods. UK Childhood Cancer St
- T6 34996973 ↗ — Inappropriate sinus tachycardia in post-COVID-19 syndrome
- T6INDIRECT 35594017 ↗ — HLX11, a Proposed Pertuzumab Biosimilar: Pharmacokinetics, Immunogenicity, and Safety Profiles Compa
- T6INDIRECT 36558506 ↗ — Comparative Pharmacokinetic of Curcuminoids Formulations with an Omega-3 Fatty Acids Monoglyceride C
- T6INDIRECT 22848387 ↗ — Low serum urate levels are associated to female gender in multiple sclerosis patients
- T6INDIRECT 24134216 ↗ — Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or mode
- T6INDIRECT 37377258 ↗ — SBC Guideline on the Diagnosis and Treatment of Patients with Cardiomyopathy of Chagas Disease - 202
- T6INDIRECT 26911448 ↗ — COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evalu
- T6INDIRECT 32750291 ↗ — Serum Activity Against G Protein-Coupled Receptors and Severity of Orthostatic Symptoms in Postural
- T6INDIRECT 35251166 ↗ — Changes in Physiological Levels of Cortisol and Adrenocorticotropic Hormone upon Hospitalization Can
- T6INDIRECT 31401614 ↗ — Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract
- T6INDIRECT 35978253 ↗ — The effect of the BNT162b2 vaccine on antinuclear antibody and antiphospholipid antibody levels
- T6 30362018 ↗ — The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort description
- T6 34376193 ↗ — High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular d
- T6 35482424 ↗ — EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology
- T6 32414139 ↗ — Zinc Concentration Dynamics Indicate Neurological Impairment Odds after Traumatic Spinal Cord Injury
- T6 26561290 ↗ — Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders
- T6 34829952 ↗ — Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chr
T2 — RCT in related condition
POTS
21 sources
- T6INDIRECT 30701543 ↗ — Phosphodiesterase 5 inhibitors for pulmonary hypertension
- T6INDIRECT 15846646 ↗ — Prostacyclin for pulmonary hypertension in adults
- T6INDIRECT 31096477 ↗ — What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisen
- T6INDIRECT 16060962 ↗ — Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
- T6INDIRECT 34262260 ↗ — A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosp
- T2 40034063 ↗ — Early Administration of Bosentan in High-Risk COVID-19 Outpatients at Risk of Sarcopenia: A Randomiz
- T6INDIRECT 42023995 ↗ — Effect of Once-Daily Macitentan 75 mg on the Pharmacokinetics of Sildenafil, Riociguat, or Rosuvasta
- T6INDIRECT 28881378 ↗ — Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy Subjects
- T6 30218025 ↗ — Mechanisms, biomarkers and targets for adult-onset Still's disease
- T6 26711459 ↗ — Cerebrovascular disease in ageing and Alzheimer's disease
- T6INDIRECT 10219752 ↗ — Diabetic neuropathies: features and mechanisms
- T6INDIRECT 40159403 ↗ — Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart R
- T6INDIRECT 33230704 ↗ — Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell
- T6INDIRECT 35772032 ↗ — State-of-the-Art Treatments for Sarcoidosis
- T6INDIRECT 26836930 ↗ — Persistent Challenges in Pediatric Pulmonary Hypertension
- T6INDIRECT 26401246 ↗ — Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute
- T6 34948113 ↗ — Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 11094506 ↗ — Understanding gastrointestinal perfusion in critical care: so near, and yet so far
T2 — RCT in related condition
RegisteredPOTS
6 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 25792354 ↗ — Inspiratory resistance improves postural tachycardia: a randomized study
- T6 26198889 ↗ — Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance
- T6 32848835 ↗ — Venous and Arterial Responses to Partial Gravity
- T6 34062971 ↗ — Effects of Respiratory Muscle Training on Baroreflex Sensitivity, Respiratory Function, and Serum Ox
- T6 33755181 ↗ — Loss of putative GABAergic neurons in the ventrolateral medulla in multiple system atrophy
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT07019519 ↗ — POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patien
T2 — RCT in related condition
POTS
30 sources
- T6INDIRECT 19821318 ↗ — Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitiv
- T6INDIRECT 20537128 ↗ — Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine lon
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32909814 ↗ — Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension : A Systematic Review and I
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T6INDIRECT 2337713 ↗ — Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy
- T6INDIRECT 23266540 ↗ — Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic f
- T2 6986949 ↗ — Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subj
- T6INDIRECT 16060962 ↗ — Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 24090418 ↗ — Life-threatening outcomes associated with autonomic dysreflexia: a clinical review
- T6INDIRECT 28862947 ↗ — Role of Volume Redistribution in the Congestion of Heart Failure
- T6INDIRECT 23594434 ↗ — A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival
- T6INDIRECT 36787743 ↗ — Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic
- T6INDIRECT 18514747 ↗ — Salt craving: the psychobiology of pathogenic sodium intake
- T6INDIRECT 9467687 ↗ — Depression in Parkinson's disease. Pharmacological characteristics and treatment
- T6 29565029 ↗ — Hypertension
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 32213941 ↗ — Chemical Constituents and Pharmacological Activities of Garlic (<i>Allium sativum</i> L.): A Review
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 25114297 ↗ — Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart
- T6 34589395 ↗ — Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic n
- T6 20978471 ↗ — The relationship between blood pressure and cognitive function
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 25621208 ↗ — Chronic complications of spinal cord injury
- T6 17308214 ↗ — Blood pressure and ageing
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
- T6 16365341 ↗ — JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical pract
T2 — RCT in related condition
POTS
34 sources
- T2 NCT00685919 ↗ — Peripheral Dopamine in Postural Tachycardia Syndrome
- T6INDIRECT 30979821 ↗ — Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studi
- T6INDIRECT 33674954 ↗ — Overall Efficacy and Safety of Safinamide in Parkinson's Disease: A Systematic Review and a Meta-ana
- T6INDIRECT 34472659 ↗ — Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated cl
- T6INDIRECT 38054428 ↗ — A systematic practice review: Providing palliative care for people with Parkinson's disease and thei
- T6INDIRECT 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 28494751 ↗ — Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
- T2 23553478 ↗ — Hyperdopaminergic crises in familial dysautonomia: a randomized trial of carbidopa
- T6INDIRECT 32986682 ↗ — The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility
- T2 32654554 ↗ — Carbidopa for Afferent Baroreflex Failure in Familial Dysautonomia: A Double-Blind Randomized Crosso
- T6INDIRECT 38701159 ↗ — Effects of Blood Flow Restriction Resistance Training on Autonomic and Endothelial Function in Perso
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6HARM 28273839 ↗ — Parkinson's Disease: From Pathogenesis to Pharmacogenomics
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T2 24361112 ↗ — Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Par
- T6INDIRECT 15548480 ↗ — Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
- T6INDIRECT 9343116 ↗ — Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levo
- T6INDIRECT 8558148 ↗ — Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients wit
- T6INDIRECT 8527287 ↗ — Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose lev
- T6INDIRECT 12388617 ↗ — Dopamine modulates the response of the human amygdala: a study in Parkinson's disease
- T6INDIRECT 12885750 ↗ — Norepinephrine precursor therapy in neurogenic orthostatic hypotension
- T6INDIRECT 32402162 ↗ — Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease
- T6INDIRECT 26350119 ↗ — Autosomal dominant Parkinson's disease caused by SNCA duplications
- T6INDIRECT 2545827 ↗ — Diffuse Lewy body disease: clinical features in 15 cases
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 23225012 ↗ — Parkinson's disease
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 28100251 ↗ — Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) de
- T6INDIRECT 19933976 ↗ — Medical records documentation of constipation preceding Parkinson disease: A case-control study
- T6 28887905 ↗ — Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Sh
- T6 29090092 ↗ — Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential trea
- T6 26324905 ↗ — Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
- T6 31196984 ↗ — Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
T2 — RCT in related condition
POTS
29 sources
- T2 35716859 ↗ — Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysis
- T2 39067734 ↗ — Cardioneuroablation in patients with vasovagal syncope: An updated systematic review and meta-analys
- T6INDIRECT 38890128 ↗ — Therapeutic options for neurocardiogenic syncope: a meta-analysis of randomised trials with and with
- T2 36114133 ↗ — Cardioneuroablation for Reflex Syncope: Efficacy and Effects on Autonomic Cardiac Regulation-A Prosp
- T2 40117421 ↗ — The Efficacy of Left Atrial vs Biatrial Cardioneuroablation in Patients With Vasovagal Syncope: A Ra
- T6INDIRECT 41914517 ↗ — Catheter Ablation for Frequent Premature Ventricular Contractions or Paroxysmal Supraventricular Tac
- T6INDIRECT 33999698 ↗ — Durable Physiological Changes and Decreased Syncope Burden 12 Months After Unifocal Right-Sided Abla
- T3 30054828 ↗ — Electroanatomic-mapping-guided cardioneuroablation versus combined approach for vasovagal syncope: a
- T6 21712276 ↗ — Catheter ablation of severe neurally meditated reflex (neurocardiogenic or vasovagal) syncope: cardi
- T6 31330187 ↗ — Right anterior ganglionated plexus: The primary target of cardioneuroablation?
- T5 28491512 ↗ — Functional permanent 2:1 atrioventricular block treated with cardioneuroablation: Case report
- T5 35860784 ↗ — Recurrent vasovagal syncope following successful cardioneuroablation
- T4 39082698 ↗ — Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientifi
- T6INDIRECT 40056025 ↗ — Clinical neurocardiology: defining the value of neuroscience-based cardiovascular therapeutics - 202
- T4 30906551 ↗ — Potential usage of cardioneuroablation in vagally mediated functional atrioventricular block
- T6INDIRECT 37124975 ↗ — Arrhythmic syncope: From diagnosis to management
- T6INDIRECT 36845167 ↗ — Ganglionic Plexus Ablation: A Step-by-step Guide for Electrophysiologists and Review of Modalities f
- T4 37361615 ↗ — Cardioneuroablation: Where are we at?
- T6 37367403 ↗ — Cardioneuroablation Using Epicardial Pulsed Field Ablation for the Treatment of Atrial Fibrillation
- T6 36836740 ↗ — Intrinsic Cardiac Neuromodulation in the Management of Atrial Fibrillation- A Potential Missing Link
- T6 39000068 ↗ — The Brain-Heart Network of Syncope
- T6 37562487 ↗ — Ischemia-induced ventricular proarrhythmia and cardiovascular autonomic dysreflexia after cardioneur
- T6 35924289 ↗ — Procedural Characteristics, Safety, and Follow-up of Modified Right-Sided Approach for Cardioneuroab
- T6 33886735 ↗ — Dysautonomia: A Forgotten Condition - Part 1
- T6 36699671 ↗ — An assessment of heart rate and blood pressure asymmetry in the diagnosis of vasovagal syncope in fe
- T6 32036025 ↗ — Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials-Precise patie
- T6 37021351 ↗ — Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope
- T6 32034611 ↗ — Medium-term results of cardioneuroablation for clinical bradyarrhythmias and vasovagal syncope: effe
- T6 37622579 ↗ — Twenty-five years of research on syncope
T2 — RCT in related condition
WithdrawnPOTS
6 sources
- T2WITHDRAWN NCT02341300 ↗ — Use of Cast Iron Pots to Improve Maternal Anemia
- T6 34684539 ↗ — Plant-Based Dietary Practices and Socioeconomic Factors That Influence Anemia in India
- T6 34007348 ↗ — Managing Genetic Hemochromatosis: An Overview of Dietary Measures, Which May Reduce Intestinal Iron
- T6 6066580 ↗ — On a turf (peat) fire cancer: malignant change superimposed on erythema ab igne
- T6 33171944 ↗ — Micronutrient Status and Dietary Diversity of Women of Reproductive Age in Rural Pakistan
- T6 26509730 ↗ — Traditional Glue, Adhesive and Poison Used for Composite Weapons by Ju/'hoan San in Nyae Nyae, Namib
Conventional Treatment
T2
T2 — RCT in related condition
POTS
32 sources
- T2 NCT05404672 ↗ — Breathing Exercises With And Without Aerobic Training In Patients With Postural Orthostatic Tachycar
- T6INDIRECT 24895945 ↗ — Thermal insulation for preventing inadvertent perioperative hypothermia
- T6INDIRECT 34207492 ↗ — Impact of Portion Control Tools on Portion Size Awareness, Choice and Intake: Systematic Review and
- T6INDIRECT 38900335 ↗ — Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of
- T6INDIRECT 39348282 ↗ — Efficacy of Probiotics Compared With Pharmacological Treatments for Maintenance Therapy for Function
- T6INDIRECT 21745374 ↗ — Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated
- T6INDIRECT 23978222 ↗ — A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropath
- T6INDIRECT 35388029 ↗ — Effect of psychotherapy on recurrence of events and quality of life in patients with vasovagal synco
- T6INDIRECT 6801211 ↗ — Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophy
- T6 18085482 ↗ — Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide
- T6 21221114 ↗ — ATP7A-related copper transport diseases-emerging concepts and future trends
- T6 29622808 ↗ — Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal mo
- T6 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 33091160 ↗ — Electromechanical-assisted training for walking after stroke
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 15846598 ↗ — Electroconvulsive therapy for schizophrenia
- T6INDIRECT 34018146 ↗ — The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Pa
- T6INDIRECT 9562345 ↗ — The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Dia
- T6INDIRECT 17045903 ↗ — Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Co
- T6INDIRECT 34455813 ↗ — SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hyperte
- T6INDIRECT 19470886 ↗ — Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 di
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 23008748 ↗ — The therapeutic potential of cannabis and cannabinoids
- T6INDIRECT 29387043 ↗ — Strategies to Combat Antibiotic Resistance in the Wastewater Treatment Plants
- T6INDIRECT 35483386 ↗ — CDKL5 deficiency disorder: clinical features, diagnosis, and management
- T6 21092187 ↗ — Fabry disease
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 25114297 ↗ — Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart
- T6 30786722 ↗ — Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
Cosyntropin administration
T2
T2 — RCT in related condition
POTS
11 sources
- T2 NCT01764711 ↗ — Adrenocorticotropic Hormone Stimulation in Postural Orthostatic Tachycardia Syndrome (POTS)
- T6 27739587 ↗ — 2016 Annual Meetings
- T6 27114361 ↗ — Abstracts from the 2016 Society of General Internal Medicine Annual Meeting
- T6 31090026 ↗ — Abstracts from the 2019 Annual Meeting of the Society of General Internal Medicine
- T6 PMC7138092 ↗ — Research Abstract Program of the 2010 ACVIM Forum
- T6 PMC11231130 ↗ — Abstracts from the 2024 Annual Meeting of the Society of General Internal Medicine
- T6 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6 23840983 ↗ — A reversible cause of skin hyperpigmentation and postural hypotension
- T6INDIRECT 37770163 ↗ — Challenges and controversies in adrenal surgery: A practical approach
- T6 PMC2219573 ↗ — Abtracts from the 30th Annual Meeting of the Society of General Internal Medicine
- T6 42181213 ↗ — The cortisol stress response following surgery for proximal femur fractures in geriatric patients -
Counterpressure Maneuvers
T2
T2 — RCT in related condition
RegisteredPOTS
23 sources
- T2REGISTERED-ONLY NCT05633693 ↗ — Postural Sway and Counterpressure Maneuvers for Pediatric Syncope
- T2REGISTERED-ONLY NCT05555771 ↗ — Paediatric Syncope in the Emergency Department
- T6INDIRECT 32151742 ↗ — Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in you
- T6INDIRECT 36195683 ↗ — Effects of short-term hypercaloric nutrition on orthostatic tolerance in healthy individuals: a rand
- T6 35212554 ↗ — Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem
- T6 23472781 ↗ — Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hyp
- T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
- T6 27637670 ↗ — Initial orthostatic hypotension in teenagers and young adults
- T6INDIRECT 37226313 ↗ — Association between vitamin D deficiency and vasovagal syncope: A systematic review and meta-analysi
- T2 17045903 ↗ — Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Co
- T6INDIRECT 29381726 ↗ — A single-center randomized controlled trial observing the safety and efficacy of modified step-up gr
- T6 35963508 ↗ — American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Me
- T6 34386109 ↗ — JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias
- T6INDIRECT 35462637 ↗ — COVID-19 and Cardiac Arrhythmias: a Contemporary Review
- T6INDIRECT 33792518 ↗ — Dyspnea in Chronic Low Ventricular Preload States
- T6INDIRECT 41089328 ↗ — Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and
- T6INDIRECT 37167358 ↗ — A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2
- T6INDIRECT 37654428 ↗ — Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2
- T6 38827268 ↗ — Cardioneuroablation for Drug Refractory Vasovagal Syncope After COVID-19 Infection
- T6 36675975 ↗ — Transcutaneous Spinal Cord Stimulation Attenuates Blood Pressure Drops in Orthostasis
- T6 32637542 ↗ — Video education to improve clinical skills in the prevention of and response to vasovagal syncopal e
- T6 31456212 ↗ — Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer
T2 — RCT in related condition
RegisteredME/CFSMCASPOTS
70 sources
- T2 NCT02444091 ↗ — Cyclophosphamide in Myalgic Encephalopathy/ Chronic Fatigue Syndrome (ME/CFS)
- T6 NCT01384513 ↗ — A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Mali
- T6REGISTERED-ONLY NCT03779854 ↗ — Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults
- T6INDIRECT 21491378 ↗ — Interventions for preventing oral mucositis for patients with cancer receiving treatment
- T6INDIRECT 20687070 ↗ — Interventions for treating oral mucositis for patients with cancer receiving treatment
- T6INDIRECT 36103991 ↗ — Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 d
- T6INDIRECT 36228963 ↗ — Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline patho
- T6INDIRECT 23599118 ↗ — Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical tr
- T6INDIRECT 15471655 ↗ — Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer
- T6INDIRECT 26844275 ↗ — Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: R
- T6 2683611 ↗ — Biology of natural killer cells
- T6 10515901 ↗ — Q fever
- T6 32762681 ↗ — Natural killer cells in cancer biology and therapy
- T6 19375665 ↗ — Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
- T6 9560217 ↗ — Bax directly induces release of cytochrome c from isolated mitochondria
- T6INDIRECT 20548096 ↗ — Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-
- T6INDIRECT 34904799 ↗ — Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
- T2 30901302 ↗ — Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristin
- T6INDIRECT 36542826 ↗ — Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the p
- T6INDIRECT 30184451 ↗ — Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
- T6INDIRECT 25046337 ↗ — Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who rema
- T6INDIRECT 30811293 ↗ — First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Ben
- T6INDIRECT 20431041 ↗ — Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and l
- T6INDIRECT 25154820 ↗ — Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effect
- T6INDIRECT 25842160 ↗ — Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a
- T6INDIRECT 34542573 ↗ — Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephaliti
- T6INDIRECT 26561338 ↗ — Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 29271481 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 30361325 ↗ — DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
- T6INDIRECT 32244252 ↗ — Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of A
- T6INDIRECT 1739631 ↗ — Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
- T6INDIRECT 8774401 ↗ — Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal auto
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 17655751 ↗ — Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis
- T6INDIRECT 24247168 ↗ — Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer
- T6INDIRECT 29523094 ↗ — Pediatric multiple sclerosis: a review
- T6INDIRECT 29186062 ↗ — Viral Oncology: Molecular Biology and Pathogenesis
- T6INDIRECT 23452057 ↗ — Characterization of different courses of atopic dermatitis in adolescent and adult patients
- T6 34630027 ↗ — Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy
- T6 22544865 ↗ — Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action,
- T6 25315420 ↗ — Autoimmune encephalopathies
- T6 29344421 ↗ — Anti-Aging Implications of <i>Astragalus Membranaceus</i> (Huangqi): A Well-Known Chinese Tonic
- T6INDIRECT 28242845 ↗ — Focal Segmental Glomerulosclerosis
- T6INDIRECT 33649022 ↗ — Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
- T6INDIRECT 32106302 ↗ — Overview of Castleman disease
- T6INDIRECT 28213891 ↗ — Opioids and the immune system - friend or foe
- T6INDIRECT 35215786 ↗ — <i>Herpes zoster</i>: A Review of Clinical Manifestations and Management
- T6INDIRECT 29915719 ↗ — Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy
- T6INDIRECT 27777266 ↗ — A Proposal for a Serology-Based Approach to Membranous Nephropathy
- T6 32433595 ↗ — Interaction between microbiota and immunity in health and disease
- T6 32934330 ↗ — Exploring the NK cell platform for cancer immunotherapy
- T6 37169756 ↗ — Angiogenic signaling pathways and anti-angiogenic therapy for cancer
- T6 19597008 ↗ — Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis
- T6 26228647 ↗ — Colchicine--Update on mechanisms of action and therapeutic uses
- T6 32376392 ↗ — Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventio
- T6 28550082 ↗ — Primary Membranous Nephropathy
- T6 33657296 ↗ — Diffuse Large B-Cell Lymphoma
- T6INDIRECT 30049614 ↗ — Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex ence
- T6INDIRECT 24462240 ↗ — Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a c
- T6INDIRECT 24703753 ↗ — A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder assoc
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 24423978 ↗ — Adrenocortical carcinoma
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 32792490 ↗ — Podocytopathies
- T6 34988090 ↗ — Treatment of Inflammatory Bowel Disease: A Comprehensive Review
- T6 24323045 ↗ — Autophagy and human diseases
Deep Brain Stimulation
T2
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 24018704 ↗ — Physiotherapy versus placebo or no intervention in Parkinson's disease
- T6INDIRECT 15846598 ↗ — Electroconvulsive therapy for schizophrenia
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 19205066 ↗ — Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 24361112 ↗ — Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Par
- T6INDIRECT 23128427 ↗ — Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease
- T6INDIRECT 20679638 ↗ — Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- T6INDIRECT 12023411 ↗ — Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, dou
- T2 17823535 ↗ — Motor and nonmotor symptom follow-up in parkinsonian patients after deep brain stimulation of the su
- T6INDIRECT 32402162 ↗ — Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 25496901 ↗ — Wilson's disease and other neurological copper disorders
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 23225012 ↗ — Parkinson's disease
- T6INDIRECT 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6INDIRECT 23359374 ↗ — Criteria for the diagnosis of corticobasal degeneration
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 28887905 ↗ — Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Sh
- T6 20060022 ↗ — The cholinergic system and Parkinson disease
- T6 27125836 ↗ — Technology in Parkinson's disease: Challenges and opportunities
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 28653647 ↗ — Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic app
Dexmedetomidine Sublingual
T2
T2 — RCT in related condition
POTS
3 sources
- T2 36630319 ↗ — Sublingual dexmedetomidine (BXCL501) reduces opioid withdrawal symptoms: findings from a multi-site,
- T2 36002761 ↗ — Sublingual Dexmedetomidine for Agitation Associated with Schizophrenia or Bipolar Disorder: A Post H
- T6 40654581 ↗ — Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024)
T2 — RCT in related condition
POTS
30 sources
- T2 NCT03261570 ↗ — Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 34883203 ↗ — Heart rate variability in relation to cognition and behavior in neurodegenerative diseases: A system
- T6INDIRECT 27388039 ↗ — Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy
- T6INDIRECT 31473866 ↗ — Characteristics and natural history of autonomic involvement in hereditary ATTR amyloidosis: a syste
- T6INDIRECT 35498768 ↗ — Pediatric Intestinal Pseudo-Obstruction: Progress and Challenges
- T6INDIRECT 32923331 ↗ — A Systematic Review of the Spectrum of Cardiac Arrhythmias in Sub-Saharan Africa
- T6INDIRECT 33125753 ↗ — Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR
- T6 21321035 ↗ — Health effects of energy drinks on children, adolescents, and young adults
- T6 28428055 ↗ — Sex differences in cardiovascular disease - Impact on care and outcomes
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 33624299 ↗ — Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 29916559 ↗ — Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review
- T2 16864724 ↗ — Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis in
- T6INDIRECT 8198938 ↗ — Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients wit
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 25408161 ↗ — Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from or
- T6INDIRECT 24090418 ↗ — Life-threatening outcomes associated with autonomic dysreflexia: a clinical review
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 21483018 ↗ — Amyloidosis: pathogenesis and new therapeutic options
- T6 30975301 ↗ — Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Ar
- T6 11751653 ↗ — Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
- T6 31196984 ↗ — Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
- T6 25514304 ↗ — The diagnosis and management of mild cognitive impairment: a clinical review
T2 — RCT in related condition
POTS
25 sources
- T6INDIRECT 24158454 ↗ — Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data a
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 31917972 ↗ — Towards chamber specific heart-on-a-chip for drug testing applications
- T6INDIRECT 31167038 ↗ — Pharmacotherapy for hypertension in adults 60 years or older
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 30962677 ↗ — Single- and multiple-dose tolerability, safety, pharmacokinetics, and pharmacodynamics of the dual e
- T2 25377242 ↗ — Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa i
- T6INDIRECT 10577041 ↗ — Botulinum toxin is a useful treatment in excessive drooling in saliva
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 25408161 ↗ — Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from or
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 9723817 ↗ — Grapefruit juice-drug interactions
- T6 23850704 ↗ — Phenotypic screens as a renewed approach for drug discovery
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 33895845 ↗ — 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral A
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
- T6 16365341 ↗ — JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical pract
T2 — RCT in related condition
POTS
28 sources
- T6INDIRECT 26561338 ↗ — Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 15548480 ↗ — Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
- T6INDIRECT 27956826 ↗ — Nonmotor gastrointestinal disorders in older patients with Parkinson's disease: is there hope?
- T6INDIRECT 9343116 ↗ — Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levo
- T2 17557339 ↗ — Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkin
- T6INDIRECT 28202786 ↗ — Dopamine Modulates Adaptive Prediction Error Coding in the Human Midbrain and Striatum
- T6INDIRECT 7608665 ↗ — Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo
- T6INDIRECT 9810943 ↗ — Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 2666581 ↗ — Multiple system atrophy--the nature of the beast
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 28100251 ↗ — Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) de
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 23184849 ↗ — Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 24699931 ↗ — Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
- T6 33586685 ↗ — Gastrointestinal motility disorders in neurologic disease
- T6 31473980 ↗ — Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations
- T6 27505015 ↗ — Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharma
- T6 26366103 ↗ — An update of clinical management of acute intermittent porphyria
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 16678566 ↗ — Childhood functional gastrointestinal disorders: child/adolescent
- T6 23147521 ↗ — Clinical guideline: management of gastroparesis
T2 — RCT in related condition
WithdrawnME/CFSPOTS
57 sources
- T2WITHDRAWN NCT00977171 ↗ — Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
- T2WITHDRAWN NCT03070730 ↗ — Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And
- T6INDIRECT 41225175 ↗ — Systematic literature review: treatment of postural orthostatic tachycardia syndrome (POTS)
- T6 29222399 ↗ — Pediatric Disorders of Orthostatic Intolerance
- T6 23569093 ↗ — Common syndromes of orthostatic intolerance
- T6 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
- T6 24819031 ↗ — Adolescent fatigue, POTS, and recovery: a guide for clinicians
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 28885363 ↗ — Prevalence, risk factors, and prognosis of orthostatic hypotension in diabetic patients: A systemati
- T6INDIRECT 34000076 ↗ — Fludrocortisone for orthostatic hypotension
- T2 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 10599797 ↗ — The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine: a rando
- T2 28494751 ↗ — Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
- T6INDIRECT 23616163 ↗ — Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study
- T6INDIRECT 27372462 ↗ — Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, doubl
- T6INDIRECT 32986682 ↗ — The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility
- T6INDIRECT 34657222 ↗ — Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 tr
- T6INDIRECT 28967294 ↗ — An Autonomic Neuroprosthesis: Noninvasive Electrical Spinal Cord Stimulation Restores Autonomic Card
- T6 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 34752479 ↗ — Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled
- T2 25350981 ↗ — Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsi
- T2 25487613 ↗ — Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinso
- T6INDIRECT 25185131 ↗ — Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic f
- T2 24326693 ↗ — Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (N
- T6INDIRECT 12885750 ↗ — Norepinephrine precursor therapy in neurogenic orthostatic hypotension
- T6INDIRECT 2890806 ↗ — Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency
- T2 11710796 ↗ — L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic
- T6INDIRECT 29326369 ↗ — Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using na
- T6INDIRECT 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
- T6INDIRECT 38390594 ↗ — Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
- T6INDIRECT 37204997 ↗ — Postural Orthostatic Tachycardia Syndrome in COVID-19: A Contemporary Review of Mechanisms, Clinical
- T6INDIRECT 41089328 ↗ — Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and
- T6INDIRECT 37654428 ↗ — Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2
- T6 33786405 ↗ — Recent advances in carbon nanomaterials for biomedical applications: A review
- T6 33886735 ↗ — Dysautonomia: A Forgotten Condition - Part 1
- T6 37764145 ↗ — Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in
- T6 32949293 ↗ — Program and Abstracts of the 31st International Symposium on the Autonomic Nervous System
- T6 PMC11231130 ↗ — Abstracts from the 2024 Annual Meeting of the Society of General Internal Medicine
- T6 35212554 ↗ — Orthostatic Hypotension: Management of a Complex, But Common, Medical Problem
- T6 32222376 ↗ — Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment
- T6 35720084 ↗ — Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic
- T6INDIRECT 32402162 ↗ — Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 35841911 ↗ — Diagnosis and treatment of orthostatic hypotension
- T6INDIRECT 24433463 ↗ — Review of pharmacological therapies in fibromyalgia syndrome
- T6INDIRECT 33649021 ↗ — Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 36810524 ↗ — Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 26729077 ↗ — The Prodrug Approach: A Successful Tool for Improving Drug Solubility
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 33427939 ↗ — The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 23425518 ↗ — Guideline of transthyretin-related hereditary amyloidosis for clinicians
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
T2 — RCT in related condition
RegisteredPOTS
28 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 33674954 ↗ — Overall Efficacy and Safety of Safinamide in Parkinson's Disease: A Systematic Review and a Meta-ana
- T6INDIRECT 34964392 ↗ — Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6HARM 28273839 ↗ — Parkinson's Disease: From Pathogenesis to Pharmacogenomics
- T6 23225012 ↗ — Parkinson's disease
- T6 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6 22675666 ↗ — Clinical approach to Parkinson's disease: features, diagnosis, and principles of management
- T6 35279112 ↗ — Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor flu
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 35010624 ↗ — Systematic Review on Parkinson's Disease Medications, Emphasizing on Three Recently Approved Drugs t
- T6INDIRECT 9343116 ↗ — Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levo
- T2 8558148 ↗ — Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients wit
- T6INDIRECT 8527287 ↗ — Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose lev
- T6INDIRECT 23336248 ↗ — Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following
- T6INDIRECT 27332626 ↗ — Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hyp
- T6INDIRECT 33164945 ↗ — Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study
- T6INDIRECT 32345378 ↗ — Effectiveness and safety of opicapone in Parkinson's disease patients with motor fluctuations: the O
- T6INDIRECT 17894650 ↗ — Catechol-O-methyltransferase and its inhibitors in Parkinson's disease
- T6INDIRECT 32456656 ↗ — Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH<sub>4</sub&g
- T6INDIRECT 32373652 ↗ — Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: Th
- T6INDIRECT 28261151 ↗ — The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice
- T6INDIRECT 32484584 ↗ — COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy
- T6 28887905 ↗ — Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Sh
- T6 29090092 ↗ — Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential trea
- T6 36810524 ↗ — Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
- T6 27803666 ↗ — Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
- T6 26324905 ↗ — Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
Entacapone & Propranolol
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
T2 — RCT in related condition
POTS
18 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T2 31628568 ↗ — A Meta-analysis to Guide the Enhancement of CBT for Childhood Anxiety: Exposure Over Anxiety Managem
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 26352916 ↗ — Interventions for Individuals With High Levels of Needle Fear: Systematic Review of Randomized Contr
- T6INDIRECT 38588457 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 25457929 ↗ — Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatri
- T2 29939055 ↗ — Measuring fear change within exposures: Functionally-defined habituation predicts outcome in three r
- T6INDIRECT 30852257 ↗ — Fear extinction learning as a predictor of response to cognitive behavioral therapy for pediatric ob
- T6 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 35430029 ↗ — Functional neurological disorder: new subtypes and shared mechanisms
- T6INDIRECT 37436070 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 25138725 ↗ — The diagnosis of and treatment recommendations for anxiety disorders
- T6INDIRECT 20726290 ↗ — Best practice guide for the treatment of nightmare disorder in adults
- T6 26062169 ↗ — Fear and the Defense Cascade: Clinical Implications and Management
- T6 21440852 ↗ — Cognitive-behavioral therapy for anxiety disorders in youth
- T6 25936504 ↗ — Brains in the city: Neurobiological effects of urbanization
- T6 22259614 ↗ — Vestibular rehabilitation therapy: review of indications, mechanisms, and key exercises
External automated abdominal binder
T2
T2 — RCT in related condition
WithdrawnPOTS
1 source
- T2WITHDRAWN NCT01771484 ↗ — High Sodium Diet and External Abdominal Compression in POTS
T2 — RCT in related condition
RegisteredWithdrawnMCASPOTS
42 sources
- T6WITHDRAWN NCT01773395 ↗ — GVAX vs. Placebo for MDS/AML After Allo HSCT
- T6 NCT01384513 ↗ — A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Mali
- T6REGISTERED-ONLY NCT03779854 ↗ — Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults
- T6INDIRECT 36542826 ↗ — Lisocabtagene maraleucel as second-line therapy for large B-cell lymphoma: primary analysis of the p
- T2 12393618 ↗ — Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) reg
- T6INDIRECT 25154820 ↗ — Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effect
- T2 8648382 ↗ — Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma
- T6INDIRECT 38659046 ↗ — Long-term remission and survival in patients with relapsed or refractory multiple myeloma after trea
- T2 15741224 ↗ — Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine,
- T6 32934330 ↗ — Exploring the NK cell platform for cancer immunotherapy
- T6 11229815 ↗ — The CD40/CD154 receptor/ligand dyad
- T6 29915719 ↗ — Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy
- T6 24859366 ↗ — Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid d
- T6INDIRECT 37756687 ↗ — Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta
- T6INDIRECT 28971751 ↗ — Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 19263294 ↗ — Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 33895845 ↗ — 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral A
- T6 31210940 ↗ — European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gl
- T6 22308288 ↗ — CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 a
- T6 22762314 ↗ — Eltrombopag and improved hematopoiesis in refractory aplastic anemia
- T6INDIRECT 30705099 ↗ — IgG4-related disease: what a hematologist needs to know
- T6INDIRECT 34774343 ↗ — A review of FLT3 inhibitors in acute myeloid leukemia
- T6INDIRECT 29844705 ↗ — Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
- T6INDIRECT 32522746 ↗ — Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies
- T6INDIRECT 33875812 ↗ — Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approac
- T6INDIRECT 29475724 ↗ — A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a
- T6 19099185 ↗ — Mcl-1 is a potential therapeutic target in multiple types of cancer
- T6 22075983 ↗ — BCL2A1: the underdog in the BCL2 family
- T6 24975478 ↗ — Getting Syk: spleen tyrosine kinase as a therapeutic target
- T6 23060872 ↗ — Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodefici
- T6INDIRECT 30348186 ↗ — Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and mult
- T6INDIRECT 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6INDIRECT 37345050 ↗ — The Black Hole: CAR T Cell Therapy in AML
- T6INDIRECT 25124015 ↗ — Noninvasive imaging of cardiovascular injury related to the treatment of cancer
- T6 30130469 ↗ — Iron and Cancer
- T6 28174091 ↗ — Inhibitors of cyclin-dependent kinases as cancer therapeutics
- T6 25561510 ↗ — Advances in anticancer immunotoxin therapy
- T6 26566663 ↗ — The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel th
- T6 26391778 ↗ — Cancer-treatment-induced neurotoxicity--focus on newer treatments
T2 — RCT in related condition
RegisteredPOTS
4 sources
- T2REGISTERED-ONLY NCT07019519 ↗ — POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patien
- T6 35232225 ↗ — Worsening Postural Tachycardia Syndrome Is Associated With Increased Glucose-Dependent Insulinotropi
- T6 28795195 ↗ — 53 <sup>rd</sup> EASD Annual Meeting of the European Association for the Study of Diabet
- T6 32840677 ↗ — 56<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : 21-25 Se
T2 — RCT in related condition
RegisteredPOTS
11 sources
- T2REGISTERED-ONLY NCT07019519 ↗ — POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patien
- T6 41096559 ↗ — Gut Microbiome as a Source of Probiotic Drugs for Parkinson's Disease
- T6 19898904 ↗ — High-affinity alphavbeta3 integrin targeted optical probe as a new imaging biomarker for early ather
- T6 19018511 ↗ — Diet, delusion and diabetes
- T6 28795195 ↗ — 53 <sup>rd</sup> EASD Annual Meeting of the European Association for the Study of Diabet
- T6 27539147 ↗ — Abstracts of 52nd EASD Annual Meeting
- T6 32840677 ↗ — 56<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : 21-25 Se
- T6INDIRECT 34559267 ↗ — European Association of Nuclear Medicine October 20-23, 2021 Virtual
- T4 PMC6907427 ↗ — Clinical Diabetes/Therapeutics
- T6INDIRECT 23949610 ↗ — Abstracts of the 49th EASD (European Association for the Study of Diabetes) Annual Meeting. Septembe
- T6 41465588 ↗ — GLP-1 Signalling as a Therapeutic Avenue in Parkinson's Disease: A Comprehensive Review
T2 — RCT in related condition
POTS
32 sources
- T2 NCT04345432 ↗ — Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)
- T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 24920437 ↗ — Central changes associated with chronic pelvic pain and endometriosis
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
- T6INDIRECT 19029129 ↗ — Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study
- T6INDIRECT 18281407 ↗ — Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with bord
- T6INDIRECT 34444817 ↗ — Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Qu
- T6INDIRECT 33662112 ↗ — Overminus Lens Therapy for Children 3 to 10 Years of Age With Intermittent Exotropia: A Randomized C
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6 31663402 ↗ — Consensus statement for perioperative care in total hip replacement and total knee replacement surge
- T6INDIRECT 17943857 ↗ — Antidepressants for neuropathic pain
- T6INDIRECT 30673120 ↗ — Pregabalin for neuropathic pain in adults
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 22281448 ↗ — Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances
- T6INDIRECT 26902950 ↗ — Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 21092187 ↗ — Fabry disease
- T6 20194146 ↗ — Recommendations for the pharmacological management of neuropathic pain: an overview and literature u
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 28620280 ↗ — Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 23425518 ↗ — Guideline of transthyretin-related hereditary amyloidosis for clinicians
- T6 36178003 ↗ — World guidelines for falls prevention and management for older adults: a global initiative
T2 — RCT in related condition
RegisteredPOTS
1 source
GammaCore intervention
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT06268288 ↗ — Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Synd
T2 — RCT in related condition
POTS
23 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 23450540 ↗ — Methadone at tapered doses for the management of opioid withdrawal
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 28486271 ↗ — Withdrawal of antihypertensive medication: a systematic review
- T6INDIRECT 37818791 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T2 19877974 ↗ — Safety and effectiveness of coadministration of guanfacine extended release and psychostimulants in
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 34204991 ↗ — A Comprehensive Review of Tic Disorders in Children
- T6INDIRECT 29335879 ↗ — Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 30192094 ↗ — Management of common adverse effects of antipsychotic medications
- T6INDIRECT 21445724 ↗ — European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 16554257 ↗ — Contemporary assessment and pharmacotherapy of Tourette syndrome
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
Home transcutaneous vagal nerve stimulation
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT04632134 ↗ — Long-term Effects of Transcutaneous Vagal Nerve Stimulation on Postural Orthostatic Tachycardia Synd
Hybrid Exercise Training
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT04603157 ↗ — Remote Self-training Program for Patients With Postural Orthostatic Tachycardia Syndrome
T2 — RCT in related condition
POTS
32 sources
- T2 NCT00865917 ↗ — Cardiovascular Effects of Selective I(f)-Channel Blockade
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 19687359 ↗ — Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less i
- T6INDIRECT 28893208 ↗ — Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients
- T6INDIRECT 36723919 ↗ — Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrilla
- T6INDIRECT 11804991 ↗ — Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance
- T6INDIRECT 33602468 ↗ — Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syn
- T6INDIRECT 23266540 ↗ — Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic f
- T6 22258608 ↗ — The promise of induced pluripotent stem cells in research and therapy
- T6HARM 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 30673120 ↗ — Pregabalin for neuropathic pain in adults
- T6INDIRECT 26551272 ↗ — A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 28642330 ↗ — Effects of Intensive BP Control in CKD
- T6INDIRECT 22573363 ↗ — Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY
- T6INDIRECT 29133606 ↗ — Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gast
- T6INDIRECT 24126931 ↗ — Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with mini
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 36148880 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes As
- T6 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 20663977 ↗ — Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and
- T6 29565029 ↗ — Hypertension
Individual tailored exercise
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT05877534 ↗ — Effects of Individual Tailored Physical Exercise in Patients With POTS After COVID-19 - a Randomized
T2 — RCT in related condition
RegisteredPOTS
31 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 37147116 ↗ — Multidisciplinary consensus guideline for the diagnosis and management of spontaneous intracranial h
- T6INDIRECT 34000076 ↗ — Fludrocortisone for orthostatic hypotension
- T6INDIRECT 34143333 ↗ — The effects of caffeine in adults with neurogenic orthostatic hypotension: a systematic review
- T6INDIRECT 27372462 ↗ — Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: a phase 4, doubl
- T6INDIRECT 40747556 ↗ — Altered Blood Pressure Reflexes in Women With Endometriosis
- T6INDIRECT 30466384 ↗ — Lifestyle modifications as therapy for medication refractory post-traumatic headache (PTHA) in the m
- T6 21749363 ↗ — Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- T6 2666581 ↗ — Multiple system atrophy--the nature of the beast
- T6 22500859 ↗ — What have we learned from brucellosis in the mouse model?
- T6 4758519 ↗ — Cardiac denervation in diabetes
- T6 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 27419911 ↗ — Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestina
- T6INDIRECT 23076930 ↗ — Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 22591985 ↗ — Efficacy of treatments for orthostatic hypotension: a systematic review
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 2875321 ↗ — Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995
- T6INDIRECT 9727818 ↗ — Contrasting actions of pressor agents in severe autonomic failure
- T6INDIRECT 20396637 ↗ — Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tool
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 28262641 ↗ — Vestibular paroxysmia: Diagnostic criteria
- T6INDIRECT 18488078 ↗ — Current aproach to cancer pain management: Availability and implications of different treatment opti
- T6 28986925 ↗ — Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and
- T6 23588782 ↗ — Applications of CYP450 testing in the clinical setting
- T6 16461471 ↗ — Diabetic neuropathy
- T6 30033869 ↗ — A Summary of Electrospun Nanofibers as Drug Delivery System: Drugs Loaded and Biopolymers Used as Ma
- T6 6811067 ↗ — Diagnosis and management of diabetic autonomic neuropathy
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
Inspiratory Threshold Device
T2
T2 — RCT in related condition
RegisteredPOTS
7 sources
- T2REGISTERED-ONLY NCT00962728 ↗ — Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)
- T2 32705393 ↗ — Inspiratory muscle training improves cerebrovascular and postural control responses during orthostat
- T6 24778619 ↗ — Arterial pressure and cerebral blood flow variability: friend or foe? A review
- T6 34992796 ↗ — Anaesthesia after neoadjuvant chemotherapy, immunotherapy or radiotherapy
- T6 23932268 ↗ — [Improving vital organs perfusion by the respiratory pump: physiology and clinical use]
- T6 24078670 ↗ — Postexercise syncope: Wingate syncope test and effective countermeasure
- T6 PMC2845228 ↗ — Commentary on Current Literature
T2 — RCT in related condition
RegisteredPOTS
23 sources
- T2REGISTERED-ONLY NCT00608725 ↗ — Pathophysiology of Orthostatic Intolerance
- T6INDIRECT 10190880 ↗ — Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic into
- T6 20497993 ↗ — Sympathetic nervous system and blood pressure in humans: individualized patterns of regulation and t
- T6 25589269 ↗ — Neural control of the circulation: how sex and age differences interact in humans
- T6 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6 21098405 ↗ — Afferent baroreflex failure in familial dysautonomia
- T6INDIRECT 31391000 ↗ — Swallow syncope: a case report and review of literature
- T6INDIRECT 33279955 ↗ — Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole
- T6INDIRECT 27736760 ↗ — Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administrati
- T6INDIRECT 32817835 ↗ — Cardioneuroablation for management of cardioinhibitory vasovagal syncope and pacemaker complications
- T6INDIRECT 33918562 ↗ — Inappropriate Sinus Tachycardia Following Viral Illness
- T6INDIRECT 42028077 ↗ — Extracardiac vagal nerve stimulation-guided cardioneuroablation in patients with interrupted superio
- T6INDIRECT 36074973 ↗ — Sinus Tachycardia: a Multidisciplinary Expert Focused Review
- T6INDIRECT 35106176 ↗ — Cardiac Pacing in Cardioinhibitory Reflex Syncope: Clinical Use of Closed-loop Stimulation
- T6INDIRECT 40725699 ↗ — Neural Correlates of Huntington's Disease Based on Electroencephalography (EEG): A Mechanistic Revie
- T6INDIRECT 24913692 ↗ — Ongoing clinical trials for Vasovagal Syncope: where are we in 2014?
- T6 24844457 ↗ — Beneficial effects of physical activity on baroreflex control in the elderly
- T6 31863250 ↗ — State of the art: leadless ventricular pacing : A national expert consensus of the Austrian Society
- T6 33204081 ↗ — Falls Risk, Circadian Rhythms and Melatonin: Current Perspectives
- T6 20123977 ↗ — Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failur
- T6 22883907 ↗ — Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein
- T6 27042032 ↗ — Impact of aging on cardiac function in a female rat model of menopause: role of autonomic control, i
- T6 29470149 ↗ — Chronic, complete cervical<sub>6-7</sub> cord transection: distinct autonomic and cardiac deficits
T2 — RCT in related condition
WithdrawnPOTS
14 sources
- T2WITHDRAWN NCT01978535 ↗ — Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS
- T6 30569038 ↗ — A novel nano-iron supplement to safely combat iron deficiency and anaemia in young children: The IHA
- T6 37051178 ↗ — Effects of vitamin and mineral supplementation during pregnancy on maternal, birth, child health and
- T6 32213001 ↗ — UEG Week 2019 Poster Presentations
- T6 28608429 ↗ — 27th Regional Congress of the ISBT, Copenhagen, Denmark, June 17-21, 2017
- T6 24737224 ↗ — Abstracts from the 37th Annual Meeting of the Society of General Internal Medicine, 2014, San Diego,
- T6INDIRECT 27140401 ↗ — Clinical iron deficiency disturbs normal human responses to hypoxia
- T6 34684433 ↗ — Iron Deficiency in Celiac Disease: Prevalence, Health Impact, and Clinical Management
- T6INDIRECT 38532802 ↗ — Patisiran exposure in early pregnancy: a case report
- T6INDIRECT 41906589 ↗ — Nonanemic Iron Deficiency: Exercise Performance Recovery After Iron Repletion in Collegiate Athlete
- T6INDIRECT 40832691 ↗ — The Management of Parkinson's Disease Before, during and after Pregnancy-an MDS Scientific Issues Co
- T6INDIRECT 31173375 ↗ — 29th Regional Congress of the ISBT, Basel, Switzerland, 22-26 June 2019
- T6INDIRECT 32745265 ↗ — 35th International Congress of the ISBT, Toronto, Canada, June 2-6, 2018
- T6 36186804 ↗ — Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults
T2 — RCT in related condition
RegisteredPOTS
29 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 27388039 ↗ — Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy
- T2 35299288 ↗ — Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: T
- T6 1423218 ↗ — Chagas' disease
- T6 27672286 ↗ — New insights into the pathophysiology of achalasia and implications for future treatment
- T6 26676662 ↗ — Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions
- T6 36228868 ↗ — Glutamatergic systems in neuropathic pain and emerging non-opioid therapies
- T6 35386135 ↗ — The Canadian Women's Heart Health Alliance Atlas on the Epidemiology, Diagnosis, and Management of C
- T6INDIRECT 32103487 ↗ — Pharmacological interventions for heart failure in people with chronic kidney disease
- T2 28219917 ↗ — Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricula
- T6INDIRECT 25300460 ↗ — NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild
- T6INDIRECT 3314956 ↗ — Efficacy of felodipine in chronic congestive heart failure: a placebo controlled haemodynamic study
- T6INDIRECT 20632059 ↗ — Optimal treatment duration of glyceryl trinitrate for chronic anal fissure: results of a prospective
- T6INDIRECT 9808874 ↗ — [Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with ne
- T6INDIRECT 33387632 ↗ — Effects of Low-Level Tragus Stimulation on Endothelial Function in Heart Failure With Reduced Ejecti
- T6INDIRECT 2515254 ↗ — Source of pain and primitive dysfunction in migraine: an identical site?
- T6INDIRECT 31236077 ↗ — Pheochromocytoma-Induced Takotsubo Cardiomyopathy
- T6INDIRECT 8364814 ↗ — Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of esse
- T6INDIRECT 24701420 ↗ — Therapeutic approaches for renal colic in the emergency department: a review article
- T6INDIRECT 2491825 ↗ — Effect of prostaglandin inhibitors on bile salt-induced mucosal damage of porcine colon
- T6INDIRECT 25869016 ↗ — Abstracts from the 38th annual meeting of the society of general internal medicine
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 16461471 ↗ — Diabetic neuropathy
- T6 34948113 ↗ — Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
- T6 21620994 ↗ — Acute retinal arterial occlusive disorders
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 27311574 ↗ — Vasodilator Therapy: Nitrates and Nicorandil
- T6 16450016 ↗ — Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosi
- T6 10890797 ↗ — Alcohol and medication interactions
Kansas City Cardiac Dysautonomia Questionnaire
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT06672861 ↗ — Development and Validation of the Kansas City Cardiac Dysautonomia Questionnaire (KCDysQ)
T2 — RCT in related condition
POTS
1 source
- T2 NCT00580619 ↗ — Autonomic Nervous System and Chronic Fatigue Syndrome
T2 — RCT in related condition
POTS
17 sources
- T2 11710796 ↗ — L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic
- T2 15666063 ↗ — Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic
- T6 28357055 ↗ — Recent advances in treating Parkinson's disease
- T6 26090077 ↗ — (123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature
- T6 10406987 ↗ — (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease
- T6 22883210 ↗ — Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP
- T6INDIRECT 9221984 ↗ — Neuroleptic malignant syndrome-like condition in multiple system atrophy
- T6INDIRECT 9221985 ↗ — Non-Hodgkin's lymphoma as a new cause of non-thrombotic superior sagittal sinus occlusion
- T6INDIRECT 34703451 ↗ — Elderly-Onset Multiple System Atrophy with Lewy Body Pathology: A Case Report
- T5 8676171 ↗ — Acute pandysautonomia: mass spectrometric and histopathological studies of the sympathetic nervous s
- T6INDIRECT 32436100 ↗ — An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis
- T6INDIRECT 32316335 ↗ — Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
- T6INDIRECT 10824045 ↗ — Progressive supranuclear palsy
- T6INDIRECT 39751950 ↗ — Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: gu
- T6 24634790 ↗ — Orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism
- T6 21577106 ↗ — New insights into atypical parkinsonism
- T6 25309444 ↗ — Role of sympathetic nerve activity in the process of fainting
T2 — RCT in related condition
POTS
21 sources
- T2 25739474 ↗ — Prevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-a
- T2 39940333 ↗ — Dietary Supplementation for Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (
- T2 40071727 ↗ — A systematic review and embryological perspective of pluripotent stem cell-derived autonomic postgan
- T2 28445783 ↗ — Jump starting shared medical appointments for diabetes with weight management: Rationale and design
- T6 31337484 ↗ — Chronic Pain Management in the Elderly
- T6 23583175 ↗ — Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects
- T6 22280551 ↗ — Combining SNP discovery from next-generation sequencing data with bulked segregant analysis (BSA) to
- T6 30795902 ↗ — Defining the Functional Role of Na<sub>V</sub>1.7 in Human Nociception
- T6 20975614 ↗ — Energy imbalance and the risk of overfeeding in critically ill children
- T6 38740499 ↗ — Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised
- T5 31911410 ↗ — Low-dose naltrexone as a treatment for chronic fatigue syndrome
- T5 23546884 ↗ — Treatment of Complex Regional Pain Syndrome (CRPS) using low dose naltrexone (LDN)
- T4 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
- T4 30248938 ↗ — Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization
- T4 32950543 ↗ — Pain management in hidradenitis suppurativa and a proposed treatment algorithm
- T4 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6 32204380 ↗ — The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
- T6 23285249 ↗ — Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus inf
- T6 35025863 ↗ — WAPO-A1 is the causal gene of the 7AL QTL for spikelet number per spike in wheat
- T6 27480492 ↗ — Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation i
- T6 24285961 ↗ — Bedside evaluation of dizzy patients
T2 — RCT in related condition
POTS
21 sources
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 27884691 ↗ — AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions
- T2 33763699 ↗ — Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnos
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 21483018 ↗ — Amyloidosis: pathogenesis and new therapeutic options
- T6 23095830 ↗ — Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and preven
- T6 22184404 ↗ — A phase 1, multicenter, open-label, dose escalation study of elotuzumab in patients with advanced mu
- T6 26561559 ↗ — Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924)
- T6 24920586 ↗ — Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multipl
- T6INDIRECT 30348186 ↗ — Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and mult
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 24672257 ↗ — Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- T6INDIRECT 29222231 ↗ — AL amyloidosis: from molecular mechanisms to targeted therapies
- T6INDIRECT 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6INDIRECT 34729520 ↗ — AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: <i>JACC: CardioOncolog
- T6INDIRECT 32906684 ↗ — Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adv
- T6 34236546 ↗ — Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new
- T6 32708302 ↗ — Small Molecule NF-κB Pathway Inhibitors in Clinic
- T6 19528374 ↗ — Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peri
- T6 26391778 ↗ — Cancer-treatment-induced neurotoxicity--focus on newer treatments
LifeWrap Compression Garment
T2
T2 — RCT in related condition
POTS
1 source
T2 — RCT in related condition
RegisteredPOTS
11 sources
- T2REGISTERED-ONLY NCT07077278 ↗ — Effect of Low Sodium Oxybate (LXB) on Autonomic Symptom Burden in Idiopathic Hypersomnia Patients Wi
- T6 38217475 ↗ — Brain fog in central disorders of hypersomnolence: a review
- T6 39912238 ↗ — Current knowledge on the pathophysiology of idiopathic hypersomnia and potential mechanisms of actio
- T6 38662324 ↗ — Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consen
- T6 40489042 ↗ — A Patient-centric Clinical Trial Design to Comprehensively Evaluate Low-Sodium Oxybate in People wit
- T6 40472564 ↗ — Idiopathic hypersomnia symptoms over Time: Longitudinal follow up from the Hypersomnia Foundation re
- T6 41831073 ↗ — Effectiveness and Safety of Low-Sodium Oxybate in Participants with Idiopathic Hypersomnia: Primary
- T6 37621721 ↗ — Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate
- T6INDIRECT 42006054 ↗ — Narcolepsy as an immune-associated hypothalamic encephalopathy: orexin dysfunction and implications
- T6 41375746 ↗ — A Comprehensive Review of Current and Emerging Treatments for Narcolepsy Type 1
- T6 41678063 ↗ — Idiopathic hypersomnia is a 24-hour disorder
T2 — RCT in related condition
RegisteredPOTS
21 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6 22192366 ↗ — Olfaction in Parkinson's disease and related disorders
- T6HARM 16554257 ↗ — Contemporary assessment and pharmacotherapy of Tourette syndrome
- T6 28725692 ↗ — Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease
- T6 36496996 ↗ — Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies
- T6 20945818 ↗ — Vascular dysfunctions following spinal cord injury
- T6INDIRECT 18480694 ↗ — Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depress
- T2 24114425 ↗ — Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and witho
- T2 29319910 ↗ — Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitiv
- T6 17227286 ↗ — Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cess
- T6 11212590 ↗ — Antidepressants as analgesics: an overview of central and peripheral mechanisms of action
- T6 20189159 ↗ — Topical mecamylamine for diabetic macular edema
- T6INDIRECT 27590099 ↗ — Cardiac sympatho-vagal balance and ventricular arrhythmia
- T6INDIRECT 30643668 ↗ — Merging the Pathophysiology and Pharmacotherapy of Tics
- T6INDIRECT 23861643 ↗ — Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders
- T6INDIRECT 36456693 ↗ — ACNP 61<sup>st</sup> Annual Meeting: Poster Abstracts P1 - P270
- T6INDIRECT 16858760 ↗ — Abstracts of the 29th Annual Meeting of the Japan Neuroscience Society, July 19-21, 2006
- T4 PMC7172550 ↗ — Subject Index
- T6 21256603 ↗ — Treatment of nicotine addiction: present therapeutic options and pipeline developments
- T6 19232953 ↗ — Endothelial nicotinic acetylcholine receptors and angiogenesis
- T6 25878903 ↗ — Clinical and biochemical manifestations of depression: relation to the neurobiology of stress
Medications that modulate heart rate and blood pressure
T2
T2 — RCT in related condition
RegisteredPOTS
2 sources
- T2REGISTERED-ONLY NCT04881318 ↗ — Compression Garments in the Community With POTS
- T6 39297140 ↗ — Reduced Stroke Volume and Brain Perfusion Drive Postural Hyperventilation in Postural Orthostatic Ta
T2 — RCT in related condition
RegisteredWithdrawnMCASPOTS
51 sources
- T6WITHDRAWN NCT01773395 ↗ — GVAX vs. Placebo for MDS/AML After Allo HSCT
- T6REGISTERED-ONLY NCT03779854 ↗ — Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults
- T2 21855836 ↗ — Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease
- T6INDIRECT 31046809 ↗ — Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arth
- T6INDIRECT 25046337 ↗ — Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who rema
- T6INDIRECT 30943337 ↗ — Benralizumab for <i>PDGFRA</i>-Negative Hypereosinophilic Syndrome
- T6INDIRECT 30343531 ↗ — Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-
- T6INDIRECT 35671774 ↗ — Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor
- T6INDIRECT 28435464 ↗ — Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of F
- T6INDIRECT 25154820 ↗ — Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effect
- T6INDIRECT 25789989 ↗ — A pilot study of omalizumab in eosinophilic esophagitis
- T6 35732831 ↗ — The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 34542573 ↗ — Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephaliti
- T6INDIRECT 28816346 ↗ — Homocysteine-lowering interventions for preventing cardiovascular events
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 26561338 ↗ — Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
- T6INDIRECT 27382171 ↗ — Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid a
- T6INDIRECT 1739631 ↗ — Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
- T6INDIRECT 17965121 ↗ — Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of respo
- T6INDIRECT 17655751 ↗ — Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis
- T6INDIRECT 24275598 ↗ — Treating inflammation by blocking interleukin-1 in humans
- T6INDIRECT 32107531 ↗ — Pediatric hemophagocytic lymphohistiocytosis
- T6INDIRECT 33077936 ↗ — Kinase inhibition in autoimmunity and inflammation
- T6INDIRECT 35215786 ↗ — <i>Herpes zoster</i>: A Review of Clinical Manifestations and Management
- T6INDIRECT 29915719 ↗ — Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy
- T6INDIRECT 24366648 ↗ — Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations
- T6INDIRECT 23109216 ↗ — Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for p
- T6 34824210 ↗ — The JAK/STAT signaling pathway: from bench to clinic
- T6 21303899 ↗ — International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of ad
- T6 18758473 ↗ — Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
- T6 25287861 ↗ — Calcitonin gene-related peptide: physiology and pathophysiology
- T6 24587990 ↗ — Oxidative stress, prooxidants, and antioxidants: the interplay
- T6 38311623 ↗ — Extracellular vesicles as tools and targets in therapy for diseases
- T6 37169756 ↗ — Angiogenic signaling pathways and anti-angiogenic therapy for cancer
- T6INDIRECT 30218025 ↗ — Mechanisms, biomarkers and targets for adult-onset Still's disease
- T6INDIRECT 35655306 ↗ — Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine
- T6INDIRECT 31954495 ↗ — Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 24672257 ↗ — Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- T6INDIRECT 31485575 ↗ — Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 37919282 ↗ — Smart nanoparticles for cancer therapy
- T6 34988090 ↗ — Treatment of Inflammatory Bowel Disease: A Comprehensive Review
- T6 32213941 ↗ — Chemical Constituents and Pharmacological Activities of Garlic (<i>Allium sativum</i> L.): A Review
- T6 29163522 ↗ — The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Trac
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
Microcrystalline cellulose
T2
T2 — RCT in related condition
RegisteredPOTS
21 sources
- T2REGISTERED-ONLY NCT05363514 ↗ — Low Dose Naltrexone Use in Patients With POTS
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30556597 ↗ — Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people
- T6INDIRECT 36103313 ↗ — Fluvoxamine for the treatment of COVID-19
- T6INDIRECT 35174663 ↗ — Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE r
- T6INDIRECT 33408364 ↗ — Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overwei
- T6INDIRECT 32676977 ↗ — A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety,
- T6INDIRECT 39294522 ↗ — Atomoxetine on neurogenic orthostatic hypotension: a randomized, double-blind, placebo-controlled cr
- T6 22547984 ↗ — Technologies for beneficial microorganisms inocula used as biofertilizers
- T6 21690484 ↗ — Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndro
- T6INDIRECT 36971690 ↗ — Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- T6INDIRECT 34739197 ↗ — Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- T6INDIRECT 24968000 ↗ — A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onch
- T6INDIRECT 35126309 ↗ — Efficacy and Safety of <i>Lactobacillus plantarum</i> K50 on Lipids in Koreans With Obesity: A Rando
- T6INDIRECT 37651553 ↗ — Interventions for fatigue in people with kidney failure requiring dialysis
- T6INDIRECT 36686404 ↗ — FDM-based additive manufacturing of recycled thermoplastics and associated composites
- T6INDIRECT 34683875 ↗ — Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case S
- T6INDIRECT 36677490 ↗ — Domiciliation of <i>Trichoderma asperellum</i> Suppresses <i>Globiosporangium ultimum</i> and Promot
- T6 35516564 ↗ — Widely used catalysts in biodiesel production: a review
Microcystalline Cellulose Capsules
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
T2 — RCT in related condition
RegisteredPOTS
28 sources
- T2REGISTERED-ONLY NCT07585513 ↗ — Beta-3 Enhanced Autonomic Therapy for POTS
- T2 NCT06133075 ↗ — Using Mirabegron to Increase BP in Patients With POTS
- T6 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6 33593479 ↗ — Current Treatment for Benign Prostatic Hyperplasia
- T6 33065745 ↗ — Neurogenic Bladder: Epidemiology, Diagnosis, and Management
- T6 33999297 ↗ — The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrativ
- T2 39729463 ↗ — Evaluating the safety and effectiveness of α-blockers versus mirabegron for medical expulsive therap
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T2 41255616 ↗ — A systematic review and meta-analysis of the efficacy and safety of mirabegron vs. tamsulosin in all
- T2 40176903 ↗ — The efficacy and safety of mirabegron and α-adrenergic receptor antagonist in the treatment of dista
- T6INDIRECT 39139772 ↗ — How Can We Treat If We Do Not Measure: A Systematic Review of Neurogenic Bowel Objective Measures
- T2 38178860 ↗ — Efficacy of mirabegron for ureteral stones: a systematic review with meta-analysis of randomized con
- T2 38041752 ↗ — Evaluation of the efficacy and safety of either or both mirabegron and silodosin, as a medical expul
- T6INDIRECT 35297106 ↗ — Combination therapy with tamsulosin and traditional herbal medicine for lower urinary tract symptoms
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6INDIRECT 33029723 ↗ — Sleep Issues in Parkinson's Disease and Their Management
- T6INDIRECT 32789741 ↗ — Autonomic Dysfunction in Parkinson's Disease
- T6INDIRECT 33205381 ↗ — Approach to Cognitive Impairment in Parkinson's Disease
- T6INDIRECT 31434341 ↗ — A Stage-Based Approach to Therapy in Parkinson's Disease
- T6INDIRECT 32676851 ↗ — Four-Repeat Tauopathies: Current Management and Future Treatments
- T6INDIRECT 36927875 ↗ — Multiple system atrophy
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 36986631 ↗ — Current Treatments and New, Tentative Therapies for Parkinson's Disease
- T6 40274830 ↗ — Diabetic neuropathy: cutting-edge research and future directions
- T6 34885733 ↗ — Treatment of Benign Prostatic Hyperplasia by Natural Drugs
Modafinil & Propranolol
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
T2 — RCT in related condition
RegisteredPOTS
29 sources
- T2REGISTERED-ONLY NCT04050410 ↗ — Autonomic Determinants of POTS - Pilot1
- T6 30875083 ↗ — Human pluripotent stem cell-derived models and drug screening in CNS precision medicine
- T6 12933912 ↗ — Autonomic diseases: clinical features and laboratory evaluation
- T6 20304932 ↗ — Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension
- T6 34979961 ↗ — Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic
- T6 33577130 ↗ — Baroreceptor Modulation of the Cardiovascular System, Pain, Consciousness, and Cognition
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 31841279 ↗ — Central blood pressure for the management of hypertension: Is it a practical clinical tool in curren
- T2 1576046 ↗ — A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive
- T6INDIRECT 30302936 ↗ — Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive pat
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
- T6 20827352 ↗ — Potentially inappropriate medications in the elderly: the PRISCUS list
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 38807350 ↗ — Not first-line antihypertensive agents, but still effective-The efficacy and safety of imidazoline r
- T6INDIRECT 39258018 ↗ — Accelerated hypertension following mavacamten introduction in severe obstructive hypertrophic cardio
- T6INDIRECT 41227153 ↗ — Early Diagnostic Markers in Crisponi Syndrome: Two Cases and Review
- T6INDIRECT 26298728 ↗ — Parkinson's disease between internal medicine and neurology
- T6INDIRECT 25018961 ↗ — Chapter 2: Lifestyle and pharmacological treatments for lowering blood pressure in CKD ND patients
- T6INDIRECT 34280980 ↗ — Prescription Habits Related to Chronic Pathologies of Elderly People in Primary Care in the Western
- T6INDIRECT 32745277 ↗ — Abstracts of the Heart Failure 2019 and the World Congress on Acute Heart Failure, 25-28 May 2019, M
- T6INDIRECT 41413609 ↗ — Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients w
- T6 22048570 ↗ — Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications
- T6 30728760 ↗ — Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
- T6 35411324 ↗ — Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From t
- T6 30639431 ↗ — Sympathetic nervous system in age-related cardiovascular dysfunction: Pathophysiology and therapeuti
- T6 25767284 ↗ — The sympathetic nervous system alterations in human hypertension
- T6 17485976 ↗ — Centrally acting antihypertensive agents: an update
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT04140721 ↗ — Autonomic Determinants of POTS - Pilot 2
T2 — RCT in related condition
RegisteredPOTS
34 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 23013600 ↗ — Associations of kidney disease measures with mortality and end-stage renal disease in individuals wi
- T6INDIRECT 21571570 ↗ — Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis
- T6INDIRECT 28854296 ↗ — Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake In
- T6INDIRECT 35445419 ↗ — The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
- T6INDIRECT 29740819 ↗ — Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursor
- T6INDIRECT 25233067 ↗ — Systematic review of potential health risks posed by pharmaceutical, occupational and consumer expos
- T6INDIRECT 19029129 ↗ — Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study
- T6INDIRECT 1739631 ↗ — Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
- T6INDIRECT 17965121 ↗ — Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of respo
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 32541925 ↗ — Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million p
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 26551272 ↗ — A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- T6INDIRECT 20228401 ↗ — Effects of intensive blood-pressure control in type 2 diabetes mellitus
- T6INDIRECT 20427088 ↗ — Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt l
- T6INDIRECT 27195814 ↗ — Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75
- T6INDIRECT 32409561 ↗ — Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, ra
- T6INDIRECT 19114612 ↗ — Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
- T6INDIRECT 27382171 ↗ — Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid a
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 22160349 ↗ — The novel object recognition memory: neurobiology, test procedure, and its modifications
- T6 28585944 ↗ — Cellular uptake of nanoparticles: journey inside the cell
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
Non-invasive Neuromodulation
T2
T2 — RCT in related condition
POTS
23 sources
- T6 NCT05648695 ↗ — Efficacy of Non-invasive NESA Neuromodulation in Fibromyalgia
- T6INDIRECT 30560316 ↗ — Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans
- T6INDIRECT 33085647 ↗ — Repetitive transcranial magnetic stimulation of the cerebellum improves ataxia and cerebello-fronto
- T6INDIRECT 36041704 ↗ — Transcutaneous cervical vagus nerve stimulation reduces behavioral and physiological manifestations
- T6INDIRECT 37451734 ↗ — Motor and autonomic concomitant health improvements with neuromodulation and exercise (MACHINE) trai
- T6INDIRECT 41003459 ↗ — Noninvasive Vagus Nerve Stimulation Reduces Withdrawal-Related Affective Distress and Improves Funct
- T2 29649928 ↗ — Non-Invasive Activation of Cervical Spinal Networks after Severe Paralysis
- T6 38129427 ↗ — Central neuropathic pain
- T6 34989884 ↗ — The role of electrical stimulation for rehabilitation and regeneration after spinal cord injury
- T6 35720084 ↗ — Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic
- T6 36397122 ↗ — Infraslow closed-loop brain training for anxiety and depression (ISAD): a protocol for a randomized,
- T6INDIRECT 30813143 ↗ — The role of robotic gait training and tDCS in Friedrich ataxia rehabilitation: A case report
- T6INDIRECT 26627895 ↗ — Case report of vasovagal syncope associated with single pulse transcranial magnetic stimulation in a
- T6INDIRECT 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
- T6INDIRECT 34248714 ↗ — Developmental Considerations in Obsessive Compulsive Disorder: Comparing Pediatric and Adult-Onset C
- T6INDIRECT 28208601 ↗ — Surgical Neurostimulation for Spinal Cord Injury
- T6INDIRECT 37654428 ↗ — Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2
- T6 33807256 ↗ — Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
- T6 39443513 ↗ — A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors f
- T6 39587517 ↗ — Potential hypothalamic mechanisms in trigeminal neuropathic pain: a comparative analysis with migrai
- T6 39997046 ↗ — The Spectrum of Cognitive Impairment in Atypical Parkinsonism Syndromes: A Comprehensive Review of C
- T6 33760875 ↗ — Is the heart rate variability monitoring using the analgesia nociception index a predictor of illnes
- T6 30828289 ↗ — Evolution in the Treatment of Psychiatric Disorders: From Psychosurgery to Psychopharmacology to Neu
Non-invasive transcutaneous vagus nerve stimulation
T2
T2 — RCT in related condition
POTS
7 sources
- T2 39969124 ↗ — Non-invasive vagus nerve stimulation and exercise capacity in healthy volunteers: a randomized trial
- T6INDIRECT 41068419 ↗ — Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson's disease: a dou
- T6 32435491 ↗ — Altered cardiorespiratory regulation during exercise in patients with Parkinson's disease: A challen
- T6 38173801 ↗ — Non-invasive Vagus Nerve Simulation in Postural Orthostatic Tachycardia Syndrome
- T6 40701604 ↗ — Non-invasive neuromodulation for alleviating dyspnoea: protocol for a feasibility sham-controlled ra
- T6 41938682 ↗ — Novel Ultrasound-Guided Bilateral Simultaneous Hydrodissection of the Cervical Sympathetic Chain and
- T6INDIRECT 41016890 ↗ — Short and long term effects of a two-week transcutaneous vagus nerve stimulation in hyperadrenergic
T2 — RCT in related condition
RegisteredPOTS
32 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 32826308 ↗ — The management of adult patients with severe chronic small intestinal dysmotility
- T6INDIRECT 34000076 ↗ — Fludrocortisone for orthostatic hypotension
- T6INDIRECT 35498768 ↗ — Pediatric Intestinal Pseudo-Obstruction: Progress and Challenges
- T6INDIRECT 35280448 ↗ — Therapeutic Upper Gastrointestinal Endoscopy in Pediatric Gastroenterology
- T6INDIRECT 39908479 ↗ — Novel Approaches to Treatment of Immune-Mediated Chronic Intestinal Pseudo-Obstruction
- T6INDIRECT 41225175 ↗ — Systematic literature review: treatment of postural orthostatic tachycardia syndrome (POTS)
- T6INDIRECT 22345429 ↗ — A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance
- T6INDIRECT 26387781 ↗ — Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motilit
- T2 17036177 ↗ — Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine
- T6 25378951 ↗ — Systemic AA amyloidosis: epidemiology, diagnosis, and management
- T6 26900156 ↗ — The Differential Diagnosis and Treatment of Atypical Parkinsonism
- T6 29222399 ↗ — Pediatric Disorders of Orthostatic Intolerance
- T6INDIRECT 23990266 ↗ — Antipsychotics for acute and chronic pain in adults
- T6INDIRECT 23758443 ↗ — A systematic review of the pharmacological management of orthostatic hypotension
- T6INDIRECT 34932836 ↗ — Transfusion thresholds for guiding red blood cell transfusion
- T6INDIRECT 26366058 ↗ — Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors
- T6INDIRECT 2875321 ↗ — Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995
- T2 8665540 ↗ — Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled
- T6 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 7825766 ↗ — Postprandial hypotension: epidemiology, pathophysiology, and clinical management
- T6 11751653 ↗ — Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
T2 — RCT in related condition
POTS
1 source
Parasym Transcutaneous Electrical Nerve Stimulation Device
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT03930914 ↗ — Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome
T2 — RCT in related condition
POTS
34 sources
- T6 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 35739136 ↗ — Long-COVID in children and adolescents: a systematic review and meta-analyses
- T6INDIRECT 23013600 ↗ — Associations of kidney disease measures with mortality and end-stage renal disease in individuals wi
- T6INDIRECT 35445419 ↗ — The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
- T6INDIRECT 29740819 ↗ — Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursor
- T6INDIRECT 33925784 ↗ — Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Com
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 1739631 ↗ — Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
- T6INDIRECT 20856865 ↗ — Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with sympt
- T6INDIRECT 33831043 ↗ — Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 6326753 ↗ — Oxygen toxicity, oxygen radicals, transition metals and disease
- T2 32541925 ↗ — Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million p
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 26551272 ↗ — A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- T6INDIRECT 20228401 ↗ — Effects of intensive blood-pressure control in type 2 diabetes mellitus
- T6INDIRECT 30688979 ↗ — Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical T
- T6INDIRECT 27195814 ↗ — Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75
- T6INDIRECT 20566676 ↗ — Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and e
- T6INDIRECT 19114612 ↗ — Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
- T6INDIRECT 27382171 ↗ — Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid a
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 22160349 ↗ — The novel object recognition memory: neurobiology, test procedure, and its modifications
- T6 28585944 ↗ — Cellular uptake of nanoparticles: journey inside the cell
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
Patient and Healthy Volunteers training protocol
T2
T2 — RCT in related condition
POTS
1 source
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 31473866 ↗ — Characteristics and natural history of autonomic involvement in hereditary ATTR amyloidosis: a syste
- T6INDIRECT 32311072 ↗ — Pharmacological treatment for familial amyloid polyneuropathy
- T2 39286810 ↗ — Assessing the effectiveness and safety of Patisiran and Vutrisiran in ATTRv amyloidosis with polyneu
- T6INDIRECT 32587078 ↗ — Overview of treatments used in transthyretin-related hereditary amyloidosis: a systematic review
- T6INDIRECT 42266139 ↗ — Pharmacological Interventions for Hereditary Transthyretin-Related Amyloidosis With Polyneuropathy:
- T2 28893208 ↗ — Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients
- T2 31728713 ↗ — Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in pat
- T6 28739313 ↗ — Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment
- T6 31607664 ↗ — How to Image Cardiac Amyloidosis: A Practical Approach
- T6 26611723 ↗ — Evolving landscape in the management of transthyretin amyloidosis
- T6INDIRECT 38441582 ↗ — Cardiac Amyloidosis Due to Transthyretin Protein: A Review
- T6INDIRECT 30829617 ↗ — Clinical Presentation, Diagnosis and Treatment of TTR Amyloidosis
- T6INDIRECT 32328845 ↗ — Advances in the Treatment of Cardiac Amyloidosis
- T6INDIRECT 35884871 ↗ — Re-Definition of the Epidemiology of Cardiac Amyloidosis
- T6INDIRECT 31706583 ↗ — New developments in diagnosis, risk assessment and management in systemic amyloidosis
- T6INDIRECT 36094752 ↗ — Targeting Amyloid Fibrils by Passive Immunotherapy in Systemic Amyloidosis
- T6INDIRECT 31498378 ↗ — Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review
- T6 36625940 ↗ — Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic target
- T6 32110029 ↗ — Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Pers
- T6 35256455 ↗ — Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis
- T6 31368669 ↗ — Advances in the treatment of hereditary transthyretin amyloidosis: A review
- T6 31118583 ↗ — Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
- T6 33825853 ↗ — Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myo
- T6 32785879 ↗ — A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Tran
Percutaneous electrical nerve field stimulation
T2
T2 — RCT in related condition
POTS
10 sources
- T2 39888101 ↗ — Cardiac Vagal Efficiency Is Enhanced by Percutaneous Auricular Neurostimulation in Adolescents With
- T6 39867596 ↗ — Efficacy of vagus nerve stimulation in gastrointestinal disorders: a systematic review
- T6 41553718 ↗ — Overlap of Structural Gastrointestinal Disorders in Children With Disorders of Gut-Brain Interaction
- T6INDIRECT 35616609 ↗ — Neuromodulation Using Computer-Altered Music to Treat a Ten-Year-Old Child Unresponsive to Standard
- T6 40544377 ↗ — The prevalence and predictive factors of overlapping disorders of gut-brain interaction and celiac d
- T4 PMC12463576 ↗ — Abstract
- T4 PMC11493558 ↗ — Abstract
- T4 PMC11094350 ↗ — ESPGHAN 56th Annual Meeting Abstracts
- T6 40208134 ↗ — Auricular Allodynia is Associated With Worse Outcomes in Children With Functional Abdominal Pain Dis
- T6 41735242 ↗ — Percutaneous Electrical Nerve Field Stimulation Improves Weight and Other Anthropometric Outcomes in
Percutaneous vagal nerve stimulation device
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT05212129 ↗ — Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
Physical exercise program
T2
T2 — RCT in related condition
RegisteredPOTS
24 sources
- T2REGISTERED-ONLY NCT05094622 ↗ — Physical Training in Patients With POTS After Covid-19
- T6INDIRECT 33428616 ↗ — Mindfulness-based programmes for mental health promotion in adults in nonclinical settings: A system
- T6INDIRECT 38375882 ↗ — Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obes
- T6INDIRECT 38995808 ↗ — Telerehabilitation - Historical Perspectives and Conceptual Framework in Reference to Neurological D
- T6 37990730 ↗ — Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association
- T6 32823577 ↗ — Time Course of Autonomic Symptoms in Postural Orthostatic Tachycardia Syndrome (POTS) Patients: Two-
- T6 39198662 ↗ — Individually tailored exercise in patients with postural orthostatic tachycardia syndrome related to
- T6 33823928 ↗ — Effect of the combination of automated peripheral mechanical stimulation and physical exercise on ae
- T6INDIRECT 24018704 ↗ — Physiotherapy versus placebo or no intervention in Parkinson's disease
- T6INDIRECT 33999947 ↗ — Effect of exercise training on heart rate variability in type 2 diabetes mellitus patients: A system
- T2 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T2 38588457 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T2 29721504 ↗ — Multicomponent Exercise Improves Physical Functioning but Not Cognition and Hemodynamic Parameters i
- T6 39743381 ↗ — Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults
- T6 34409961 ↗ — International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines
- T6INDIRECT 34108836 ↗ — Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Co
- T6INDIRECT 33630722 ↗ — Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Co
- T6INDIRECT 32150216 ↗ — Abstract: Symposia, Conferences, Oral communications: 10th International Conference on Frailty, Sarc
- T6INDIRECT 30583728 ↗ — Abstracts from hydrocephalus 2018: the tenth meeting of the International Society for Hydrocephalus
- T6INDIRECT 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
- T6 37358956 ↗ — Differences in fall-related characteristics across cognitive disorders
- T6 32290164 ↗ — Autonomic and Cognitive Function Response to Normobaric Hyperoxia Exposure in Healthy Subjects. Prel
- T6 32218879 ↗ — Abstracts of the 14th International Congress of the European Geriatric Medicine Society: 10-12 Octob
- T6 PMC9735049 ↗ — Abstracts of the 18th Congress of the European Geriatric Medicine Society : Live from London and Onl
Physical training program
T2
T2 — RCT in related condition
POTS
15 sources
- T6INDIRECT 32103487 ↗ — Pharmacological interventions for heart failure in people with chronic kidney disease
- T2 24714795 ↗ — Physical training as non-pharmacological treatment of neurocardiogenic syncope
- T6 39458423 ↗ — Acute Sarcopenia: Mechanisms and Management
- T6 22738091 ↗ — Exercise in multiple sclerosis -- an integral component of disease management
- T6 24278164 ↗ — Oxygen and ventilatory output during several activities of daily living performed by COPD patients s
- T6 24278871 ↗ — Effect of long-term resistance exercise on body composition, blood lipid factors, and vascular compl
- T6INDIRECT 37623481 ↗ — Feasibility of a Virtual-Reality-Enabled At-Home Telerehabilitation Program for Stroke Survivors: A
- T6INDIRECT 31204865 ↗ — Supplement
- T4 PMC8487351 ↗ — UEG Week 2021 Poster Presentations
- T4 PMC7103906 ↗ — Posters
- T4 PMC3459571 ↗ — POSTER AWARD WINNER EDUCATION : SCI-U: AN INNOVATIVE APPROACH TO ONLINE PATIENT EDUCATION IN SPINAL
- T6 PMC1876334 ↗ — Abstracts
- T6 38792307 ↗ — Multi-Modal Prehabilitation in Thoracic Surgery: From Basic Concepts to Practical Modalities
- T6 35034521 ↗ — Pathophysiology and clinical evaluation of the patient with unexplained persistent dyspnea
- T6 40318694 ↗ — Multimorbidity, Muscle Strength, and Falls among Older Mexican Americans
Postural orthostatic tachycardia syndrome
T2
T2 — RCT in related condition
POTS
29 sources
- T6 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6INDIRECT 34509649 ↗ — Post-COVID syndrome. A case series and comprehensive review
- T6INDIRECT 36223120 ↗ — Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic R
- T6INDIRECT 31755549 ↗ — Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention o
- T6INDIRECT 29740819 ↗ — Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursor
- T6INDIRECT 34017846 ↗ — Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic
- T2 19687359 ↗ — Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less i
- T6INDIRECT 26690066 ↗ — The international POTS registry: Evaluating the efficacy of an exercise training intervention in a c
- T6INDIRECT 25304766 ↗ — The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods
- T2 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6 34308300 ↗ — Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 35594336 ↗ — Pathophysiology and mechanism of long COVID: a comprehensive review
- T6INDIRECT 29503439 ↗ — Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T4 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 37748514 ↗ — Distinguishing features of long COVID identified through immune profiling
- T4 29036855 ↗ — Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): Consensus document of the c
- T6 35105985 ↗ — Pathological sequelae of long-haul COVID
- T6 37919282 ↗ — Smart nanoparticles for cancer therapy
- T6 33856918 ↗ — COVID-19 and Cardiovascular Disease: From Bench to Bedside
- T6 30871703 ↗ — Autonomic Nervous System Dysfunction: JACC Focus Seminar
- T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
- T6 25420112 ↗ — Pulmonary arteriovenous malformations
- T6 31447842 ↗ — Fatigue, Sleep, and Autoimmune and Related Disorders
- T6 26275795 ↗ — Vaccines, adjuvants and autoimmunity
- T6 21777306 ↗ — Myalgic encephalomyelitis: International Consensus Criteria
T2 — RCT in related condition
RegisteredPOTS
2 sources
- T2REGISTERED-ONLY NCT06593600 ↗ — Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostati
- T6 41703216 ↗ — Natriuretic peptide signaling as a therapeutic target in POTS: physiological opportunities and cavea
T2 — RCT in related condition
POTS
6 sources
- T2 NCT02725060 ↗ — Autoimmune Basis for Postural Tachycardia Syndrome
- T6 36399385 ↗ — Cardiac function, structural, and electrical remodeling by microgravity exposure
- T6INDIRECT 40944681 ↗ — Exacerbation of Postural Orthostatic Tachycardia Syndrome With Tirzepatide Prescribed for Weight Los
- T6 25059240 ↗ — Acute volume loading and exercise capacity in postural tachycardia syndrome
- T6 31633009 ↗ — Inflight leg cuff test does not identify the risk for orthostatic hypotension after long-duration sp
- T6 35547180 ↗ — The Elevated Central Chemosensitivity in Obstructive Sleep Apnea Patients with Hypertension
T2 — RCT in related condition
POTS
30 sources
- T2 NCT02854683 ↗ — Reducing Orthostatic Intolerance With Oral Rehydration in Myalgic Encephalomyelitis/Chronic Fatigue
- T6INDIRECT 36697370 ↗ — Interventions to improve sanitation for preventing diarrhoea
- T6INDIRECT 31549742 ↗ — Interventions to improve disposal of child faeces for preventing diarrhoea and soil-transmitted helm
- T6INDIRECT 33832950 ↗ — Delivering nutrition interventions to women and children in conflict settings: a systematic review
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T6INDIRECT 40859389 ↗ — Mapping cerebral blood flow in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and ortho
- T6INDIRECT 31973701 ↗ — The value of monitoring data in a process evaluation of hygiene behaviour change in Community Health
- T2 31405524 ↗ — The Benefits of Oral Rehydration on Orthostatic Intolerance in Children with Postural Tachycardia Sy
- T6HARM 30001836 ↗ — Exercise and non-pharmacological treatment of POTS
- T6 25475887 ↗ — Severe acute malnutrition and infection
- T6 20388747 ↗ — Proteomic analysis of the effects of ABA treatments on ripening Vitis vinifera berries
- T6 25887480 ↗ — Proteomic analysis of Citrus sinensis roots and leaves in response to long-term magnesium-deficiency
- T6 26975701 ↗ — Physiological and proteomic responses to salt stress in chloroplasts of diploid and tetraploid black
- T6INDIRECT 29198916 ↗ — Anxiety-related adverse events following immunization (AEFI): A systematic review of published clust
- T6INDIRECT 25928418 ↗ — Travellers' diarrhoea
- T6INDIRECT 23869185 ↗ — The effect of intraoperative use of high-dose remifentanil on postoperative insulin resistance and m
- T6INDIRECT 34885995 ↗ — Narrative Review of Primary Preventive Interventions against Water-Borne Diseases: Scientific Eviden
- T6INDIRECT 40059405 ↗ — International society of sports nutrition position stand: nutrition and weight cut strategies for mi
- T6INDIRECT 26079713 ↗ — Valuing and Sustaining (or Not) the Ability of Volunteer Community Health Workers to Deliver Integra
- T6 21723922 ↗ — Calpain inhibition protected spinal cord motoneurons against 1-methyl-4-phenylpyridinium ion and rot
- T6 33604464 ↗ — A comparative proteomic study of cold responses in potato leaves
- T6 31640549 ↗ — 2-DE-based proteomic analysis of protein changes associated with etiolated mesocotyl growth in Zea m
- T6 30745707 ↗ — Clinical Practice Guidelines on Assessment and Management of Substance Abuse Disorder in Children an
- T6 29682691 ↗ — Abstracts of the MASCC/ISOO Annual Meeting 2018
- T6 3595395 ↗ — Prospects for effective non-antimicrobial antidiarrheal agents. Conference on Non-antimicrobial Anti
- T6 PMC7166990 ↗ — Research Abstract Program of the 20th Annual ACVIM Forum Dallas, TX, May 29‐June 1, 2002
- T6 24194646 ↗ — Management strategies in the treatment of neonatal and pediatric gastroenteritis
- T6 21694853 ↗ — Acute gastroenteritis: from guidelines to real life
- T6 23443111 ↗ — Wheat drought-responsive grain proteome analysis by linear and nonlinear 2-DE and MALDI-TOF mass spe
- T6 27350278 ↗ — Body Mass Index (BMI) is Associated with the Therapeutic Response to Oral Rehydration Solution in Ch
T2 — RCT in related condition
RegisteredPOTS
2 sources
- T2REGISTERED-ONLY NCT04271878 ↗ — Hypercapnia and Orthostatic Tolerance in Postural Orthostatic Tachycardia Syndrome
- T6 37157056 ↗ — Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease
STEPS management protocol
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT06268288 ↗ — Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Synd
Safinamide Methanesulfonate
T2
T2 — RCT in related condition
POTS
1 source
- T2 33674954 ↗ — Overall Efficacy and Safety of Safinamide in Parkinson's Disease: A Systematic Review and a Meta-ana
T2 — RCT in related condition
RegisteredPOTS
30 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 28854296 ↗ — Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake In
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 26130211 ↗ — A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER
- T6INDIRECT 33687070 ↗ — Smoking cessation for improving mental health
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T2 15507582 ↗ — Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obse
- T6INDIRECT 20855047 ↗ — Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study
- T6INDIRECT 22024003 ↗ — Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training
- T6INDIRECT 21934055 ↗ — Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorde
- T6 26111766 ↗ — SLC transporters as therapeutic targets: emerging opportunities
- T6 35430029 ↗ — Functional neurological disorder: new subtypes and shared mechanisms
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 17943857 ↗ — Antidepressants for neuropathic pain
- T6INDIRECT 28178949 ↗ — Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 19092112 ↗ — A controlled trial of antidepressants in patients with Parkinson disease and depression
- T6INDIRECT 12388617 ↗ — Dopamine modulates the response of the human amygdala: a study in Parkinson's disease
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 24229653 ↗ — What are the causes of late-life depression?
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6 10379421 ↗ — Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines an
- T6 22407614 ↗ — Serotonin and blood pressure regulation
- T6 15320756 ↗ — Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?
- T6 30975301 ↗ — Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Ar
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 29975336 ↗ — Depression and Anxiety in Heart Failure: A Review
Shared medical appointment
T2
T2 — RCT in related condition
POTS
11 sources
- T2 NCT05454137 ↗ — A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS
- T6 32725471 ↗ — Abstracts from the 2020 Annual Meeting of the Society of General Internal Medicine
- T6 24737224 ↗ — Abstracts from the 37th Annual Meeting of the Society of General Internal Medicine, 2014, San Diego,
- T6 PMC6796246 ↗ — UEG Week 2018 Poster Presentations
- T6 17703327 ↗ — Abstracts of the Society of General Internal Medicine 29th Annual Meeting, April 26-29, 2006, Los An
- T6 PMC13111897 ↗ — 2026 International Congress Abstract Supplement
- T2 28445783 ↗ — Jump starting shared medical appointments for diabetes with weight management: Rationale and design
- T6 30972554 ↗ — Assessing an Interprofessional Polypharmacy and Deprescribing Educational Intervention for Primary C
- T6 23625304 ↗ — Abstracts of the 36th Annual Meeting of the Society of General Internal Medicine. April 24-27, 2013.
- T4 PMC9471381 ↗ — ICIMH 2022 Abstracts
- T6INDIRECT 31123663 ↗ — CPNP 2019 Annual Meeting Poster Abstracts
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 30701543 ↗ — Phosphodiesterase 5 inhibitors for pulmonary hypertension
- T2 20484178 ↗ — A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis
- T6INDIRECT 31841599 ↗ — Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2
- T2 10930961 ↗ — Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir
- T2 11511713 ↗ — Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson'
- T6INDIRECT 15540759 ↗ — Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and
- T6INDIRECT 24316514 ↗ — Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results
- T6INDIRECT 23266540 ↗ — Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic f
- T6INDIRECT 27113485 ↗ — Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
- T6INDIRECT 22857780 ↗ — Avanafil for the treatment of erectile dysfunction: a multicenter, randomized, double-blind study in
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 30218025 ↗ — Mechanisms, biomarkers and targets for adult-onset Still's disease
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 16461471 ↗ — Diabetic neuropathy
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 25621208 ↗ — Chronic complications of spinal cord injury
Sodium Chloride Capsules
T2
T2 — RCT in related condition
POTS
2 sources
- T2 33926653 ↗ — Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome
- T6INDIRECT 30298552 ↗ — Efficacy of fluid loading as a countermeasure to the hemodynamic and hormonal changes of 28-h head-d
T2 — RCT in related condition
POTS
32 sources
- T2 NCT03602482 ↗ — Standing Cognition and Co-morbidities of POTS Evaluation
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 21571570 ↗ — Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis
- T6INDIRECT 30873598 ↗ — Multiple-micronutrient supplementation for women during pregnancy
- T6INDIRECT 35445419 ↗ — The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
- T6INDIRECT 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 8673750 ↗ — Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained synco
- T6INDIRECT 8828642 ↗ — Orthostatic intolerance after spaceflight
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 8941538 ↗ — Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight
- T6INDIRECT 29649928 ↗ — Non-Invasive Activation of Cervical Spinal Networks after Severe Paralysis
- T6 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6HARM 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 26551272 ↗ — A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- T6INDIRECT 20228401 ↗ — Effects of intensive blood-pressure control in type 2 diabetes mellitus
- T6INDIRECT 27195814 ↗ — Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75
- T6INDIRECT 19114612 ↗ — Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
- T6INDIRECT 24067431 ↗ — Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflo
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 28642330 ↗ — Effects of Intensive BP Control in CKD
- T6INDIRECT 16505299 ↗ — Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 28467028 ↗ — Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 33894193 ↗ — Challenges in the diagnosis of Parkinson's disease
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6 34308300 ↗ — Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
Stellate Ganglion Block
T2
T2 — RCT in related condition
POTS
22 sources
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 36375174 ↗ — Pharmacological interventions for people with borderline personality disorder
- T6INDIRECT 34291816 ↗ — Interventions for the management of abdominal pain in ulcerative colitis
- T2 41973314 ↗ — Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review
- T2 24496086 ↗ — Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clin
- T2 40504522 ↗ — Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: A Randomized Clinical Trial
- T2 40739539 ↗ — A prospective randomized clinical trial on the differential effect of left versus right stellate gan
- T6INDIRECT 8792601 ↗ — Intravenous regional anesthesia with ketorolac-lidocaine for the management of sympathetically-media
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6 29276402 ↗ — Ganglion blocks as a treatment of pain: current perspectives
- T5 34922127 ↗ — Stellate ganglion block reduces symptoms of Long COVID: A case series
- T5 36106285 ↗ — Stellate Ganglion Block for Anosmia and Dysgeusia Due to Long COVID
- T6INDIRECT 25584767 ↗ — Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy
- T4 36949968 ↗ — A Review of Stellate Ganglion Block as an Adjunctive Treatment Modality
- T6INDIRECT 37166736 ↗ — Autonomic control of ventricular function in health and disease: current state of the art
- T6INDIRECT 36074973 ↗ — Sinus Tachycardia: a Multidisciplinary Expert Focused Review
- T6 34603069 ↗ — Asymmetry and Heterogeneity: Part and Parcel in Cardiac Autonomic Innervation and Function
- T6 35411324 ↗ — Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From t
- T6 40046430 ↗ — Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechan
- T6 39340173 ↗ — Neurocardiology: translational advancements and potential
- T6 35811701 ↗ — The Mechanism of Cardiac Sympathetic Activity Assessment Methods: Current Knowledge
- T6 34386109 ↗ — JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias
T2 — RCT in related condition
RegisteredPOTS
32 sources
- T2REGISTERED-ONLY NCT02281097 ↗ — Transdermal Vagal Stimulation for POTS
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 16614072 ↗ — Element interactions limit soil carbon storage
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 36915214 ↗ — Roles of neuropathology-associated reactive astrocytes: a systematic review
- T6INDIRECT 25233067 ↗ — Systematic review of potential health risks posed by pharmaceutical, occupational and consumer expos
- T6INDIRECT 24920437 ↗ — Central changes associated with chronic pelvic pain and endometriosis
- T6INDIRECT 19205066 ↗ — Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique
- T6INDIRECT 29649928 ↗ — Non-Invasive Activation of Cervical Spinal Networks after Severe Paralysis
- T6INDIRECT 31830003 ↗ — Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cy
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 26447819 ↗ — Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medicat
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 24361112 ↗ — Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Par
- T6INDIRECT 16505299 ↗ — Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI
- T2 27382171 ↗ — Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid a
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 21749363 ↗ — Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 23359374 ↗ — Criteria for the diagnosis of corticobasal degeneration
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 23968694 ↗ — Sugar for the brain: the role of glucose in physiological and pathological brain function
- T6 36148880 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes As
- T6 27980341 ↗ — Induced pluripotent stem cell technology: a decade of progress
- T6 17273548 ↗ — Physiology and immunology of the cholinergic antiinflammatory pathway
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
T2 — RCT in related condition
WithdrawnPOTS
26 sources
- T2WITHDRAWN NCT04855266 ↗ — Iron Sucrose in Patients With Iron Deficiency and POTS
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30556597 ↗ — Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people
- T6INDIRECT 25233067 ↗ — Systematic review of potential health risks posed by pharmaceutical, occupational and consumer expos
- T6INDIRECT 34564844 ↗ — Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: a
- T6INDIRECT 30635141 ↗ — Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
- T6INDIRECT 26275453 ↗ — Effect of fortified complementary food supplementation on child growth in rural Bangladesh: a cluste
- T6INDIRECT 25029210 ↗ — Metabolic fate of fructose ingested with and without glucose in a mixed meal
- T6INDIRECT 24878745 ↗ — Learning to eat vegetables in early life: the role of timing, age and individual eating traits
- T6 22859206 ↗ — Defining the core Arabidopsis thaliana root microbiome
- T6 17406292 ↗ — Agrobacterium-mediated transformation of Arabidopsis thaliana using the floral dip method
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 22937145 ↗ — Oxytocin increases heart rate variability in humans at rest: implications for social approach-relate
- T6INDIRECT 23642721 ↗ — Guillain-Barré syndrome and variants
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 18085482 ↗ — Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide
- T6INDIRECT 32039382 ↗ — From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 12034882 ↗ — Regulation of SOS1, a plasma membrane Na+/H+ exchanger in Arabidopsis thaliana, by SOS2 and SOS3
- T6 24274116 ↗ — Enhancement of oxidative and drought tolerance in Arabidopsis by overaccumulation of antioxidant fla
- T6 30013066 ↗ — Root exudate metabolites drive plant-soil feedbacks on growth and defense by shaping the rhizosphere
- T6 24196324 ↗ — Rhizosphere microbiome assemblage is affected by plant development
T2 — RCT in related condition
POTS
33 sources
- T2 NCT03602482 ↗ — Standing Cognition and Co-morbidities of POTS Evaluation
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 21571570 ↗ — Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 35445419 ↗ — The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
- T6INDIRECT 26607938 ↗ — Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, doub
- T6INDIRECT 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 8673750 ↗ — Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained synco
- T6INDIRECT 8828642 ↗ — Orthostatic intolerance after spaceflight
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 8941538 ↗ — Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight
- T6 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6 21890520 ↗ — Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may b
- T6INDIRECT 26447819 ↗ — Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medicat
- T6INDIRECT 19114612 ↗ — Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
- T6INDIRECT 24067431 ↗ — Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflo
- T6INDIRECT 9091692 ↗ — Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind m
- T6INDIRECT 22446170 ↗ — Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in pati
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 2666581 ↗ — Multiple system atrophy--the nature of the beast
- T6INDIRECT 29503439 ↗ — Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 25834232 ↗ — Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 26595642 ↗ — Lewy body dementias
- T6 24713270 ↗ — Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in hu
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 36178003 ↗ — World guidelines for falls prevention and management for older adults: a global initiative
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
TVNS + Slow-Paced Breathing
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT06996314 ↗ — Effects of Auricular Vagus Nerve Stimulation Combined With Slow-paced Breathing on Individuals With
TVNS without Breathing Training
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT06996314 ↗ — Effects of Auricular Vagus Nerve Stimulation Combined With Slow-paced Breathing on Individuals With
Tamsulosin Hydrochloride
T2
T2 — RCT in related condition
POTS
18 sources
- T6INDIRECT 29620795 ↗ — Alpha-blockers as medical expulsive therapy for ureteral stones
- T6INDIRECT 29161773 ↗ — Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- T2 21745239 ↗ — Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for urosel
- T6 21753871 ↗ — Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
- T6 37415648 ↗ — Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia
- T6 21455413 ↗ — Benign prostatic hyperplasia: An overview of existing treatment
- T6 34876420 ↗ — Randomised, quadruple blinded, placebo controlled, multicentre trial investigating prophylactic tams
- T6INDIRECT 42015293 ↗ — Overflow urinary incontinence as an early manifestation of neuronal intranuclear inclusion disease (
- T6INDIRECT 40433175 ↗ — Case report: Case series of urinary retention in young adults with severe autism hospitalized for be
- T6INDIRECT 32607315 ↗ — Sacral Neuromodulation in a Patient with Wolff-Parkinson-White Syndrome: A Case Report
- T6INDIRECT 38805053 ↗ — Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directio
- T6INDIRECT 41393662 ↗ — The Comparative Effectiveness of PDE5 Inhibitors and β3 Agonists Versus α-Blockers in Medical Expuls
- T6INDIRECT 38217372 ↗ — ACVIM consensus statement on diagnosis and management of urinary incontinence in dogs
- T6 36051157 ↗ — Evolving Role of Silodosin for the Treatment of Urological Disorders - A Narrative Review
- T6 8531059 ↗ — [Discovery and development of tamsulosin hydrochloride, a new alpha 1-adrenoceptor antagonist]
- T6 25328864 ↗ — Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient
- T6 24198606 ↗ — Management of benign prostatic hyperplasia with silodosin
- T6 33678164 ↗ — Evaluation of static and dynamic Pupillometry changes in men using Silodosin for benign prostatic hy
T2 — RCT in related condition
POTS
7 sources
- T2 1375659 ↗ — The safety, efficacy and compliance of terazosin therapy for benign prostatic hyperplasia
- T2 18159592 ↗ — High-dose terazosin therapy (5mg) in Korean patients with lower urinary tract symptoms with or witho
- T6 15860960 ↗ — Treatment of benign prostatic hyperplasia in hypertensive men
- T6 21455413 ↗ — Benign prostatic hyperplasia: An overview of existing treatment
- T6 39044238 ↗ — Effect of low-dose terazosin on arterial stiffness improvement: A pilot study
- T6 15369424 ↗ — Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hype
- T6INDIRECT 28100576 ↗ — Perioperative management of a large, late presenting phaeochromocytoma
Time restricted eating
T2
T2 — RCT in related condition
RegisteredPOTS
22 sources
- T2REGISTERED-ONLY NCT05409651 ↗ — Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.
- T6INDIRECT 38375882 ↗ — Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obes
- T2 36839342 ↗ — An Intervention of Four Weeks of Time-Restricted Eating (16/8) in Male Long-Distance Runners Does No
- T6 35465246 ↗ — Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for
- T6 37990730 ↗ — Thirty Obesity Myths, Misunderstandings, and/or Oversimplifications: An Obesity Medicine Association
- T6 34468792 ↗ — 57<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes
- T6INDIRECT 42124054 ↗ — Intermittent Fasting and Healthy Aging in Older Adults: A Systematic Review of Cardiometabolic, Ment
- T2 41859904 ↗ — Effect of 2 Weeks of Time-Restricted Eating on Innate Immunity and Systemic Inflammation in Patients
- T6 36148880 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes As
- T6 36151309 ↗ — Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes A
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 34327491 ↗ — Ten things to know about ten cardiovascular disease risk factors
- T6 39651983 ↗ — 5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Ca
- T6INDIRECT 39334239 ↗ — Cardiovascular adaptations and pathological changes induced by spaceflight: from cellular mechanisms
- T6INDIRECT 38731912 ↗ — Brain-Periphery Interactions in Huntington's Disease: Mediators and Lifestyle Interventions
- T6INDIRECT 41470894 ↗ — Endocrine Adaptations to Prolonged Fasting: From Physiology, Clinical Uncertainties, Translational C
- T6INDIRECT 39091005 ↗ — 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of t
- T6INDIRECT 40631460 ↗ — 2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Dia
- T6INDIRECT 35500564 ↗ — ZoomForward2022: European Congress on Obesity
- T6 40492113 ↗ — Linking oxidative stress biomarkers to disease progression and antioxidant therapy in hypertension a
- T6 41500519 ↗ — Unlocking the potential of circadian biology for cardiovascular health
- T6 35517870 ↗ — Ten things to know about ten cardiovascular disease risk factors - 2022
T2 — RCT in related condition
RegisteredWithdrawnPOTS
33 sources
- T2REGISTERED-ONLY NCT05554107 ↗ — The Effect of Physical Activity on Postural Orthostatic Tachycardia Syndrome
- T2WITHDRAWN NCT04702217 ↗ — Physical Activity as a Complementary Treatment in POTS
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T2 29939051 ↗ — Brief mindfulness training for negative affectivity: A systematic review and meta-analysis
- T6INDIRECT 33428616 ↗ — Mindfulness-based programmes for mental health promotion in adults in nonclinical settings: A system
- T2 36497565 ↗ — The Effect of Resistance Training on the Rehabilitation of Elderly Patients with Sarcopenia: A Meta-
- T6INDIRECT 36282618 ↗ — Support for healthy breastfeeding mothers with healthy term babies
- T6INDIRECT 20223994 ↗ — Supine cycling plus volume loading prevent cardiovascular deconditioning during bed rest
- T6INDIRECT 22345434 ↗ — Effect of rowing ergometry and oral volume loading on cardiovascular structure and function during b
- T6INDIRECT 31685792 ↗ — Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary s
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 14711655 ↗ — Census of the bacterial community of the gypsy moth larval midgut by using culturing and culture-ind
- T6 16537132 ↗ — Costs and benefits of symbiont infection in aphids: variation among symbionts and across temperature
- T6 19363018 ↗ — The Alzheimer's Disease Knowledge Scale: development and psychometric properties
- T6INDIRECT 24018704 ↗ — Physiotherapy versus placebo or no intervention in Parkinson's disease
- T6INDIRECT 24748784 ↗ — Physical activity and cognitive function in individuals over 60 years of age: a systematic review
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 22807627 ↗ — A randomized controlled trial of Tai chi for balance, sleep quality and cognitive performance in eld
- T6INDIRECT 25229735 ↗ — A randomized trial of functional electrical stimulation for walking in incomplete spinal cord injury
- T6INDIRECT 35679471 ↗ — Human temperature regulation under heat stress in health, disease, and injury
- T6INDIRECT 18665659 ↗ — Pathophysiology and treatment of psychosis in Parkinson's disease: a review
- T6INDIRECT 26198889 ↗ — Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance
- T6INDIRECT 24093767 ↗ — Genotype- and phenotype-guided management of congenital long QT syndrome
- T6INDIRECT 30001836 ↗ — Exercise and non-pharmacological treatment of POTS
- T6INDIRECT 26715466 ↗ — The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease
- T6INDIRECT 25274845 ↗ — Cerebrovascular regulation, exercise, and mild traumatic brain injury
- T6 18054395 ↗ — Treatment of Argentine hemorrhagic fever
- T6 20852669 ↗ — Optimal management of sarcopenia
- T6 39743381 ↗ — Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults
- T6 30786722 ↗ — Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
- T6 22012131 ↗ — A practical approach to the treatment of depression in patients with chronic kidney disease and end-
- T6 34409961 ↗ — International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines
Transcutaneous Vagus Nerve Stimulation
T2
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 40857067 ↗ — Phenotype characterization of heart failure with preserved ejection fraction in medical device and s
- T6INDIRECT 35023349 ↗ — Neuromodulation of Inflammation to Treat Heart Failure With Preserved Ejection Fraction: A Pilot Ran
- T6INDIRECT 30560316 ↗ — Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans
- T6INDIRECT 37999672 ↗ — Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
- T6INDIRECT 39969124 ↗ — Non-invasive vagus nerve stimulation and exercise capacity in healthy volunteers: a randomized trial
- T2 39402309 ↗ — Acute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in pa
- T6INDIRECT 39969545 ↗ — Feasibility and acceptance of transdermal auricular vagus nerve stimulation using a TENS device in f
- T6INDIRECT 41068419 ↗ — Feasibility, safety and efficacy of multi-dose vagus nerve stimulation in Parkinson's disease: a dou
- T6 35269591 ↗ — The Interplay between Autonomic Nervous System and Inflammation across Systemic Autoimmune Diseases
- T6 33999297 ↗ — The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrativ
- T6INDIRECT 35616609 ↗ — Neuromodulation Using Computer-Altered Music to Treat a Ten-Year-Old Child Unresponsive to Standard
- T5 38110825 ↗ — Transcutaneous vagus nerve stimulation as a potential novel treatment for cyclic vomiting syndrome:
- T6INDIRECT 40056025 ↗ — Clinical neurocardiology: defining the value of neuroscience-based cardiovascular therapeutics - 202
- T6INDIRECT 39319097 ↗ — Effect of neuromodulation for chronic pain on the autonomic nervous system: a systematic review
- T6INDIRECT 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
- T6INDIRECT 39896735 ↗ — Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people w
- T4 37532979 ↗ — Safety and feasibility of transcutaneous vagus nerve stimulation in mild cognitive impairment: VINCI
- T4 35318234 ↗ — Transcutaneous vagus nerve stimulation in erosive hand osteoarthritis: protocol for the randomised,
- T6 31083399 ↗ — Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amylo
- T6 33532701 ↗ — The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer's Disease and Aging: A Review
- T6 33807256 ↗ — Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
- T6 32435491 ↗ — Altered cardiorespiratory regulation during exercise in patients with Parkinson's disease: A challen
- T6 34159566 ↗ — Current Insights into Treating Vertigo in Older Adults
- T6 30623126 ↗ — A unifying conceptual framework of factors associated to cardiac vagal control
Transcutaneous auricular vagus nerve stimulation
T2
T2 — RCT in related condition
RegisteredPOTS
26 sources
- T2REGISTERED-ONLY NCT07163130 ↗ — Tragus Stimulation for POTS Treatment
- T6INDIRECT 40356702 ↗ — The developments and emerging trends of Autonomic Nervous System Research in Arrhythmia: a bibliomet
- T6INDIRECT 39969545 ↗ — Feasibility and acceptance of transdermal auricular vagus nerve stimulation using a TENS device in f
- T6INDIRECT 36940750 ↗ — Prefrontal tDCS modulates autonomic responses in COVID-19 inpatients
- T6INDIRECT 41927730 ↗ — Post-exercise auricular vagus nerve stimulation modulates autonomic and recovery responses in physic
- T6INDIRECT 40908377 ↗ — Effects of taVNS on physiological responses and cognitive performance during a mental stressor
- T2 41345210 ↗ — Bilateral transcutaneous auricular vagus nerve stimulation for the treatment of insomnia in breast c
- T6 33828455 ↗ — Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases
- T6 35784842 ↗ — "The Wandering Nerve Linking Heart and Mind" - The Complementary Role of Transcutaneous Vagus Nerve
- T6 37388279 ↗ — Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
- T6 34446089 ↗ — A method to quantify autonomic nervous system function in healthy, able-bodied individuals
- T6 39448636 ↗ — Vagus nerve stimulation in Parkinson's disease: a scoping review of animal studies and human subject
- T6INDIRECT 40995146 ↗ — Non-invasive brain stimulation for stroke-related motor impairment and disability: an umbrella revie
- T2 41549029 ↗ — Home-based transcutaneous auricular vagus nerve stimulation (taVNS) improves motor and non-motor sym
- T5 38110825 ↗ — Transcutaneous vagus nerve stimulation as a potential novel treatment for cyclic vomiting syndrome:
- T6INDIRECT 39867596 ↗ — Efficacy of vagus nerve stimulation in gastrointestinal disorders: a systematic review
- T6INDIRECT 40279198 ↗ — Gut neuropeptide involvement in Parkinson's disease
- T6INDIRECT 39967766 ↗ — A Review of Advances in Multimodal Treatment Strategies for Chronic Disorders of Consciousness Follo
- T6INDIRECT 41781173 ↗ — A Review of Vagus Nerve Stimulation for Disease: Comprehensive Theory and Evidence for Mechanisms of
- T6INDIRECT 40218285 ↗ — Current Concepts in Gastroparesis and Gastric Neuromuscular Disorders-Pathophysiology, Diagnosis, an
- T6INDIRECT 39896735 ↗ — Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people w
- T6 40305215 ↗ — Heart Rate Variability, Microvascular Dysfunction, and Inflammation: Exploring the Potential of taVN
- T6 37554394 ↗ — Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating f
- T6 36873318 ↗ — Low-level tragus stimulation improves autoantibody-induced hyperadrenergic postural tachycardia synd
- T6 39648211 ↗ — Exploring the efficacy of Transcutaneous Auricular Vagus nerve stimulation (taVNS) in modulating loc
- T6 37374012 ↗ — Social Isolation: A Narrative Review on the Dangerous Liaison between the Autonomic Nervous System a
Transcutaneous vagal nerve stimulation
T2
T2 — RCT in related condition
POTS
17 sources
- T2 NCT04632134 ↗ — Long-term Effects of Transcutaneous Vagal Nerve Stimulation on Postural Orthostatic Tachycardia Synd
- T6 33586685 ↗ — Gastrointestinal motility disorders in neurologic disease
- T6 34692718 ↗ — Immunopathophysiology of Juvenile Spondyloarthritis (jSpA): The "Out of the Box" View on Epigenetics
- T6 37771451 ↗ — Treatment of non-epileptic episodes of anxious, fearful behavior in adolescent juvenile neuronal cer
- T6 35959570 ↗ — Association of Autonomic Activation with traumatic reminder challenges in posttraumatic stress disor
- T6 33043826 ↗ — <b>UEG</b> Week 2020 Poster Presentations
- T2 34925341 ↗ — Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tum
- T6 27330903 ↗ — Recent advances in migraine therapy
- T6 37416924 ↗ — When blood pressure refuses to budge: exploring the complexity of resistant hypertension
- T6 36845167 ↗ — Ganglionic Plexus Ablation: A Step-by-step Guide for Electrophysiologists and Review of Modalities f
- T6 37532979 ↗ — Safety and feasibility of transcutaneous vagus nerve stimulation in mild cognitive impairment: VINCI
- T6INDIRECT 38586798 ↗ — Refractory Autonomic Instability in Mild Traumatic Brain Injury: A Case Report
- T6INDIRECT 41134786 ↗ — Case-control study of autonomic symptoms in the setting of Long COVID with tilt table testing
- T6INDIRECT 32949293 ↗ — Program and Abstracts of the 31st International Symposium on the Autonomic Nervous System
- T4 PMC8317256 ↗ — BNA 2021 Festival of Neuroscience Poster abstracts
- T6 35024055 ↗ — Neuromodulatory Approaches for Atrial Fibrillation Ablation
- T6 41359106 ↗ — Peripheral Parasympathetic Networks in Pain: A Systems-Level Review of Mechanisms and Modulations
Transdiagnostic Group-Based Treatment
T2
T2 — RCT in related condition
POTS
1 source
T2 — RCT in related condition
RegisteredPOTS
32 sources
- T2REGISTERED-ONLY NCT03124355 ↗ — Vagal Stimulation in POTS
- T6REGISTERED-ONLY NCT05043051 ↗ — Autoimmune Basis for Postural Tachycardia Syndrome
- T6INDIRECT 41668172 ↗ — Potential application of brain-gut axis-based treatments in Long COVID and ME/CFS: a case-based syst
- T6INDIRECT 18240245 ↗ — A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyal
- T6INDIRECT 39969124 ↗ — Non-invasive vagus nerve stimulation and exercise capacity in healthy volunteers: a randomized trial
- T6INDIRECT 34582903 ↗ — Effects of lidocaine and esmolol on hemodynamic response to tracheal intubation: a randomized clinic
- T6INDIRECT 41927730 ↗ — Post-exercise auricular vagus nerve stimulation modulates autonomic and recovery responses in physic
- T6INDIRECT 26387781 ↗ — Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motilit
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6 29467611 ↗ — The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis
- T6 33243837 ↗ — Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
- T6 30871703 ↗ — Autonomic Nervous System Dysfunction: JACC Focus Seminar
- T6 34128471 ↗ — Brain-gut axis dysfunction in the pathogenesis of traumatic brain injury
- T6 42342403 ↗ — Effects of auricular vagal neuromodulation therapy combined with slow-paced diaphragmatic breathing
- T6INDIRECT 31391000 ↗ — Swallow syncope: a case report and review of literature
- T6INDIRECT 30560316 ↗ — Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans
- T2 974610 ↗ — Observations on electrocardiogram and plasma catecholamines during dental procedures: the forgotten
- T6INDIRECT 27736760 ↗ — Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administrati
- T6INDIRECT 33387632 ↗ — Effects of Low-Level Tragus Stimulation on Endothelial Function in Heart Failure With Reduced Ejecti
- T6INDIRECT 21263060 ↗ — Swallow syncope: a case report and review of the literature
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 30961531 ↗ — Primary headaches during lifespan
- T6INDIRECT 39082698 ↗ — Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientifi
- T6INDIRECT 35449490 ↗ — Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature
- T6INDIRECT 16632674 ↗ — Cardiac disease and Rett syndrome
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 22331383 ↗ — Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular d
- T6 33828455 ↗ — Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases
- T6 10814617 ↗ — Recreational drug misuse: issues for the cardiologist
- T6 32700055 ↗ — The extended autonomic system, dyshomeostasis, and COVID-19
- T6 35269591 ↗ — The Interplay between Autonomic Nervous System and Inflammation across Systemic Autoimmune Diseases
- T6 25621208 ↗ — Chronic complications of spinal cord injury
Waist-High Compression Tights
T2
T2 — RCT in related condition
RegisteredPOTS
2 sources
- T2REGISTERED-ONLY NCT04881318 ↗ — Compression Garments in the Community With POTS
- T6 39582711 ↗ — One Size Does Not Fit All: An Exploration of Compression Garment Use in Patients With Postural Ortho
Whole-body Electrical Muscle Stimulation Exercise
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT07478172 ↗ — Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
T2 — RCT in related condition
POTS
25 sources
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 25432016 ↗ — Exercise for reducing fear of falling in older people living in the community
- T6INDIRECT 33687070 ↗ — Smoking cessation for improving mental health
- T6INDIRECT 33428616 ↗ — Mindfulness-based programmes for mental health promotion in adults in nonclinical settings: A system
- T6INDIRECT 24595586 ↗ — Non-surgical interventions for the management of chronic pelvic pain
- T6INDIRECT 35056352 ↗ — Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis
- T6INDIRECT 24748784 ↗ — Physical activity and cognitive function in individuals over 60 years of age: a systematic review
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T2 20946990 ↗ — A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalg
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6INDIRECT 25420112 ↗ — Pulmonary arteriovenous malformations
- T6INDIRECT 25309504 ↗ — Management of fatigue in persons with multiple sclerosis
- T6INDIRECT 29628432 ↗ — Cognitive and psychological issues in postural tachycardia syndrome
- T6INDIRECT 21115758 ↗ — Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Asso
- T6 29090092 ↗ — Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential trea
- T6 29163522 ↗ — The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Trac
- T6 26062169 ↗ — Fear and the Defense Cascade: Clinical Implications and Management
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
- T6 36178003 ↗ — World guidelines for falls prevention and management for older adults: a global initiative
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
- T6 34409961 ↗ — International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines
T2 — RCT in related condition
POTS
26 sources
- T6INDIRECT 31511863 ↗ — Opioids and Their Endocrine Effects: A Systematic Review and Meta-analysis
- T6INDIRECT 22591985 ↗ — Efficacy of treatments for orthostatic hypotension: a systematic review
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 8080348 ↗ — Noradrenergic dysregulation during discontinuation of cocaine use in addicts
- T2 20837887 ↗ — Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotensio
- T6INDIRECT 30153753 ↗ — Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder
- T6INDIRECT 22311903 ↗ — Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in au
- T6INDIRECT 10662747 ↗ — The pressor response to water drinking in humans : a sympathetic reflex?
- T6INDIRECT 9727818 ↗ — Contrasting actions of pressor agents in severe autonomic failure
- T6INDIRECT 12403667 ↗ — Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 17227286 ↗ — Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cess
- T6INDIRECT 25200111 ↗ — Drooling in Parkinson's disease: a review
- T6INDIRECT 31031694 ↗ — Autonomic Dysfunction in α-Synucleinopathies
- T6INDIRECT 28050310 ↗ — Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments
- T6INDIRECT 25589266 ↗ — Sympathoneural and adrenomedullary responses to mental stress
- T6 22192366 ↗ — Olfaction in Parkinson's disease and related disorders
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 18308299 ↗ — Sympathetic modulation of immunity: relevance to disease
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 21890520 ↗ — Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may b
- T6 22094370 ↗ — Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis
Zoex compression garment
T2
T2 — RCT in related condition
POTS
1 source
- T2 NCT01795469 ↗ — Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients
alpha-lipoic acid (ALA)
T2
T2 — RCT in related condition
POTS
28 sources
- T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
- T6INDIRECT 31076938 ↗ — Physical activity and dietary interventions in diabetic neuropathy: a systematic review
- T6INDIRECT 35767077 ↗ — Systematic review about complementary medical hyperthermia in oncology
- T6INDIRECT 39940333 ↗ — Dietary Supplementation for Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (
- T6INDIRECT 33513879 ↗ — Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Cont
- T6INDIRECT 27869661 ↗ — An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effect
- T6INDIRECT 33114210 ↗ — Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and
- T6INDIRECT 27283929 ↗ — Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis
- T6INDIRECT 39339645 ↗ — Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic
- T2 37944311 ↗ — Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a d
- T6INDIRECT 10219752 ↗ — Diabetic neuropathies: features and mechanisms
- T6INDIRECT 30236383 ↗ — Peripheral neuropathy in children and adolescents treated for cancer
- T6INDIRECT 32950543 ↗ — Pain management in hidradenitis suppurativa and a proposed treatment algorithm
- T4 36615676 ↗ — Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Feat
- T6INDIRECT 37054777 ↗ — Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequela
- T6INDIRECT 36148558 ↗ — Neurological post-acute sequelae of SARS-CoV-2 infection
- T6INDIRECT 27665271 ↗ — Nutritional interventions in primary mitochondrial disorders: Developing an evidence base
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 28620280 ↗ — Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- T6 16461471 ↗ — Diabetic neuropathy
- T6 29056658 ↗ — Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 33101584 ↗ — Oxidative Stress in Parkinson's Disease: Potential Benefits of Antioxidant Supplementation
- T6 30136449 ↗ — Diagnosing Diabetic Neuropathy: Something Old, Something New
- T6 18194747 ↗ — The spectrum of diabetic neuropathies
- T6 23385875 ↗ — Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and ther
- T6 35198136 ↗ — Neurological manifestations of long-COVID syndrome: a narrative review
- T6 34181102 ↗ — The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection
atenolol (beta-blocker)
T2
T2 — RCT in related condition
POTS
23 sources
- T6INDIRECT 19821318 ↗ — Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitiv
- T6INDIRECT 24158454 ↗ — Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data a
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 34739197 ↗ — Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- T6INDIRECT 11435337 ↗ — Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope:
- T2 11216978 ↗ — Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic
- T2 7484777 ↗ — Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained sync
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 31954495 ↗ — Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- T6INDIRECT 24636754 ↗ — Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 22071859 ↗ — Antidepressants for pain management in rheumatoid arthritis
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T2 20679638 ↗ — Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- T6INDIRECT 31853557 ↗ — Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide
- T2 25185131 ↗ — Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic f
- T2 34919634 ↗ — A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
- T6INDIRECT 22311903 ↗ — Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in au
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 35841911 ↗ — Diagnosis and treatment of orthostatic hypotension
- T6INDIRECT 31031694 ↗ — Autonomic Dysfunction in α-Synucleinopathies
- T6INDIRECT 21445724 ↗ — European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological
- T6 37230968 ↗ — Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
- T6 28837986 ↗ — Sleep Disturbance, Cognitive Decline, and Dementia: A Review
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 21956442 ↗ — Parkinson's disease therapeutics: new developments and challenges since the introduction of levodopa
- T6 16554257 ↗ — Contemporary assessment and pharmacotherapy of Tourette syndrome
- T6 29523389 ↗ — Postural tachycardia syndrome - Diagnosis, physiology, and prognosis
- T6 23753844 ↗ — Postural tachycardia syndrome (POTS)
- T6 22519513 ↗ — The solute carrier 6 family of transporters
T2 — RCT in related condition
POTS
30 sources
- T2 NCT00865917 ↗ — Cardiovascular Effects of Selective I(f)-Channel Blockade
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
- T6INDIRECT 26607938 ↗ — Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, doub
- T6INDIRECT 19687359 ↗ — Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less i
- T6INDIRECT 27665708 ↗ — Orthostatic changes in systolic blood pressure among SPRINT participants at baseline
- T6INDIRECT 11198485 ↗ — Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fl
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6HARM 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6INDIRECT 28816346 ↗ — Homocysteine-lowering interventions for preventing cardiovascular events
- T6INDIRECT 26551272 ↗ — A Randomized Trial of Intensive versus Standard Blood-Pressure Control
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 24126931 ↗ — Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with mini
- T6INDIRECT 27170530 ↗ — Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, ran
- T6INDIRECT 34739197 ↗ — Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- T6INDIRECT 19470886 ↗ — Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 di
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 18085482 ↗ — Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6 29565029 ↗ — Hypertension
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 26468341 ↗ — Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations
- T6 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
bisoprolol (beta-blocker)
T2
T2 — RCT in related condition
POTS
27 sources
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 29059199 ↗ — Effectiveness of beta-blockers depending on the genotype of congenital long-QT syndrome: A meta-anal
- T6INDIRECT 23796325 ↗ — Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using pl
- T6INDIRECT 31167038 ↗ — Pharmacotherapy for hypertension in adults 60 years or older
- T6INDIRECT 23730991 ↗ — Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years
- T6INDIRECT 28655357 ↗ — Drug-related problems and medication reviews among old people with dementia
- T6INDIRECT 17786067 ↗ — A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safet
- T6INDIRECT 24650926 ↗ — A randomized pilot study of aortic waveform guided therapy in chronic heart failure
- T2 11198485 ↗ — Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fl
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 38441582 ↗ — Cardiac Amyloidosis Due to Transthyretin Protein: A Review
- T6INDIRECT 35830976 ↗ — Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditi
- T6INDIRECT 28261151 ↗ — The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice
- T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 11129673 ↗ — Chagas' heart disease
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T2 — RCT in related condition
RegisteredME/CFSPOTS
61 sources
- T2 NCT01507701 ↗ — Pilot Study for the NorCAPITAL Trial
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 23076904 ↗ — Printed educational materials: effects on professional practice and healthcare outcomes
- T6INDIRECT 25379990 ↗ — Pharmacological interventions for somatoform disorders in adults
- T6INDIRECT 17021301 ↗ — Interventions for the treatment, management and rehabilitation of patients with chronic fatigue synd
- T6INDIRECT 31906979 ↗ — Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyel
- T6INDIRECT 31478755 ↗ — Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot T
- T6INDIRECT 22824921 ↗ — The effect of intraoperative infusion of dexmedetomidine on the quality of recovery after major spin
- T2 24493300 ↗ — Disease mechanisms and clonidine treatment in adolescent chronic fatigue syndrome: a combined cross-
- T2 37296432 ↗ — Effect of propranolol and clonidine after severe traumatic brain injury: a pilot randomized clinical
- T2 27457818 ↗ — Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic
- T2 25887557 ↗ — The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised p
- T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
- T6INDIRECT 19406310 ↗ — A systematic review of the management of orthostatic hypotension after spinal cord injury
- T6INDIRECT 28852322 ↗ — Acute colonic pseudo-obstruction: A systematic review of aetiology and mechanisms
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 23266540 ↗ — Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic f
- T6INDIRECT 14695722 ↗ — Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unane
- T6INDIRECT 24002370 ↗ — Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome
- T6INDIRECT 9819368 ↗ — Yohimbine in neurally mediated syncope. Pathophysiological implications
- T6INDIRECT 21876972 ↗ — Dexmedetomidine for the prevention of shivering during spinal anesthesia
- T6INDIRECT 33926653 ↗ — Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome
- T6INDIRECT 9244228 ↗ — Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia
- T6 33243837 ↗ — Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T2 19602964 ↗ — Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks: a meta-analysi
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 26355598 ↗ — Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualit
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 16864724 ↗ — Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis in
- T6INDIRECT 29133606 ↗ — Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gast
- T6INDIRECT 18161012 ↗ — Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 26198889 ↗ — Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance
- T6INDIRECT 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 32787804 ↗ — Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for t
- T6 21575632 ↗ — Stress and visceral pain: from animal models to clinical therapies
- T6 29867317 ↗ — Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
- T6 33936095 ↗ — Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity
- T6 34414219 ↗ — Antidepressant Drugs Effects on Blood Pressure
- T6 19789072 ↗ — Targeting voltage-gated calcium channels for neuropathic pain management
- T6 38123150 ↗ — The Concise Guide to PHARMACOLOGY 2023/24: Ion channels
- T6 22593735 ↗ — Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids
- T6 29222399 ↗ — Pediatric Disorders of Orthostatic Intolerance
- T6 15298528 ↗ — The burden of illness of irritable bowel syndrome: current challenges and hope for the future
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
clonidine (alpha-2 agonist)
T2
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T2 19602964 ↗ — Clonidine as an adjuvant to local anesthetics for peripheral nerve and plexus blocks: a meta-analysi
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 26355598 ↗ — Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualit
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 16864724 ↗ — Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis in
- T6INDIRECT 29133606 ↗ — Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gast
- T6INDIRECT 18161012 ↗ — Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse
- T6INDIRECT 9244228 ↗ — Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
compression garments (POTS)
T2
T2 — RCT in related condition
POTS
30 sources
- T6INDIRECT 9091692 ↗ — Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind m
- T6INDIRECT 25350981 ↗ — Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsi
- T6INDIRECT 25185131 ↗ — Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic f
- T6INDIRECT 28494751 ↗ — Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
- T2 27271310 ↗ — Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotensi
- T2 33478652 ↗ — Compression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostat
- T2 19456003 ↗ — Compression garments as countermeasures to orthostatic intolerance
- T2 25448247 ↗ — Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults wi
- T2 22194814 ↗ — Are compression stockings an effective treatment for orthostatic presyncope?
- T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 32880754 ↗ — A case report of postural tachycardia syndrome after COVID-19
- T6INDIRECT 30001836 ↗ — Exercise and non-pharmacological treatment of POTS
- T6INDIRECT 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6INDIRECT 34218857 ↗ — Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clini
- T6 19541551 ↗ — Association of N-type calcium channel autoimmunity in patients with autoimmune autonomic ganglionopa
- T6 33271870 ↗ — The Relationship between Autism and Ehlers-Danlos Syndromes/Hypermobility Spectrum Disorders
- T6 36444232 ↗ — AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: <i>JACC: CardioO
- T6 22678960 ↗ — Mechanisms of sympathetic regulation in orthostatic intolerance
- T6 40274830 ↗ — Diabetic neuropathy: cutting-edge research and future directions
- T6 23472781 ↗ — Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hyp
- T6 33806183 ↗ — Biology of Lymphedema
- T6 32974246 ↗ — Postural Tachycardia Syndrome in Children and Adolescents: Pathophysiology and Clinical Management
- T6 33243837 ↗ — Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
- T6 18420158 ↗ — Management of neurogenic orthostatic hypotension: an update
- T6 36178003 ↗ — World guidelines for falls prevention and management for older adults: a global initiative
T2 — RCT in related condition
POTS
25 sources
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 29161773 ↗ — Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- T6INDIRECT 30306544 ↗ — Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperp
- T6INDIRECT 29953167 ↗ — Interventions for chronic non-hypovolaemic hypotonic hyponatraemia
- T6INDIRECT 30584530 ↗ — Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine
- T6INDIRECT 36525900 ↗ — Self-reported symptom burden in postural orthostatic tachycardia syndrome (POTS): A narrative review
- T6INDIRECT 20552588 ↗ — Clinostatic hypertension and orthostatic hypotension
- T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
- T2 22561596 ↗ — Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrom
- T2 3089519 ↗ — The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypote
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 26900156 ↗ — The Differential Diagnosis and Treatment of Atypical Parkinsonism
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6 24699931 ↗ — Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 29486781 ↗ — Vasoplegia treatments: the past, the present, and the future
- T6 19124673 ↗ — Neurogenic orthostatic hypotension: a pathophysiological approach
- T6 29523389 ↗ — Postural tachycardia syndrome - Diagnosis, physiology, and prognosis
- T6 27495201 ↗ — Diagnostic Approach to Atypical Parkinsonian Syndromes
- T6 23753844 ↗ — Postural tachycardia syndrome (POTS)
- T6 26742931 ↗ — Wolfram Syndrome: Diagnosis, Management, and Treatment
diaphragmatic breathing exercise
T2
T2 — RCT in related condition
RegisteredPOTS
6 sources
- T2REGISTERED-ONLY NCT07579026 ↗ — Effects of Breathing Retraining Exercises in Pregnant Females With Postural Orthostatic Tachycardia
- T6 38298551 ↗ — HEART Rate Variability Biofeedback for LOng COVID Dysautonomia (HEARTLOC): Results of a Feasibility
- T6 36410797 ↗ — HEART rate variability biofeedback for long COVID symptoms (HEARTLOC): protocol for a feasibility st
- T6 PPR723180 ↗ — HEART rate variability biofeedback breathing programme for LOng Covid dysautonomia (HEARTLOC): resul
- T6 PMC9204751 ↗ — Supplement
- T6 PPR513768 ↗ — HEART rate variability biofeedback for LOng Covid symptoms (HEARTLOC): protocol for a feasibility st
droxidopa (norepinephrine precursor)
T2
T2 — RCT in related condition
POTS
28 sources
- T6INDIRECT 34752479 ↗ — Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled
- T2 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T2 25350981 ↗ — Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsi
- T2 25487613 ↗ — Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinso
- T6INDIRECT 25185131 ↗ — Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic f
- T2 24326693 ↗ — Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson's disease (N
- T6INDIRECT 12885750 ↗ — Norepinephrine precursor therapy in neurogenic orthostatic hypotension
- T6INDIRECT 28967294 ↗ — An Autonomic Neuroprosthesis: Noninvasive Electrical Spinal Cord Stimulation Restores Autonomic Card
- T6INDIRECT 2890806 ↗ — Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency
- T2 11710796 ↗ — L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic
- T6INDIRECT 32402162 ↗ — Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 35841911 ↗ — Diagnosis and treatment of orthostatic hypotension
- T6INDIRECT 24433463 ↗ — Review of pharmacological therapies in fibromyalgia syndrome
- T6INDIRECT 33649021 ↗ — Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 36810524 ↗ — Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 26729077 ↗ — The Prodrug Approach: A Successful Tool for Improving Drug Solubility
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 33427939 ↗ — The mechanistic link between selective vulnerability of the locus coeruleus and neurodegeneration in
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 23425518 ↗ — Guideline of transthyretin-related hereditary amyloidosis for clinicians
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
T2 — RCT in related condition
POTS
23 sources
- T6INDIRECT 28854296 ↗ — Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake In
- T6INDIRECT 30673120 ↗ — Pregabalin for neuropathic pain in adults
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T2 17472422 ↗ — An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlle
- T6INDIRECT 18253994 ↗ — Antidepressants for non-specific low back pain
- T6INDIRECT 24920437 ↗ — Central changes associated with chronic pelvic pain and endometriosis
- T6INDIRECT 19092112 ↗ — A controlled trial of antidepressants in patients with Parkinson disease and depression
- T6INDIRECT 29243164 ↗ — Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter
- T6INDIRECT 34919634 ↗ — A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 24672257 ↗ — Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6 20194146 ↗ — Recommendations for the pharmacological management of neuropathic pain: an overview and literature u
- T6 26111766 ↗ — SLC transporters as therapeutic targets: emerging opportunities
- T6 30190489 ↗ — Wilson disease
- T6 30909387 ↗ — Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 19118286 ↗ — Standards of medical care in diabetes--2009
ear blood pressure monitor
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
educational retraining
T2
T2 — RCT in related condition
RegisteredPOTS
1 source
- T2REGISTERED-ONLY NCT07579026 ↗ — Effects of Breathing Retraining Exercises in Pregnant Females With Postural Orthostatic Tachycardia
intravenous immunoglobulin (IVIg)
T2
T2 — RCT in related condition
RegisteredLong COVIDPOTS
45 sources
- T6 NCT05350774 ↗ — Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
- T6 32744608 ↗ — Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplast
- T6 29661905 ↗ — Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.
- T6 22561833 ↗ — IgE and mast cells in allergic disease.
- T6 25517090 ↗ — Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.
- T6 31676858 ↗ — TIM3 comes of age as an inhibitory receptor.
- T6INDIRECT 33837630 ↗ — Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated wit
- T6INDIRECT 35660931 ↗ — Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis
- T6INDIRECT 34365148 ↗ — Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-1
- T6INDIRECT 34386902 ↗ — Association of CNS demyelination and COVID-19 infection: an updated systematic review
- T6INDIRECT 33036570 ↗ — Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
- T6INDIRECT 32454187 ↗ — Review of trials currently testing treatment and prevention of COVID-19
- T6INDIRECT 35316551 ↗ — A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendat
- T6INDIRECT 35752132 ↗ — Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccinati
- T6INDIRECT 36098903 ↗ — Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 34542573 ↗ — Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephaliti
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 32855289 ↗ — Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six month
- T6INDIRECT 33949300 ↗ — Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review
- T2 31782181 ↗ — Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
- T6INDIRECT 23168581 ↗ — Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a ra
- T2 21745374 ↗ — Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated
- T2 8774401 ↗ — Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal auto
- T6 31541214 ↗ — Diagnosis and management of Guillain-Barré syndrome in ten steps
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 32653054 ↗ — Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally a
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 34281357 ↗ — Myocarditis With COVID-19 mRNA Vaccines
- T6INDIRECT 33903743 ↗ — Systemic and organ-specific immune-related manifestations of COVID-19
- T6 36707719 ↗ — The role of platelets in immune-mediated inflammatory diseases
- T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
- T6 33219837 ↗ — Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological
- T6 34716418 ↗ — Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison
- T6 34454673 ↗ — 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
- T6INDIRECT 24462240 ↗ — Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a c
- T6INDIRECT 30218025 ↗ — Mechanisms, biomarkers and targets for adult-onset Still's disease
- T6 23642721 ↗ — Guillain-Barré syndrome and variants
- T6 33894193 ↗ — Challenges in the diagnosis of Parkinson's disease
- T6 26659576 ↗ — Neurotropic virus infections as the cause of immediate and delayed neuropathology
- T6 30285773 ↗ — Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
T2 — RCT in related condition
RegisteredPOTS
27 sources
- T2REGISTERED-ONLY NCT07197905 ↗ — Restoring Iron Deficiency in POTS
- T6INDIRECT 30873598 ↗ — Multiple-micronutrient supplementation for women during pregnancy
- T6INDIRECT 33687070 ↗ — Smoking cessation for improving mental health
- T6INDIRECT 26488938 ↗ — Interventions to improve water quality for preventing diarrhoea
- T6INDIRECT 35445419 ↗ — The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
- T6INDIRECT 36915214 ↗ — Roles of neuropathology-associated reactive astrocytes: a systematic review
- T6INDIRECT 25233067 ↗ — Systematic review of potential health risks posed by pharmaceutical, occupational and consumer expos
- T6INDIRECT 34017846 ↗ — Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic
- T6INDIRECT 26607938 ↗ — Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, doub
- T6INDIRECT 30635141 ↗ — Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6 6326753 ↗ — Oxygen toxicity, oxygen radicals, transition metals and disease
- T6 28585944 ↗ — Cellular uptake of nanoparticles: journey inside the cell
- T6INDIRECT 27731885 ↗ — Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 20427088 ↗ — Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt l
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6 33894193 ↗ — Challenges in the diagnosis of Parkinson's disease
- T6 20042772 ↗ — Standards of medical care in diabetes--2010
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
T2 — RCT in related condition
POTS
31 sources
- T2 NCT02725060 ↗ — Autoimmune Basis for Postural Tachycardia Syndrome
- T6INDIRECT 31888497 ↗ — Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome v
- T6INDIRECT 8673750 ↗ — Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained synco
- T6INDIRECT 9505918 ↗ — Midodrine: a role in the management of neurocardiogenic syncope
- T6INDIRECT 11804991 ↗ — Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance
- T6INDIRECT 35107563 ↗ — Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial
- T6INDIRECT 37999672 ↗ — Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
- T6INDIRECT 9819368 ↗ — Yohimbine in neurally mediated syncope. Pathophysiological implications
- T6INDIRECT 10190880 ↗ — Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic into
- T6INDIRECT 11914255 ↗ — Baroreflex buffering and susceptibility to vasoactive drugs
- T6INDIRECT 10065030 ↗ — Increased orthostatic tolerance following moderate exercise training in patients with unexplained sy
- T6 21890520 ↗ — Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may b
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
- T6INDIRECT 23041006 ↗ — Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 16505178 ↗ — Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prev
- T6INDIRECT 1670907 ↗ — Utility of upright tilt-table testing in the evaluation and management of syncope of unknown origin
- T6INDIRECT 4612057 ↗ — The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human s
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 17894650 ↗ — Catechol-O-methyltransferase and its inhibitors in Parkinson's disease
- T6INDIRECT 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6INDIRECT 29628432 ↗ — Cognitive and psychological issues in postural tachycardia syndrome
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6 32213941 ↗ — Chemical Constituents and Pharmacological Activities of Garlic (<i>Allium sativum</i> L.): A Review
- T6 19639282 ↗ — Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophys
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 18308299 ↗ — Sympathetic modulation of immunity: relevance to disease
- T6 29717928 ↗ — Impact of the Autonomic Nervous System on the Skeleton
- T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
ivabradine (If channel blocker)
T2
T2 — RCT in related condition
POTS
26 sources
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
- T6INDIRECT 29759520 ↗ — Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature
- T2 29330767 ↗ — Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review
- T6INDIRECT 38673384 ↗ — Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
- T6INDIRECT 36723919 ↗ — Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrilla
- T2 33602468 ↗ — Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syn
- T6INDIRECT 37999672 ↗ — Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
- T6INDIRECT 31841279 ↗ — Central blood pressure for the management of hypertension: Is it a practical clinical tool in curren
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 32117030 ↗ — Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome
- T6INDIRECT 26198889 ↗ — Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
- T6 29359025 ↗ — Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
- T6 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
- T6 33999297 ↗ — The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrativ
- T6 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
- T6 39125722 ↗ — Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detectio
- T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
- T6 28428055 ↗ — Sex differences in cardiovascular disease - Impact on care and outcomes
- T6 29222399 ↗ — Pediatric Disorders of Orthostatic Intolerance
T2 — RCT in related condition
RegisteredPOTS
33 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 30556597 ↗ — Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people
- T6INDIRECT 34883203 ↗ — Heart rate variability in relation to cognition and behavior in neurodegenerative diseases: A system
- T6INDIRECT 25791142 ↗ — Assessment and management of treatment-refractory obsessive-compulsive disorder in children
- T6INDIRECT 30294976 ↗ — Available and future treatments for atypical parkinsonism. A systematic review
- T6INDIRECT 34472659 ↗ — Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated cl
- T6INDIRECT 31853557 ↗ — Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide
- T6INDIRECT 34919634 ↗ — A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
- T6INDIRECT 32986682 ↗ — The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility
- T6INDIRECT 41416579 ↗ — Phase 2 study of zervimesine (CT1812) in participants with mild-to-moderate dementia with Lewy bodie
- T6INDIRECT 28707277 ↗ — Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 31866818 ↗ — ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 22419314 ↗ — Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 21649634 ↗ — Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of random
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 19700947 ↗ — Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation
- T6INDIRECT 28604926 ↗ — ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease
- T6INDIRECT 28833562 ↗ — Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 23225012 ↗ — Parkinson's disease
- T6INDIRECT 28106066 ↗ — The psychosis spectrum in Parkinson disease
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 28781611 ↗ — Best practice in the management of behavioural and psychological symptoms of dementia
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6 20194146 ↗ — Recommendations for the pharmacological management of neuropathic pain: an overview and literature u
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 26595642 ↗ — Lewy body dementias
- T6 21875407 ↗ — N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, va
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
T2 — RCT in related condition
POTS
31 sources
- T2 NCT00580619 ↗ — Autonomic Nervous System and Chronic Fatigue Syndrome
- T6INDIRECT 36268467 ↗ — Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review
- T6INDIRECT 39538129 ↗ — Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review
- T6INDIRECT 8443479 ↗ — Double blind clinical and laboratory study of hypoglycaemia with human and porcine insulin in diabet
- T6 33243837 ↗ — Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
- T6 23225012 ↗ — Parkinson's disease
- T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 37818791 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 28834483 ↗ — Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes
- T6INDIRECT 12023411 ↗ — Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, dou
- T6INDIRECT 9343116 ↗ — Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levo
- T6INDIRECT 8558148 ↗ — Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients wit
- T6INDIRECT 8527287 ↗ — Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose lev
- T6INDIRECT 23336248 ↗ — Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6 29565029 ↗ — Hypertension
- T6 36507632 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 25767284 ↗ — The sympathetic nervous system alterations in human hypertension
- T6 17308214 ↗ — Blood pressure and ageing
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T2 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 33687070 ↗ — Smoking cessation for improving mental health
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 23233021 ↗ — A randomised controlled trial of bumetanide in the treatment of autism in children
- T6INDIRECT 22024003 ↗ — Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training
- T6INDIRECT 34743319 ↗ — Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind
- T6INDIRECT 12023411 ↗ — Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, dou
- T6INDIRECT 9727818 ↗ — Contrasting actions of pressor agents in severe autonomic failure
- T6 21777306 ↗ — Myalgic encephalomyelitis: International Consensus Criteria
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 30192094 ↗ — Management of common adverse effects of antipsychotic medications
- T6 26595642 ↗ — Lewy body dementias
- T6 27803666 ↗ — Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
- T6 23506866 ↗ — SLC6 transporters: structure, function, regulation, disease association and therapeutics
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 29717928 ↗ — Impact of the Autonomic Nervous System on the Skeleton
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 19847337 ↗ — The economies of synthesis
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
metoprolol (beta-blocker)
T2
T2 — RCT in related condition
POTS
27 sources
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 23796325 ↗ — Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using pl
- T6INDIRECT 32409561 ↗ — Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, ra
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T2 16505178 ↗ — Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prev
- T6INDIRECT 31618127 ↗ — Phase IIb, Randomized, Double-Blind Trial of GC4419 Versus Placebo to Reduce Severe Oral Mucositis D
- T2 2337713 ↗ — Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy
- T6INDIRECT 23730991 ↗ — Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years
- T6INDIRECT 21301135 ↗ — Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycar
- T6INDIRECT 23094876 ↗ — Brugada phenocopy: new terminology and proposed classification
- T6INDIRECT 28862947 ↗ — Role of Volume Redistribution in the Congestion of Heart Failure
- T6INDIRECT 24636754 ↗ — Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment
- T6INDIRECT 24093767 ↗ — Genotype- and phenotype-guided management of congenital long QT syndrome
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 27671918 ↗ — Anxiety Disorders and Cardiovascular Disease
- T6 23588782 ↗ — Applications of CYP450 testing in the clinical setting
- T6 11129673 ↗ — Chagas' heart disease
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T2 — RCT in related condition
RegisteredPOTS
36 sources
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T6INDIRECT 19406310 ↗ — A systematic review of the management of orthostatic hypotension after spinal cord injury
- T6INDIRECT 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 28893208 ↗ — Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients
- T2 9505918 ↗ — Midodrine: a role in the management of neurocardiogenic syncope
- T6INDIRECT 28494751 ↗ — Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
- T2 23978222 ↗ — A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropath
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 9244228 ↗ — Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia
- T6INDIRECT 28967294 ↗ — An Autonomic Neuroprosthesis: Noninvasive Electrical Spinal Cord Stimulation Restores Autonomic Card
- T2 21301135 ↗ — Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycar
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T2 9091692 ↗ — Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind m
- T2 7687093 ↗ — Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine
- T6INDIRECT 12521968 ↗ — Multifactorial intervention after a fall in older people with cognitive impairment and dementia pres
- T6INDIRECT 22045363 ↗ — The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale
- T6INDIRECT 16476804 ↗ — Pyridostigmine treatment trial in neurogenic orthostatic hypotension
- T6INDIRECT 32244252 ↗ — Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of A
- T2 9674789 ↗ — A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 30192094 ↗ — Management of common adverse effects of antipsychotic medications
- T6 28571527 ↗ — Assessment and management of acute spinal cord injury: From point of injury to rehabilitation
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 21483018 ↗ — Amyloidosis: pathogenesis and new therapeutic options
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 36810524 ↗ — Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
- T6 35963508 ↗ — American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Me
- T6 26138942 ↗ — When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 23425518 ↗ — Guideline of transthyretin-related hereditary amyloidosis for clinicians
midodrine (alpha-1 agonist)
T2
T2 — RCT in related condition
POTS
27 sources
- T2 9091692 ↗ — Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind m
- T2 7687093 ↗ — Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine
- T6INDIRECT 12521968 ↗ — Multifactorial intervention after a fall in older people with cognitive impairment and dementia pres
- T6INDIRECT 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 22045363 ↗ — The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale
- T6INDIRECT 16476804 ↗ — Pyridostigmine treatment trial in neurogenic orthostatic hypotension
- T6INDIRECT 32244252 ↗ — Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of A
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T2 9674789 ↗ — A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 30192094 ↗ — Management of common adverse effects of antipsychotic medications
- T6 28571527 ↗ — Assessment and management of acute spinal cord injury: From point of injury to rehabilitation
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 21483018 ↗ — Amyloidosis: pathogenesis and new therapeutic options
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 36810524 ↗ — Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
- T6 35963508 ↗ — American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Me
- T6 26138942 ↗ — When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 23425518 ↗ — Guideline of transthyretin-related hereditary amyloidosis for clinicians
T2 — RCT in related condition
POTS
24 sources
- T6INDIRECT 23990266 ↗ — Antipsychotics for acute and chronic pain in adults
- T6INDIRECT 23758443 ↗ — A systematic review of the pharmacological management of orthostatic hypotension
- T6INDIRECT 34932836 ↗ — Transfusion thresholds for guiding red blood cell transfusion
- T6INDIRECT 32826308 ↗ — The management of adult patients with severe chronic small intestinal dysmotility
- T6INDIRECT 26366058 ↗ — Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors
- T6INDIRECT 2875321 ↗ — Treatment of autonomic neuropathy with a somatostatin analogue SMS-201-995
- T2 8665540 ↗ — Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled
- T6INDIRECT 26387781 ↗ — Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motilit
- T2 17036177 ↗ — Treatment of postural tachycardia syndrome: a comparison of octreotide and midodrine
- T6 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 25378951 ↗ — Systemic AA amyloidosis: epidemiology, diagnosis, and management
- T6INDIRECT 26900156 ↗ — The Differential Diagnosis and Treatment of Atypical Parkinsonism
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 7825766 ↗ — Postprandial hypotension: epidemiology, pathophysiology, and clinical management
- T6 11751653 ↗ — Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
T2 — RCT in related condition
WithdrawnPOTS
23 sources
- T6WITHDRAWN NCT05121766 ↗ — Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among
- T6INDIRECT 30873598 ↗ — Multiple-micronutrient supplementation for women during pregnancy
- T2 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 33882506 ↗ — European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Syste
- T6INDIRECT 28816346 ↗ — Homocysteine-lowering interventions for preventing cardiovascular events
- T2 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T2 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 22696350 ↗ — Omega 3 fatty acid for the prevention of cognitive decline and dementia
- T6INDIRECT 30556597 ↗ — Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people
- T6INDIRECT 27643725 ↗ — Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional wei
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 35812394 ↗ — Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease
- T6 29090092 ↗ — Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential trea
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 30018614 ↗ — Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration
- T6 33242416 ↗ — Fundamental Biological Features of Spaceflight: Advancing the Field to Enable Deep-Space Exploration
- T6 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 28927897 ↗ — Does nutrition play a role in the prevention and management of sarcopenia?
- T6 16365341 ↗ — JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical pract
T2 — RCT in related condition
POTS
31 sources
- T2 NCT02725060 ↗ — Autoimmune Basis for Postural Tachycardia Syndrome
- T6INDIRECT 25892369 ↗ — Saline nasal irrigation for acute upper respiratory tract infections
- T6INDIRECT 11804991 ↗ — Selective norepinephrine reuptake inhibition as a human model of orthostatic intolerance
- T6INDIRECT 21963834 ↗ — Sex differences in carotid baroreflex control of arterial blood pressure in humans: relative contrib
- T6INDIRECT 35107563 ↗ — Association of Generalized Anxiety Disorder With Autonomic Hypersensitivity and Blunted Ventromedial
- T6INDIRECT 14670816 ↗ — Mechanisms of postspaceflight orthostatic hypotension: low alpha1-adrenergic receptor responses befo
- T6INDIRECT 15191897 ↗ — Influence of increased central venous pressure on baroreflex control of sympathetic activity in huma
- T6INDIRECT 14561843 ↗ — Influences of hydration on post-exercise cardiovascular control in humans
- T6INDIRECT 10190880 ↗ — Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic into
- T6INDIRECT 19401460 ↗ — Menstrual cycle alters sympathetic neural responses to orthostatic stress in young, eumenorrheic wom
- T6INDIRECT 11914255 ↗ — Baroreflex buffering and susceptibility to vasoactive drugs
- T6 21890520 ↗ — Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may b
- T6 20103559 ↗ — Cardiac autonomic neuropathy in diabetes: a clinical perspective
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 24358002 ↗ — Serotonin syndrome
- T6INDIRECT 28100251 ↗ — Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) de
- T6INDIRECT 32019600 ↗ — Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatme
- T6INDIRECT 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
- T6INDIRECT 24715569 ↗ — Dysautonomia in Parkinson disease
- T6INDIRECT 35648703 ↗ — Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6INDIRECT 34386109 ↗ — JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias
- T6 29565029 ↗ — Hypertension
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 30871703 ↗ — Autonomic Nervous System Dysfunction: JACC Focus Seminar
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 32412940 ↗ — Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paragangl
T2 — RCT in related condition
POTS
24 sources
- T2 30673120 ↗ — Pregabalin for neuropathic pain in adults
- T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 29138154 ↗ — Pharmacologic management of chronic neuropathic pain: Review of the Canadian Pain Society consensus
- T6INDIRECT 32523555 ↗ — Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 27286745 ↗ — An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropa
- T2 21719618 ↗ — Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain mana
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6INDIRECT 23642721 ↗ — Guillain-Barré syndrome and variants
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 21092187 ↗ — Fabry disease
- T6 20194146 ↗ — Recommendations for the pharmacological management of neuropathic pain: an overview and literature u
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 28620280 ↗ — Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- T6 23970715 ↗ — Mechanisms and management of diabetic painful distal symmetrical polyneuropathy
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 23425518 ↗ — Guideline of transthyretin-related hereditary amyloidosis for clinicians
T2 — RCT in related condition
RegisteredPOTS
33 sources
- T2REGISTERED-ONLY NCT04186286 ↗ — Crossover Study of Propranolol vs Ivabradine in POTS
- T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
- T2REGISTERED-ONLY NCT01988883 ↗ — Modafinil and Cognitive Function in POTS
- T2 NCT02171988 ↗ — Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
- T6INDIRECT 35056352 ↗ — Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 29759520 ↗ — Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature
- T6INDIRECT 33224097 ↗ — Cyclic Vomiting Syndrome in Children
- T2 19687359 ↗ — Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less i
- T6INDIRECT 30635141 ↗ — Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
- T2 23616163 ↗ — Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study
- T6INDIRECT 37999672 ↗ — Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6HARM 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 16678566 ↗ — Childhood functional gastrointestinal disorders: child/adolescent
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 28834483 ↗ — Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes
- T2 8198938 ↗ — Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients wit
- T6INDIRECT 19700947 ↗ — Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation
- T6INDIRECT 26902950 ↗ — Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A
- T6INDIRECT 4612057 ↗ — The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human s
- T6 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 32213941 ↗ — Chemical Constituents and Pharmacological Activities of Garlic (<i>Allium sativum</i> L.): A Review
- T6 30018614 ↗ — Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 6811067 ↗ — Diagnosis and management of diabetic autonomic neuropathy
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
propranolol (beta-blocker)
T2
T2 — RCT in related condition
POTS
23 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 28834483 ↗ — Effect of Intensive Blood-Pressure Treatment on Patient-Reported Outcomes
- T2 19687359 ↗ — Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less i
- T2 8198938 ↗ — Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients wit
- T6INDIRECT 19700947 ↗ — Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation
- T6INDIRECT 26902950 ↗ — Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A
- T6INDIRECT 30635141 ↗ — Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 4612057 ↗ — The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human s
- T6 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 32213941 ↗ — Chemical Constituents and Pharmacological Activities of Garlic (<i>Allium sativum</i> L.): A Review
- T6 30018614 ↗ — Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 6811067 ↗ — Diagnosis and management of diabetic autonomic neuropathy
- T6 16678566 ↗ — Childhood functional gastrointestinal disorders: child/adolescent
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
pyridostigmine (acetylcholinesterase inhibitor)
T2
T2 — RCT in related condition
POTS
30 sources
- T6INDIRECT 34752479 ↗ — Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled
- T6INDIRECT 22591985 ↗ — Efficacy of treatments for orthostatic hypotension: a systematic review
- T6INDIRECT 31214762 ↗ — Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
- T2 16476804 ↗ — Pyridostigmine treatment trial in neurogenic orthostatic hypotension
- T6INDIRECT 15911704 ↗ — Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
- T2 20837887 ↗ — Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotensio
- T6INDIRECT 22677718 ↗ — A randomised controlled study of the effect of cholinesterase inhibition on colon function in patien
- T6INDIRECT 23978222 ↗ — A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropath
- T6INDIRECT 12933939 ↗ — Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypoten
- T6INDIRECT 19506222 ↗ — Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopa
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 26493934 ↗ — Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effe
- T6 28303218 ↗ — The modification of natural products for medical use
- T6 29717928 ↗ — Impact of the Autonomic Nervous System on the Skeleton
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 29359025 ↗ — Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
- T6 21962754 ↗ — Multiple system atrophy: a clinical and neuropathological perspective
- T6 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6 20103559 ↗ — Cardiac autonomic neuropathy in diabetes: a clinical perspective
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 23122672 ↗ — Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
- T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
ranitidine (H2 antihistamine)
T2
T2 — RCT in related condition
MCASPOTS
46 sources
- T6INDIRECT 31025714 ↗ — Interventions for hand eczema
- T6INDIRECT 35268051 ↗ — Vitamin D Supplementation and Sleep: A Systematic Review and Meta-Analysis of Intervention Studies
- T6INDIRECT 22419335 ↗ — Histamine H2-receptor antagonists for urticaria
- T6INDIRECT 33206207 ↗ — Histamine receptors and COVID-19
- T6INDIRECT 33080623 ↗ — Isatuximab as monotherapy and combined with dexamethasone in patients with relapsed/refractory multi
- T2 2878811 ↗ — Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 4
- T6INDIRECT 24507460 ↗ — Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study
- T6INDIRECT 8676090 ↗ — Recombinant human stem cell factor (kit ligand) promotes human mast cell and melanocyte hyperplasia
- T2 6150641 ↗ — Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patient
- T6 30150993 ↗ — The Role of Histamine and Histamine Receptors in Mast Cell-Mediated Allergy and Inflammation: The Hu
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 29694674 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 36190739 ↗ — Pharmacological interventions for prevention of weight gain in people with schizophrenia
- T6INDIRECT 28893208 ↗ — Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients
- T6INDIRECT 28655357 ↗ — Drug-related problems and medication reviews among old people with dementia
- T6INDIRECT 26461064 ↗ — Nurse-Led Medicines' Monitoring for Patients with Dementia in Care Homes: A Pragmatic Cohort Stepped
- T6INDIRECT 23179472 ↗ — Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compare
- T6INDIRECT 10646881 ↗ — Phase I study of dose-escalated paclitaxel, ifosfamide, and cisplatin (PIC) combination chemotherapy
- T6 16678566 ↗ — Childhood functional gastrointestinal disorders: child/adolescent
- T6 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 34684008 ↗ — Improving Curcumin Bioavailability: Current Strategies and Future Perspectives
- T6INDIRECT 21668033 ↗ — Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations
- T6INDIRECT 31640115 ↗ — Adverse Effects of Proton Pump Inhibitors-Evidence and Plausibility
- T6INDIRECT 35964548 ↗ — Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer
- T6INDIRECT 32128023 ↗ — IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position p
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6INDIRECT 23452057 ↗ — Characterization of different courses of atopic dermatitis in adolescent and adult patients
- T6INDIRECT 15870014 ↗ — In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation
- T6 31739596 ↗ — Therapeutic Potential of α- and β-Pinene: A Miracle Gift of Nature
- T6 23476052 ↗ — Idiosyncratic adverse drug reactions: current concepts
- T6 27620496 ↗ — Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral C
- T6 21134576 ↗ — Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAI
- T6 23268454 ↗ — World allergy organization guidelines for the assessment and management of anaphylaxis
- T6INDIRECT 18085482 ↗ — Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 29796248 ↗ — Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of cloza
- T6INDIRECT 24473486 ↗ — Medications and impaired driving
- T6INDIRECT 18959359 ↗ — Early acute management in adults with spinal cord injury: a clinical practice guideline for health-c
- T6INDIRECT 29210346 ↗ — Serious Neurological Adverse Events after Ivermectin-Do They Occur beyond the Indication of Onchocer
- T6 32872533 ↗ — Ionic Liquids Toxicity-Benefits and Threats
- T6 30884251 ↗ — Recent advances in our understanding of mast cell activation - or should it be mast cell mediator di
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 17608249 ↗ — Risks of combined alcohol/medication use in older adults
- T6 32785879 ↗ — A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Tran
T2 — RCT in related condition
POTS
23 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 28854296 ↗ — Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake In
- T6INDIRECT 17943857 ↗ — Antidepressants for neuropathic pain
- T6INDIRECT 28178949 ↗ — Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T2 15507582 ↗ — Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obse
- T6INDIRECT 19092112 ↗ — A controlled trial of antidepressants in patients with Parkinson disease and depression
- T6INDIRECT 20855047 ↗ — Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study
- T6INDIRECT 12388617 ↗ — Dopamine modulates the response of the human amygdala: a study in Parkinson's disease
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 24229653 ↗ — What are the causes of late-life depression?
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 35430029 ↗ — Functional neurological disorder: new subtypes and shared mechanisms
- T6 26111766 ↗ — SLC transporters as therapeutic targets: emerging opportunities
- T6 10379421 ↗ — Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines an
- T6 22407614 ↗ — Serotonin and blood pressure regulation
- T6 15320756 ↗ — Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?
- T6 30975301 ↗ — Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Ar
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 29975336 ↗ — Depression and Anxiety in Heart Failure: A Review
T2 — RCT in related condition
POTS
22 sources
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 27115217 ↗ — Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
- T6INDIRECT 23710959 ↗ — Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic
- T6INDIRECT 25919144 ↗ — Interventions for rosacea
- T6INDIRECT 29932206 ↗ — Saline irrigation for allergic rhinitis
- T6INDIRECT 28614232 ↗ — The efficiency and safety of dexamethasone for pain control in total joint arthroplasty: A meta-anal
- T6INDIRECT 37496207 ↗ — Efficacy of hydrodilatation in frozen shoulder: a systematic review and meta-analysis
- T6INDIRECT 27115215 ↗ — Different types of intranasal steroids for chronic rhinosinusitis
- T2 20427088 ↗ — Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt l
- T6INDIRECT 17088333 ↗ — Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 31954495 ↗ — Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- T6INDIRECT 31871494 ↗ — Therapeutic Approaches for Peripheral and Central Neuropathic Pain
- T6INDIRECT 24436882 ↗ — Oropharyngeal Dysphagia after anterior cervical spine surgery: a review
- T6INDIRECT 33586020 ↗ — Peripheral Nervous System Manifestations Associated with COVID-19
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 27551328 ↗ — The use of inhaled corticosteroids in pediatric asthma: update
- T6 34948113 ↗ — Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
- T6 31506830 ↗ — Emerging Insights and Interventions for Diabetic Retinopathy
- T6 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 28632002 ↗ — Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension
- T6 24940130 ↗ — Steroids: pharmacology, complications, and practice delivery issues
T4 — Case series
POTS
10 sources
- T6 35379908 ↗ — Halotolerant biofilm-producing rhizobacteria mitigate seawater-induced salt stress and promote growt
- T6 31090026 ↗ — Abstracts from the 2019 Annual Meeting of the Society of General Internal Medicine
- T6 22696014 ↗ — Guidelines for status epilepticus: are we there yet?
- T6 23625304 ↗ — Abstracts of the 36th Annual Meeting of the Society of General Internal Medicine. April 24-27, 2013.
- T6 PMC7159487 ↗ — Poster Sessions
- T4 PMC6661815 ↗ — Intensive Care Society State of the Art 2018 Abstracts
- T6INDIRECT 37650038 ↗ — PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023
- T4 PMC7167762 ↗ — III. Abstracts
- T4 PMC4587627 ↗ — Abstracts of Scientific Presentations : 2015 AALAS National Meeting Phoenix, Arizona
- T6 32226274 ↗ — The Use of Antiallergic and Antiasthmatic Drugs in Viral Infections of the Upper Respiratory Tract
T4 — Case series
POTS
9 sources
- T6 32708302 ↗ — Small Molecule NF-κB Pathway Inhibitors in Clinic
- T6 39185033 ↗ — Paraneoplastic hypoglycemia: An overview for optimal clinical guidance
- T6 41465487 ↗ — iNOS in Macrophage Polarization: Pharmacological and Regulatory Insights
- T6 31612778 ↗ — Meeting Abstracts - Academy of Managed Care Pharmacy Nexus 2019
- T6 PMC11635028 ↗ — Index
- T6INDIRECT 40498965 ↗ — EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025
- T4 PMC11231130 ↗ — Abstracts from the 2024 Annual Meeting of the Society of General Internal Medicine
- T4 PMC9205280 ↗ — Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine
- T6 41048472 ↗ — Assessing the Impact of Antidepressants on Cancer Treatment: A Retrospective Analysis of 14 Antineop
Cardiac sympathetic denervation
T4
T4 — Case series
POTS
26 sources
- T6INDIRECT 35694936 ↗ — Association Between Parkinson's Disease and Coronary Artery Disease: A Systematic Review and Meta-An
- T6INDIRECT 34964392 ↗ — Orthostatic Hypotension and Antiparkinsonian Drugs: A Systematic Review and Meta-analysis
- T6INDIRECT 40406920 ↗ — Prevalence of Supine Hypertension in Alpha-Synucleinopathies: A Systematic Review and Meta-Analysis
- T6INDIRECT 20837887 ↗ — Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotensio
- T6INDIRECT 37993489 ↗ — Relationship between Parkinson's disease and cardio-cerebrovascular diseases: a Mendelian randomized
- T6INDIRECT 11971094 ↗ — Orthostatic hypotension from sympathetic denervation in Parkinson's disease
- T6INDIRECT 31407088 ↗ — Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological
- T6 21890520 ↗ — Low-frequency power of heart rate variability is not a measure of cardiac sympathetic tone but may b
- T6 29971039 ↗ — On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
- T6 20103559 ↗ — Cardiac autonomic neuropathy in diabetes: a clinical perspective
- T6INDIRECT 26350119 ↗ — Autosomal dominant Parkinson's disease caused by SNCA duplications
- T4 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 25484925 ↗ — The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis
- T6INDIRECT 24093767 ↗ — Genotype- and phenotype-guided management of congenital long QT syndrome
- T6INDIRECT 24262198 ↗ — Autonomic disorders predicting Parkinson's disease
- T6INDIRECT 24715569 ↗ — Dysautonomia in Parkinson disease
- T6INDIRECT 26869865 ↗ — A systematic review of the cardiotoxicity of methadone
- T6INDIRECT 32789741 ↗ — Autonomic Dysfunction in Parkinson's Disease
- T6 31498132 ↗ — Brain-First versus Gut-First Parkinson's Disease: A Hypothesis
- T6 30871703 ↗ — Autonomic Nervous System Dysfunction: JACC Focus Seminar
- T6 29628907 ↗ — Diagnostic Criteria for Parkinson's Disease: From James Parkinson to the Concept of Prodromal Diseas
- T6 19124673 ↗ — Neurogenic orthostatic hypotension: a pathophysiological approach
- T6 29523389 ↗ — Postural tachycardia syndrome - Diagnosis, physiology, and prognosis
- T6 22033559 ↗ — Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative
- T6 22094370 ↗ — Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis
- T6 18606002 ↗ — Congenital long QT syndrome
T4 — Case series
POTS
11 sources
- T6INDIRECT 32365943 ↗ — Current Synthesis and Systematic Review of Main Effects of Calf Blood Deproteinized Medicine (Actove
- T6 27429559 ↗ — Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-S
- T6 33168048 ↗ — 10th European Conference on Rare Diseases & Orphan Products (ECRD 2020)
- T6 PMC6643206 ↗ — E-Poster Viewing
- T6 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
- T6INDIRECT 37874422 ↗ — ESICM LIVES 2023
- T6INDIRECT 22977921 ↗ — Abstracts of the 10th Congress of the European Association of NeuroOncology. Marseille, France. Sept
- T4 PMC10643713 ↗ — The 7th Congress of Biophysicists of Russia - conference proceedings : Abstracts
- T4 PMC11391898 ↗ — ESOC 2023 Abstract Book
- T4 PMC7103906 ↗ — Posters
- T6 26858901 ↗ — Disease and Stem Cell-Based Analysis of the 2014 ASNTR Meeting
T4 — Case series
POTS
7 sources
- T6 26232394 ↗ — Modulatory influences of estradiol and other anorexigenic hormones on metabotropic, Gi/o-coupled rec
- T6 22566994 ↗ — The influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activ
- T6 35295500 ↗ — Complex Regional Pain Syndrome. A Comprehensive Review on Neuroplastic Changes Supporting the Use of
- T6 27742893 ↗ — Dopaminergic inhibition of gonadotropin-releasing hormone neurons in the cichlid fish Astatotilapia
- T6 40827134 ↗ — Supplement
- T4 PMC7745344 ↗ — Supplement
- T6 PMC10722647 ↗ — Abstract
T4 — Case series
POTS
11 sources
- T6INDIRECT 33593124 ↗ — The Empirical Status of Mindfulness-Based Interventions: A Systematic Review of 44 Meta-Analyses of
- T6 24978634 ↗ — Treatment of advanced Parkinson's disease
- T6INDIRECT 33669438 ↗ — Three Cases of Severe ME/CFS in Adults
- T6 33831812 ↗ — Associations between weight-based teasing and disordered eating behaviors among youth
- T6 37693239 ↗ — Classic psychedelic use and current meditation practice
- T6INDIRECT 34926835 ↗ — Program Abstracts from The GSA 2021 Annual Scientific Meeting, "Disruption to Transformation: Aging
- T4 PMC11688754 ↗ — Full GSA 2024 Abstract Book PDF
- T4 PMC9009819 ↗ — CPNP 2022 Annual Meeting Poster Abstracts
- T4 PMC8922672 ↗ — Oral and Poster abstracts
- T4 PMC7741497 ↗ — Program Abstracts from The GSA 2020 Annual Scientific Meeting “Turning 75: Why Age Matters”
- T6 33059389 ↗ — Weight-based teasing in youth: Associations with metabolic and inflammatory markers
T4 — Case series
POTS
9 sources
- T6INDIRECT 34143333 ↗ — The effects of caffeine in adults with neurogenic orthostatic hypotension: a systematic review
- T6 23472781 ↗ — Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hyp
- T6 21664375 ↗ — Pharmacotherapy of autonomic failure
- T6 22581120 ↗ — Italian guidelines for primary headaches: 2012 revised version
- T6 25104940 ↗ — Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in auton
- T6 10210895 ↗ — Ergotamine/caffeine treatment of orthostatic hypotension in parkinsonism with autonomic failure
- T6INDIRECT 29076058 ↗ — Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease
- T6INDIRECT 31123663 ↗ — CPNP 2019 Annual Meeting Poster Abstracts
- T4 PMC12978741 ↗ — Abstracts - IANCON 2025
T4 — Case series
POTS
16 sources
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6INDIRECT 35207228 ↗ — Current and Emerging Medical Therapies in Pituitary Tumors
- T6INDIRECT 36835974 ↗ — The Role of Aromatase Inhibitors in Male Prolactinoma
- T6INDIRECT 34843036 ↗ — 49th ESCP virtual symposium on clinical pharmacy 19.10.2021-21.10.2021 Clinical pharmacy, working co
- T6INDIRECT 31612778 ↗ — Meeting Abstracts - Academy of Managed Care Pharmacy Nexus 2019
- T6INDIRECT 31639031 ↗ — Meeting abstracts from the 5th International Clinical Trials Methodology Conference (ICTMC 2019) : B
- T6INDIRECT 27650181 ↗ — EANM'16
- T4 PMC4212304 ↗ — UEG Week 2014 Oral Presentations
- T6INDIRECT 40767450 ↗ — SEDCYDO - SEGER - SEMO CONGRESS MADRID 2025, 8-10 MAY. Proceedings and Abstract
- T6 28174091 ↗ — Inhibitors of cyclin-dependent kinases as cancer therapeutics
- T6 41461581 ↗ — The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors
- T6 29607374 ↗ — Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
T4 — Case series
POTS
12 sources
- T6INDIRECT 34747131 ↗ — Is weight stigma associated with physical activity? A systematic review
- T6INDIRECT 26352916 ↗ — Interventions for Individuals With High Levels of Needle Fear: Systematic Review of Randomized Contr
- T6INDIRECT 21934055 ↗ — Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorde
- T6INDIRECT 28412602 ↗ — Secondary outcomes from the pediatric obsessive compulsive disorder treatment study II
- T6 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6 26062169 ↗ — Fear and the Defense Cascade: Clinical Implications and Management
- T6 27007463 ↗ — Exposure-based Interventions for the management of individuals with high levels of needle fear acros
- T6INDIRECT 32206586 ↗ — Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management
- T6INDIRECT 34111207 ↗ — The prevalence and evidence-based management of needle fear in adults with chronic disease: A scopin
- T6INDIRECT 19183470 ↗ — The Pediatric Obsessive-Compulsive Disorder Treatment Study II: rationale, design and methods
- T4 PMC11627190 ↗ — ACNP 63rd Annual Meeting: Poster Abstracts P609-P914
- T6 22800994 ↗ — Obsessive-compulsive and tic-related disorders
In-lab polysomnography
T4
T4 — Case series
POTS
10 sources
- T6INDIRECT 30053970 ↗ — Respiratory care in familial dysautonomia: Systematic review and expert consensus recommendations
- T6INDIRECT 22348451 ↗ — Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adult
- T6INDIRECT 36823241 ↗ — Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonom
- T6 33295989 ↗ — Autonomic dysregulation and sleep homeostasis in insomnia
- T6 33991086 ↗ — Association of Depressive Symptoms with Sleep Disturbance: A Co-twin Control Study
- T6 29680425 ↗ — Prevalence and characteristics of sleep-disordered breathing in familial dysautonomia
- T6INDIRECT 35251925 ↗ — Obstructive sleep apnea in a case of ehlers-danlos syndrome
- T6INDIRECT 40723062 ↗ — Sleep Disorders in Children with Rett Syndrome
- T4 PMC6935577 ↗ — Atrial Fibrillation
- T6 41444346 ↗ — Obstructive sleep apnea increases heartbeat-evoked potentials and reorganizes Granger-causal couplin
Long-COVID postural tachycardia syndrome
T4
T4 — Case series
POTS
8 sources
- T6 33740207 ↗ — Long-COVID postural tachycardia syndrome: an American Autonomic Society statement.
- T6 36339677 ↗ — Postural orthostatic tachycardia syndrome and post-acute COVID-19
- T5 40660536 ↗ — Successful treatment of long-COVID postural tachycardia syndrome with epipharyngeal abrasive therapy
- T6 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
- T6 37388279 ↗ — Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
- T6INDIRECT 36205820 ↗ — 33RD International Symposium on the Autonomic Nervous System
- T4 PMC9205280 ↗ — Abstracts from the 2022 Annual Meeting of the Society of General Internal Medicine
- T6 39449566 ↗ — Much more than a biological phenomenon: A qualitative study of women's experiences of brain fog acro
T4 — Case series
POTS
7 sources
- T6 35614479 ↗ — The role of basket trials in drug development for neurodegenerative disorders
- T6 32316335 ↗ — Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy
- T6 34512258 ↗ — Novel Therapies for Parkinsonian Syndromes-Recent Progress and Future Perspectives
- T6 23074460 ↗ — Bariatric surgery: an evidence-based analysis
- T6 35393538 ↗ — Abstracts from the 54<sup>th</sup> European Society of Human Genetics (ESHG) Conference: e-Posters
- T6INDIRECT 38743312 ↗ — Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
- T4 PMC11470995 ↗ — UEG Week 2024 Poster Presentations
T4 — Case series
POTS
8 sources
- T6INDIRECT 37610446 ↗ — Sensory neuropathy in amyotrophic lateral sclerosis: a systematic review
- T6 36096831 ↗ — Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022) : Prague, Czech Republ
- T6 39598411 ↗ — Benign Evolution of Complex Regional Pain Syndrome (CRPS) Type 1 in Patients Treated with Intravenou
- T6 35212265 ↗ — Pseudo-pheochromocytoma due to obstructive sleep apnea: a case report
- T6 40767450 ↗ — SEDCYDO - SEGER - SEMO CONGRESS MADRID 2025, 8-10 MAY. Proceedings and Abstract
- T4 PMC6777611 ↗ — Abstracts from the 50th European Society of Human Genetics Conference: Posters
- T4 PMC7103906 ↗ — Posters
- T4 PMC7104471 ↗ — Physicians Poster Abstracts : EBMT 2012
T4 — Case series
POTS
11 sources
- T6 35526973 ↗ — Trigger Point Injections
- T6 36641366 ↗ — The vagus nerve in cardiovascular physiology and pathophysiology: From evolutionary insights to clin
- T6INDIRECT 35839020 ↗ — Local anesthetics as a therapeutic tool for post COVID-19 patients: A case report
- T6INDIRECT 36714125 ↗ — Case report: Individualized pulsed electromagnetic field therapy in a Long COVID patient using the A
- T6 29855197 ↗ — ASNTR 2018 Abstracts
- T4 41564315 ↗ — Neuraltherapeutic Medicine in Post-Acute COVID-19 Vaccination Syndrome (PACVS): A Critical Review wi
- T6 22179483 ↗ — The continued promise of stem cell therapy in regenerative medicine
- T6 22125442 ↗ — A showcase of bench-to-bedside regenerative medicine at the 2010 ASNTR
- T6 26858901 ↗ — Disease and Stem Cell-Based Analysis of the 2014 ASNTR Meeting
- T6 28494821 ↗ — Abstracts for the 24th Annual Meeting of the American Society for Neural Therapy and Repair
- T6 39070159 ↗ — Neurological symphony: post-acute COVID-19 syndrome, an innovative pathophysiological exploration fr
T4 — Case series
POTS
13 sources
- T6 32404379 ↗ — Clinical trials in REM sleep behavioural disorder: challenges and opportunities
- T6 29607374 ↗ — Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
- T6 35158955 ↗ — Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
- T6 38046043 ↗ — Management of hypertension in patients with cancer: challenges and considerations
- T6 31189100 ↗ — Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization
- T6INDIRECT 39186376 ↗ — Acute Kidney Injury Associated with Anticancer Therapies: Small Molecules and Targeted Therapies
- T6INDIRECT 34559267 ↗ — European Association of Nuclear Medicine October 20-23, 2021 Virtual
- T4 PMC10408386 ↗ — Poster Abstracts - Academy of Managed Care Pharmacy Nexus 2020
- T6INDIRECT 34982365 ↗ — Proceedings of the World Molecular Imaging Congress 2021, October 5-8, 2021: General Abstracts
- T6INDIRECT 40498965 ↗ — EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025
- T4 PMC11177578 ↗ — EHA2024 Hybrid Congress
- T4 PMC9260650 ↗ — Posters
- T6 37312150 ↗ — Review of cancer therapies for the perioperative physician
Permanent pacemaker therapy
T4
T4 — Case series
POTS
15 sources
- T6INDIRECT 17208080 ↗ — The expectation effect and cardiac pacing for refractory vasovagal syncope
- T6INDIRECT 32151742 ↗ — Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in you
- T6 34455427 ↗ — 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
- T6 37754821 ↗ — Shared Decision Making and Cardioneuroablation Allow Discontinuation of Permanent Pacing in Patients
- T6 15481606 ↗ — Clinical characteristics of hypervagotonic sinus node dysfunction
- T5 34306697 ↗ — Avoidance and early diagnosis of erroneous permanent pacemaker placement into the left ventricle: A
- T6INDIRECT 39544310 ↗ — Cardioneuroablation eliminating cardiac asystole associated with area postrema syndrome: a case repo
- T6INDIRECT 42028077 ↗ — Extracardiac vagal nerve stimulation-guided cardioneuroablation in patients with interrupted superio
- T6INDIRECT 41798792 ↗ — Efficacy and safety of cardioneuroablation as a treatment for patients with functional bradyarrhythm
- T6INDIRECT 25696046 ↗ — Implantable diagnostic and therapeutic devices in children
- T4 PMC11907109 ↗ — Standard Poster Abstracts for the 17th Asia Pacific Heart Rhythm Society (APHRS) Scientific Sessions
- T4 PMC7166401 ↗ — 2012 ACVIM Forum Research Abstracts Program
- T6 39106234 ↗ — The triggers of situational syncope do not influence the head-up tilt test response and prognosis
- T6 25053240 ↗ — Highlights in clinical autonomic neurosciences: novel insights about vasovagal syncope and postural
- T6 39712356 ↗ — Vasovagal Syncope: A Review of Current and Emerging Therapies for a Common Cardiology Condition
Prazosin Hydrochloride
T4
T4 — Case series
POTS
25 sources
- T6INDIRECT 16864724 ↗ — Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis in
- T6INDIRECT 19101235 ↗ — Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis In
- T6INDIRECT 16675509 ↗ — Ondansetron does not reduce the shivering threshold in healthy volunteers
- T6 32848775 ↗ — Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Pr
- T6 26370 ↗ — The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockad
- T6 21565668 ↗ — Hypertension in pheochromocytoma: characteristics and treatment
- T6 24937433 ↗ — Netrin-1 controls sympathetic arterial innervation
- T6INDIRECT 3176460 ↗ — Pheochromocytoma--recent advances in diagnosis and treatment
- T6INDIRECT 31528576 ↗ — Pheochromocytoma-induced shock: a case report
- T6INDIRECT 34353832 ↗ — Anaesthetic challenges in perioperative management of thoracic paraganglioma in an 8-year-old child
- T4 PMC1737656 ↗ — Atlas of peripheral nerve surgery
- T4 PMC1737653 ↗ — Diagnosis and management of Alzheimer's disease and other dementias
- T4 PMC1737652 ↗ — Upper motor neurone syndrome and spasticity. Clinical management and neurophysiology
- T4 PMC1737650 ↗ — Post traumatic stress disorder diagnosis, management and treatment
- T4 PMC1737646 ↗ — Maudsley neuropsychiatry modules: a teaching package for self paced learning or small group seminars
- T6 21753871 ↗ — Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
- T6 1742694 ↗ — Non-insulin-dependent (type II) diabetes mellitus
- T6 1574883 ↗ — Pheochromocytoma
- T6 36120615 ↗ — Autonomic Dysreflexia following Spinal Cord Injury
- T6 8104650 ↗ — Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract
- T6 6138365 ↗ — Acute reduction in human platelet alpha 2-adrenoreceptor affinity for agonist by endogenous and exog
- T6 24246572 ↗ — The α1 adrenoceptor antagonist prazosin enhances sleep continuity in fear-conditioned Wistar-Kyoto r
- T6 8401939 ↗ — Altered cardiac adrenergic neurotransmission in streptozotocin-induced diabetic rats
- T6 6956401 ↗ — Hypertension secondary to pheochromocytoma
- T6 1309183 ↗ — Medications in older patients
T4 — Case series
MCASPOTS
30 sources
- T6 NCT00449748 ↗ — Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
- T6INDIRECT 24407160 ↗ — Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic
- T6 37169756 ↗ — Angiogenic signaling pathways and anti-angiogenic therapy for cancer
- T6 21235428 ↗ — Mechanisms of drug resistance in kinases
- T6 26654227 ↗ — Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell l
- T6 27549339 ↗ — Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
- T6 18559612 ↗ — Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases,
- T6 20038218 ↗ — Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients wi
- T6 24323045 ↗ — Autophagy and human diseases
- T6 31277291 ↗ — A Comprehensive Review of Autophagy and Its Various Roles in Infectious, Non-Infectious, and Lifesty
- T6 20814256 ↗ — Emerging pharmacotherapies for neurodevelopmental disorders
- T6 34944054 ↗ — Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson's Disease
- T6 22695254 ↗ — Safety and preliminary efficacy analysis of the mTOR inhibitor ridaforolimus in patients with taxane
- T6INDIRECT 20405294 ↗ — Total laparoscopic radical hysterectomy for cervical cancer in prolapsed uterus
- T6INDIRECT 23258954 ↗ — Clinical application of development of nonantibiotic macrolides that correct inflammation-driven imm
- T6INDIRECT 26062813 ↗ — Targeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloprol
- T6INDIRECT 27507155 ↗ — IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells
- T6INDIRECT 19259308 ↗ — Optimizing imatinib mesylate treatment in gastrointestinal stromal tumors
- T6INDIRECT 21484580 ↗ — The 21st conference of the asian pacific association for the study of the liver : oral presentations
- T6INDIRECT 30561866 ↗ — "Abstracts of the 77th Annual Meeting of the Japanese Cancer Association; 2018 Sept 27-29; Osaka, Ja
- T4 PMC7163973 ↗ — Poster Presentations
- T6 17934482 ↗ — Aberrant cytokine signaling in leukemia
- T6 32435640 ↗ — Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improve
- T6 21372221 ↗ — Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a
- T6INDIRECT 34559267 ↗ — European Association of Nuclear Medicine October 20-23, 2021 Virtual
- T6INDIRECT 30480124 ↗ — Program Abstracts from the 21st International Association of Gerontology and Geriatrics (IAGG) World
- T6INDIRECT 28894880 ↗ — EANM'17
- T4 PMC6216117 ↗ — Abstracts from the 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncolog
- T4 PMC4894295 ↗ — 21st Congress of the European Hematology Association Copenhagen, Denmark, June 9–12, 2016
- T4 PMC2888565 ↗ — 15th Congress of the European Hematology Association, Spain, Barcelona, June 10–13, 2010
Rabbit Anti-Thymocyte Globulin
T4
T4 — Case series
POTS
15 sources
- T6INDIRECT 39382091 ↗ — Interventions for BK virus infection in kidney transplant recipients
- T6INDIRECT 30786841 ↗ — Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a
- T6 39200392 ↗ — Heart Transplant Rejection: From the Endomyocardial Biopsy to Gene Expression Profiling
- T6 32785838 ↗ — Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK exp
- T6 21720671 ↗ — The IKEM pancreas and islet transplant program as part of healthcare for type 1 diabetes patients: r
- T6INDIRECT 25745552 ↗ — Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiothe
- T6INDIRECT 36876244 ↗ — Hypercholesterolemia due to lipoprotein-X manifesting as pseudohyponatremia in a patient with choles
- T6INDIRECT 36323940 ↗ — The 48<sup>th</sup> Annual Meeting of the European Society for Blood and Marrow Transplantation: Phy
- T6INDIRECT 27114361 ↗ — Abstracts from the 2016 Society of General Internal Medicine Annual Meeting
- T6INDIRECT 21559853 ↗ — Building 21st Century medicine through education, research, policy and practice. Abstracts of the So
- T4 PMC11177578 ↗ — EHA2024 Hybrid Congress
- T6 PMC7104471 ↗ — Physicians Poster Abstracts : EBMT 2012
- T6 PMC4894295 ↗ — 21st Congress of the European Hematology Association Copenhagen, Denmark, June 9–12, 2016
- T6 38500081 ↗ — Management of kidney transplant recipients for primary care practitioners
- T6 34841047 ↗ — Neurogenic Orthostatic Hypotension: a Common Complication of Successful Pancreas Transplantation
T4 — Case series
POTS
17 sources
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 28174091 ↗ — Inhibitors of cyclin-dependent kinases as cancer therapeutics
- T6 34604797 ↗ — Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus State
- T6 29607374 ↗ — Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
- T6 32452701 ↗ — An up-to-date overview of computational polypharmacology in modern drug discovery
- T6INDIRECT 39186376 ↗ — Acute Kidney Injury Associated with Anticancer Therapies: Small Molecules and Targeted Therapies
- T6INDIRECT 31612778 ↗ — Meeting Abstracts - Academy of Managed Care Pharmacy Nexus 2019
- T6INDIRECT 40584433 ↗ — Potential synergism of abemaciclib with chloroquine and disulfiram/copper in atypical meningioma: A
- T4 PMC10408411 ↗ — Meeting Abstracts - AMCP Managed Care & Specialty Pharmacy Annual Meeting 2019
- T4 PMC10408386 ↗ — Poster Abstracts - Academy of Managed Care Pharmacy Nexus 2020
- T6INDIRECT 28397154 ↗ — Abstracts from the 2017 Society of General Internal Medicine Annual Meeting
- T6INDIRECT 40767450 ↗ — SEDCYDO - SEGER - SEMO CONGRESS MADRID 2025, 8-10 MAY. Proceedings and Abstract
- T6 39042344 ↗ — Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer
- T6 38543080 ↗ — A Drug Safety Briefing (II) in Transplantation from Real-World Individual Pharmacotherapy Management
- T6 41810127 ↗ — Charting the Current Landscape and Future Prospects of Cancer Therapy-Related Cardiovascular Toxicit
- T6 39352628 ↗ — Glucocorticoid treatment and adrenal suppression in children: current view and open issues
- T6 37312150 ↗ — Review of cancer therapies for the perioperative physician
T4 — Case series
POTS
12 sources
- T6INDIRECT 26355598 ↗ — Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualit
- T6INDIRECT 27419911 ↗ — Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestina
- T6INDIRECT 23076930 ↗ — Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 29694674 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 40689673 ↗ — Comparison of two peripheral regional analgesic techniques for primary elective total hip arthroplas
- T6 33436442 ↗ — Pain management after open liver resection: Procedure-Specific Postoperative Pain Management (PROSPE
- T6INDIRECT 34712535 ↗ — Tardive Dyskinesia in a Postoperative Gynecological Patient After Single Dose Administration of Meto
- T6INDIRECT 41111139 ↗ — Abstracts of the ICARE 2025 79th SIAARTI National Congress
- T4 PMC12975069 ↗ — Proceedings: National multidisciplinary conference on recent advances in medical specialities
- T6 31020032 ↗ — Transition to outpatient total hip and knee arthroplasty: experience at an academic tertiary care ce
- T6 36483978 ↗ — Nomogram for Prediction of Postoperative Delirium after Deep Brain Stimulation of Subthalamic Nucleu
T5 — Case report
POTS
18 sources
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 33175411 ↗ — Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physica
- T6INDIRECT 30050569 ↗ — Noninvasive Brain Stimulations for Unilateral Spatial Neglect after Stroke: A Systematic Review and
- T6INDIRECT 40067404 ↗ — Efficacy of neuromodulation and rehabilitation approaches on pain relief in patients with spinal cor
- T6INDIRECT 26544542 ↗ — Pharmacological interventions for unilateral spatial neglect after stroke
- T6INDIRECT 40995146 ↗ — Non-invasive brain stimulation for stroke-related motor impairment and disability: an umbrella revie
- T6INDIRECT 41683658 ↗ — Beyond the Pain: Rethinking Chronic Pain Management Through Integrated Therapeutic Approaches-A Syst
- T6 31871494 ↗ — Therapeutic Approaches for Peripheral and Central Neuropathic Pain
- T6 27317916 ↗ — Demystifying Poststroke Pain: From Etiology to Treatment
- T5 19967390 ↗ — Derangement of body representation in complex regional pain syndrome: report of a case treated with
- T6INDIRECT 37631018 ↗ — Stroke-Induced Central Pain: Overview of the Mechanisms, Management, and Emerging Targets of Central
- T6INDIRECT 29973967 ↗ — Development of a Multimodal Analgesia Protocol for Perioperative Acute Pain Management for Lower Lim
- T6INDIRECT 36320223 ↗ — An Algorithm Approach to Phantom Limb Pain
- T6 41743427 ↗ — Current status and future prospects of brain-computer interfaces in the field of neurological diseas
- T6 35195724 ↗ — Association of Chiropractic Colleges Research Agenda Conference 2022: Wellness and Health Promotion:
- T6 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
- T6 34276544 ↗ — Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrom
- T6 25411651 ↗ — Special Considerations for Multiple Limb Amputation
T6 — Mechanistic / preclinical
POTS
20 sources
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 29932206 ↗ — Saline irrigation for allergic rhinitis
- T6INDIRECT 29694674 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 37496207 ↗ — Efficacy of hydrodilatation in frozen shoulder: a systematic review and meta-analysis
- T6INDIRECT 34122328 ↗ — Long-Term Results of Ultrasound-Guided Radiofrequency Ablation of Benign Thyroid Nodules: State of t
- T6INDIRECT 22733065 ↗ — Safety, tolerability, and pharmacokinetics of intravenous oseltamivir: single- and multiple-dose pha
- T6INDIRECT 34807760 ↗ — A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of a Fir
- T6INDIRECT 28707277 ↗ — Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome
- T6 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6 31642064 ↗ — Medical interventions for chronic rhinosinusitis in cystic fibrosis
- T6INDIRECT 32784744 ↗ — Foodborne Botulism: Clinical Diagnosis and Medical Treatment
- T6INDIRECT 31780881 ↗ — Inappropriate Antidiuretic Hormone Secretion and Cerebral Salt-Wasting Syndromes in Neurological Pat
- T6INDIRECT 36532656 ↗ — The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis
- T6INDIRECT 19730409 ↗ — Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-in
- T6INDIRECT 24569199 ↗ — Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infec
- T6 7049208 ↗ — Pindolol--the pharmacology of a partial agonist
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 2552038 ↗ — Localization and development of nerve growth factor-sensitive rat basal forebrain neurons and their
- T6 31189100 ↗ — Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization
- T6 30150361 ↗ — Dorsal BNST α<sub>2A</sub>-Adrenergic Receptors Produce HCN-Dependent Excitatory Actions That Initia
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
26 sources
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T6INDIRECT 8673750 ↗ — Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained synco
- T6INDIRECT 9505918 ↗ — Midodrine: a role in the management of neurocardiogenic syncope
- T6INDIRECT 11511713 ↗ — Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson'
- T6INDIRECT 12023411 ↗ — Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, dou
- T6INDIRECT 9343116 ↗ — Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levo
- T6INDIRECT 9810943 ↗ — Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up
- T6INDIRECT 4612057 ↗ — The cardiovascular effects of morphine. The peripheral capacitance and resistance vessels in human s
- T6INDIRECT 16107351 ↗ — The role of levodopa in the management of dementia with Lewy bodies
- T6INDIRECT 12397141 ↗ — Goal setting and attainment in Alzheimer's disease patients treated with donepezil
- T6INDIRECT 2545827 ↗ — Diffuse Lewy body disease: clinical features in 15 cases
- T6INDIRECT 11861698 ↗ — Positional down beating nystagmus in 50 patients: cerebellar disorders and possible anterior semicir
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 2666581 ↗ — Multiple system atrophy--the nature of the beast
- T6INDIRECT 2940082 ↗ — Metabolism and possible health effects of aluminum
- T6INDIRECT 35679471 ↗ — Human temperature regulation under heat stress in health, disease, and injury
- T6INDIRECT 17227286 ↗ — Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cess
- T6INDIRECT 33895845 ↗ — 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral A
- T6 6326753 ↗ — Oxygen toxicity, oxygen radicals, transition metals and disease
- T6 11250812 ↗ — Climate change and mosquito-borne disease
- T6 10379421 ↗ — Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines an
- T6 11694544 ↗ — Hirschsprung disease, associated syndromes, and genetics: a review
- T6 32287334 ↗ — Free radicals, oxidative stress, and antioxidants in human health and disease
- T6 8177173 ↗ — Gas vesicles
- T6 16678566 ↗ — Childhood functional gastrointestinal disorders: child/adolescent
- T6 16365341 ↗ — JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical pract
A 24-hour ROC training program with a standing posture
T6
T6 — Mechanistic / preclinical
POTS
A 48-hour ROC training program with a standing posture
T6
T6 — Mechanistic / preclinical
POTS
A regular therapy program without receiving any ROC training
T6
T6 — Mechanistic / preclinical
POTS
AAV2-GDNF gene therapy
T6
T6 — Mechanistic / preclinical
POTS
4 sources
- T6 32700249 ↗ — Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic sci
- T6 34398313 ↗ — Current experimental disease-modifying therapeutics for multiple system atrophy
- T6 38828714 ↗ — An update on multiple system atrophy
- T6 40640529 ↗ — Investigational Gene Therapies for Parkinson's Disease
AFFITOPE® PD01A + Adjuvant
T6
T6 — Mechanistic / preclinical
POTS
AFFITOPE® PD03A + Adjuvant
T6
T6 — Mechanistic / preclinical
POTS
ARC-IM Investigational System
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
1 source
- T6 39853679 ↗ — A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administe
T6 — Mechanistic / preclinical
POTS
1 source
- T6 40498965 ↗ — EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025
T6 — Mechanistic / preclinical
POTS
2 sources
- T6 26186558 ↗ — Targeting the Pim kinases in multiple myeloma
- T6 31639031 ↗ — Meeting abstracts from the 5th International Clinical Trials Methodology Conference (ICTMC 2019) : B
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
21 sources
- T6INDIRECT 31794067 ↗ — Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in pe
- T6INDIRECT 35675216 ↗ — Systematic review and meta-analysis examining the relationship between postprandial hypotension, car
- T6INDIRECT 28489279 ↗ — Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention o
- T6INDIRECT 31349678 ↗ — Acute Effects of Nutritive and Non-Nutritive Sweeteners on Postprandial Blood Pressure
- T6INDIRECT 35133603 ↗ — Hypoglycemia and Dysautonomia After Bariatric Surgery: a Systematic Review and Perspective
- T6INDIRECT 25732215 ↗ — Effects of guar gum ingestion on postprandial blood pressure in older adults
- T6INDIRECT 39064619 ↗ — Effect of Low-Dose Mulberry Fruit Extract on Postprandial Glucose and Insulin Responses: A Randomize
- T6INDIRECT 32121016 ↗ — Sensory Acceptance, Appetite Control and Gastrointestinal Tolerance of Yogurts Containing Coffee-Cas
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
- T6 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 16365341 ↗ — JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical pract
T6 — Mechanistic / preclinical
POTS
25 sources
- T6INDIRECT 30556597 ↗ — Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people
- T6INDIRECT 33441035 ↗ — Synonymous but Not Silent: The Codon Usage Code for Gene Expression and Protein Folding
- T6INDIRECT 29271481 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 35603936 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 31917873 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 24944260 ↗ — Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial
- T6INDIRECT 30635141 ↗ — Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
- T6INDIRECT 23806384 ↗ — Antiplatelet effects of dietary nitrate in healthy volunteers: involvement of cGMP and influence of
- T6INDIRECT 15749735 ↗ — Magnesium sulphate only slightly reduces the shivering threshold in humans
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6INDIRECT 21749363 ↗ — Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
- T6INDIRECT 21221114 ↗ — ATP7A-related copper transport diseases-emerging concepts and future trends
- T6INDIRECT 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6INDIRECT 2940082 ↗ — Metabolism and possible health effects of aluminum
- T6INDIRECT 35655306 ↗ — Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 21115758 ↗ — Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Asso
- T6 23968694 ↗ — Sugar for the brain: the role of glucose in physiological and pathological brain function
- T6 26593421 ↗ — RNA mis-splicing in disease
- T6 28689769 ↗ — Osteoporosis treatment: recent developments and ongoing challenges
- T6 26111766 ↗ — SLC transporters as therapeutic targets: emerging opportunities
- T6 20810645 ↗ — tRNA biology charges to the front
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 30324412 ↗ — European guidance for the diagnosis and management of osteoporosis in postmenopausal women
Adjuvant without active component
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
1 source
- T6 40542573 ↗ — Special Issue: Abstracts of the 11<sup>th</sup> Congress of the European Academy of Neurology, Helsi
T6 — Mechanistic / preclinical
POTS
10 sources
- T6INDIRECT 39297531 ↗ — Interleukin-receptor antagonist and tumour necrosis factor inhibitors for the primary and secondary
- T6INDIRECT 29271481 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 35603936 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 31917873 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 33871055 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6 37436070 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 32421085 ↗ — Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in
- T6INDIRECT 32546899 ↗ — Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in
- T6 38617189 ↗ — Structure and function of therapeutic antibodies approved by the US FDA in 2023
- T6 39202335 ↗ — Simulated Microgravity Alters Gene Regulation Linked to Immunity and Cardiovascular Disease
American Autonomic Society statement
T6
T6 — Mechanistic / preclinical
POTS
3 sources
- T6 33740207 ↗ — Long-COVID postural tachycardia syndrome: an American Autonomic Society statement.
- T6 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
- T6 35470419 ↗ — Post-COVID-19 postural orthostatic tachycardia syndrome
Androgen receptor inhibitor
T6
T6 — Mechanistic / preclinical
POTS
7 sources
- T6 34691199 ↗ — Dermatology: how to manage acne vulgaris
- T6 40142611 ↗ — Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia:
- T6 38376087 ↗ — Low-Dose Oral Minoxidil for Alopecia: A Comprehensive Review
- T6 32745289 ↗ — Research Communications of the 27<sup>th</sup> ECVIM-CA Congress. Intercontinental, Saint Julian's,
- T6 PMC6876493 ↗ — Abstracts from the 52nd European Society of Human Genetics (ESHG) Conference: Posters
- T6 23115463 ↗ — Pharmaceutical approval update
- T6 40722209 ↗ — Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert
Anodal cerebellar and cathodal spinal tDCS
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 33428616 ↗ — Mindfulness-based programmes for mental health promotion in adults in nonclinical settings: A system
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 33957075 ↗ — Dismantling, optimising, and personalising internet cognitive behavioural therapy for depression: a
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 18281407 ↗ — Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with bord
- T6INDIRECT 18398080 ↗ — Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the S
- T6INDIRECT 9570194 ↗ — Left ventricular structure and function in children infected with human immunodeficiency virus: the
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 23225012 ↗ — Parkinson's disease
- T6INDIRECT 19337156 ↗ — The IC3D classification of the corneal dystrophies
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6 21976606 ↗ — Food animals and antimicrobials: impacts on human health
- T6 22258608 ↗ — The promise of induced pluripotent stem cells in research and therapy
- T6 28887905 ↗ — Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Sh
- T6 27977393 ↗ — Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Associa
- T6 25834232 ↗ — Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing
- T6 36859484 ↗ — Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration bac
AtriCure Commercially Available Devices
T6
T6 — Mechanistic / preclinical
POTS
AtriCure ISOLATOR Synergy Surgical Ablation System
T6
T6 — Mechanistic / preclinical
POTS
1 source
- T6 37124558 ↗ — Hybrid epicardial and endocardial sinus node-sparing ablation therapy for inappropriate sinus tachyc
Autologous Mesenchymal Stem Cells
T6
T6 — Mechanistic / preclinical
POTS
13 sources
- T6INDIRECT 30294976 ↗ — Available and future treatments for atypical parkinsonism. A systematic review
- T6 21962754 ↗ — Multiple system atrophy: a clinical and neuropathological perspective
- T6 28803444 ↗ — Atypical parkinsonian syndromes: a general neurologist's perspective
- T6 32095235 ↗ — Insights into the pathogenesis of multiple system atrophy: focus on glial cytoplasmic inclusions
- T6 26749150 ↗ — Therapeutic approaches in Parkinson's disease and related disorders
- T6 31152011 ↗ — Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy
- T6INDIRECT 36660581 ↗ — Multiple system atrophy-cerebellar: A case report and literature review
- T6INDIRECT 24598411 ↗ — Towards translational therapies for multiple system atrophy
- T6INDIRECT 32436100 ↗ — An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis
- T6INDIRECT 30363880 ↗ — Current Concepts in the Treatment of Multiple System Atrophy
- T6INDIRECT 32767032 ↗ — Current Management and Emerging Therapies in Multiple System Atrophy
- T6INDIRECT 38743312 ↗ — Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review
- T6INDIRECT 21179616 ↗ — Multiple system atrophy: current and future approaches to management
T6 — Mechanistic / preclinical
POTS
23 sources
- T6INDIRECT 33175411 ↗ — Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physica
- T6INDIRECT 25919144 ↗ — Interventions for rosacea
- T6INDIRECT 27819409 ↗ — Interventions for chronic kidney disease-associated restless legs syndrome
- T6INDIRECT 34318929 ↗ — Interventions for preventing falls and fall-related fractures in community-dwelling older adults: A
- T6INDIRECT 34271512 ↗ — Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A system
- T6INDIRECT 29549458 ↗ — Gastrointestinal symptoms in postural tachycardia syndrome: a systematic review
- T6INDIRECT 35094007 ↗ — Walking improvement in chronic incomplete spinal cord injury with exoskeleton robotic training (WISE
- T6INDIRECT 29649928 ↗ — Non-Invasive Activation of Cervical Spinal Networks after Severe Paralysis
- T6INDIRECT 31802596 ↗ — Open-label pilot study: Non-invasive vagal nerve stimulation improves symptoms and gastric emptying
- T6INDIRECT 28571527 ↗ — Assessment and management of acute spinal cord injury: From point of injury to rehabilitation
- T6INDIRECT 29934758 ↗ — Diabetic Gastroparesis: Principles and Current Trends in Management
- T6INDIRECT 25954496 ↗ — The diagnosis and treatment of chronic migraine
- T6INDIRECT 18686748 ↗ — Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
- T6INDIRECT 29335879 ↗ — Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome
- T6INDIRECT 24142590 ↗ — Treatment of dystonia
- T6INDIRECT 23612753 ↗ — Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins
- T6INDIRECT 17274492 ↗ — Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care
- T6 31387301 ↗ — Mechanisms of Botulinum Toxin Type A Action on Pain
- T6 28778262 ↗ — Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau
- T6 20142810 ↗ — New treatments for chronic prostatitis/chronic pelvic pain syndrome
- T6 35411324 ↗ — Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From t
- T6 24713270 ↗ — Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in hu
- T6 23550085 ↗ — Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease
T6 — Mechanistic / preclinical
POTS
16 sources
- T6INDIRECT 33408364 ↗ — Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overwei
- T6 31655889 ↗ — The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 36357675 ↗ — Rare and common genetic determinants of metabolic individuality and their effects on human health
- T6 34693230 ↗ — Symptom Persistence Despite Improvement in Cardiopulmonary Health - Insights from longitudinal CMR,
- T6 32144319 ↗ — A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli
- T6INDIRECT 34468792 ↗ — 57<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes
- T6INDIRECT 35393538 ↗ — Abstracts from the 54<sup>th</sup> European Society of Human Genetics (ESHG) Conference: e-Posters
- T6INDIRECT 34559267 ↗ — European Association of Nuclear Medicine October 20-23, 2021 Virtual
- T6INDIRECT 28608429 ↗ — 27th Regional Congress of the ISBT, Copenhagen, Denmark, June 17-21, 2017
- T6INDIRECT 39871188 ↗ — Falls and balance impairment; what and how has this been measured in adults with joint hypermobility
- T6INDIRECT 28795195 ↗ — 53 <sup>rd</sup> EASD Annual Meeting of the European Association for the Study of Diabet
- T6INDIRECT 32840677 ↗ — 56<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : 21-25 Se
- T6 38425314 ↗ — HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease
- T6 38853153 ↗ — First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluoresc
- T6 28797221 ↗ — Use of genotyping-by-sequencing to determine the genetic structure in the medicinal plant chamomile,
Balance training by means of conventional rehabilitation
T6
T6 — Mechanistic / preclinical
POTS
Balance training over stabilometric platform
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
Behavior Change Coaching
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
2 sources
- T6 37325475 ↗ — PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potenti
- T6 40498965 ↗ — EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025
T6 — Mechanistic / preclinical
POTS
23 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 27170530 ↗ — Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double-blind, ran
- T6INDIRECT 34739197 ↗ — Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- T6INDIRECT 22281448 ↗ — Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances
- T6INDIRECT 11435337 ↗ — Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope:
- T6INDIRECT 19687359 ↗ — Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less i
- T6INDIRECT 19470886 ↗ — Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 di
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 26835847 ↗ — Hypertension and aging
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 30192094 ↗ — Management of common adverse effects of antipsychotic medications
- T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6 26062169 ↗ — Fear and the Defense Cascade: Clinical Implications and Management
- T6 34236546 ↗ — Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 35963508 ↗ — American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Me
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T6 — Mechanistic / preclinical
POTS
7 sources
- T6 9728937 ↗ — Treatment of postural hypotension
- T6 35633931 ↗ — Treatment strategies for clozapine-induced hypotension: a systematic review
- T6 37732384 ↗ — Emulsifiers in ultra-processed foods in the UK food supply
- T6 21233984 ↗ — Monoamine oxidase inhibitors: clinical review
- T6 4731440 ↗ — Amyloidosis complicated by intractable postural hypotension
- T6 20755019 ↗ — Annual Museum
- T6 29838764 ↗ — "The Hospital" Nursing Mirror
T6 — Mechanistic / preclinical
POTS
25 sources
- T6INDIRECT 26355598 ↗ — Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualit
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 27419911 ↗ — Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestina
- T6INDIRECT 23076930 ↗ — Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 26861472 ↗ — Ziconotide Monotherapy: A Systematic Review of Randomised Controlled Trials
- T6INDIRECT 7574055 ↗ — Effects of perioperative analgesic technique on rate of recovery after colon surgery
- T6INDIRECT 8214727 ↗ — Epidural anesthesia for labor in an ambulatory patient
- T6INDIRECT 24496086 ↗ — Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clin
- T6 31663402 ↗ — Consensus statement for perioperative care in total hip replacement and total knee replacement surge
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 23094876 ↗ — Brugada phenocopy: new terminology and proposed classification
- T6INDIRECT 29276402 ↗ — Ganglion blocks as a treatment of pain: current perspectives
- T6INDIRECT 26869865 ↗ — A systematic review of the cardiotoxicity of methadone
- T6INDIRECT 34295184 ↗ — The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Intervent
- T6INDIRECT 32448142 ↗ — Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence
- T6INDIRECT 18488078 ↗ — Current aproach to cancer pain management: Availability and implications of different treatment opti
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 35215352 ↗ — Chiral Switch: Between Therapeutical Benefit and Marketing Strategy
- T6 29262334 ↗ — Modulation of SF1 Neuron Activity Coordinately Regulates Both Feeding Behavior and Associated Emotio
- T6 34764220 ↗ — Consensus practice guidelines on interventions for cervical spine (facet) joint pain from a multispe
- T6 25632113 ↗ — Designer receptors enhance memory in a mouse model of Down syndrome
- T6 30090998 ↗ — Facet joint syndrome: from diagnosis to interventional management
- T6 22066560 ↗ — Why still in hospital after fast-track hip and knee arthroplasty?
- T6 19238499 ↗ — The feasibility and perioperative complications of outpatient knee arthroplasty
T6 — Mechanistic / preclinical
POTS
CERE-110: Adeno-Associated Virus injection Surgery
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 26671213 ↗ — Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched
- T6INDIRECT 38375882 ↗ — Mobile health (m-health) smartphone interventions for adolescents and adults with overweight or obes
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 31570638 ↗ — Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment
- T6INDIRECT 31129916 ↗ — Interventions for improving sleep quality in people with chronic kidney disease
- T6INDIRECT 30584530 ↗ — Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine
- T6INDIRECT 28013207 ↗ — An investigation into the prevalence of sleep disturbances in primary Sjögren's syndrome: a systemat
- T6INDIRECT 31685792 ↗ — Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary s
- T6INDIRECT 23116538 ↗ — Treatment of multiple system atrophy using intravenous immunoglobulin
- T6INDIRECT 24703753 ↗ — A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder assoc
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 30113864 ↗ — Obstructive Sleep Apnea and the Risk of Cognitive Decline in Older Adults
- T6INDIRECT 33992686 ↗ — Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 28298428 ↗ — Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of th
- T6 37230968 ↗ — Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
- T6 25514304 ↗ — The diagnosis and management of mild cognitive impairment: a clinical review
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
23 sources
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 24361112 ↗ — Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Par
- T6INDIRECT 15548480 ↗ — Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study
- T6INDIRECT 9343116 ↗ — Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levo
- T6INDIRECT 8558148 ↗ — Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients wit
- T6INDIRECT 8527287 ↗ — Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose lev
- T6INDIRECT 23336248 ↗ — Opicapone: a short lived and very long acting novel catechol-O-methyltransferase inhibitor following
- T6INDIRECT 12388617 ↗ — Dopamine modulates the response of the human amygdala: a study in Parkinson's disease
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6INDIRECT 32402162 ↗ — Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease
- T6INDIRECT 26350119 ↗ — Autosomal dominant Parkinson's disease caused by SNCA duplications
- T6INDIRECT 2545827 ↗ — Diffuse Lewy body disease: clinical features in 15 cases
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 23225012 ↗ — Parkinson's disease
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 19933976 ↗ — Medical records documentation of constipation preceding Parkinson disease: A case-control study
- T6 28887905 ↗ — Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Sh
- T6 29090092 ↗ — Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential trea
- T6 28273839 ↗ — Parkinson's Disease: From Pathogenesis to Pharmacogenomics
- T6 26324905 ↗ — Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
- T6 31196984 ↗ — Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
T6 — Mechanistic / preclinical
POTS
21 sources
- T6INDIRECT 26836199 ↗ — Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in ch
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 27884691 ↗ — AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions
- T6INDIRECT 30200910 ↗ — CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery
- T6INDIRECT 36482103 ↗ — Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the
- T6INDIRECT 31980913 ↗ — Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma pati
- T6INDIRECT 8774401 ↗ — Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal auto
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 24323045 ↗ — Autophagy and human diseases
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 24672257 ↗ — Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- T6INDIRECT 24636754 ↗ — Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment
- T6INDIRECT 25584767 ↗ — Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy
- T6 30909387 ↗ — Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
- T6 28620280 ↗ — Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- T6 30130469 ↗ — Iron and Cancer
- T6 28286483 ↗ — Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Periphera
- T6 32114384 ↗ — Resistance to Checkpoint Inhibition in Cancer Immunotherapy
- T6 23095830 ↗ — Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and preven
T6 — Mechanistic / preclinical
POTS
16 sources
- T6INDIRECT 36446613 ↗ — Anti-Hu Antibodies in Patients With Neurologic Side Effects of Immune Checkpoint Inhibitors
- T6INDIRECT 34458371 ↗ — Guillain-Barré Syndrome-Like Polyneuropathy Associated with Immune Checkpoint Inhibitors: A Systemat
- T6 34236546 ↗ — Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new
- T6 31866206 ↗ — Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary infla
- T6 35453977 ↗ — The Role and Potential of <sup>18</sup>F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitori
- T6 34281989 ↗ — Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhi
- T6INDIRECT 36561623 ↗ — Diabetes insipidus: A rare endocrine complication of immune check point inhibitors: A case report an
- T6INDIRECT 37700240 ↗ — Management of respiratory failure in immune checkpoint inhibitors-induced overlap syndrome: a case s
- T6INDIRECT 34659082 ↗ — Paraneoplastic Neuropathies: What's New Since the 2004 Recommended Diagnostic Criteria
- T6INDIRECT 40675801 ↗ — Neurological immune-related adverse events with checkpoint inhibitor therapy: challenges for the neu
- T6INDIRECT 39170102 ↗ — Diagnostic and prognostic biomarkers in immune checkpoint inhibitor-related encephalitis: a retrospe
- T6 33380303 ↗ — Immune Checkpoint Inhibitors and Neurotoxicity
- T6 38617189 ↗ — Structure and function of therapeutic antibodies approved by the US FDA in 2023
- T6 41810127 ↗ — Charting the Current Landscape and Future Prospects of Cancer Therapy-Related Cardiovascular Toxicit
- T6 41440526 ↗ — COVID-19 and Lung Cancer Interactions: A Literature Review
- T6 34559267 ↗ — European Association of Nuclear Medicine October 20-23, 2021 Virtual
Cerebellar repetitive transcranial magnetic stimulation
T6
T6 — Mechanistic / preclinical
POTS
2 sources
- T6INDIRECT 40995146 ↗ — Non-invasive brain stimulation for stroke-related motor impairment and disability: an umbrella revie
- T6 34276544 ↗ — Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrom
T6 — Mechanistic / preclinical
POTS
18 sources
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 35767077 ↗ — Systematic review about complementary medical hyperthermia in oncology
- T6INDIRECT 23981966 ↗ — Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 37919282 ↗ — Smart nanoparticles for cancer therapy
- T6 34236546 ↗ — Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new
- T6 26391778 ↗ — Cancer-treatment-induced neurotoxicity--focus on newer treatments
- T6 30503208 ↗ — NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
- T6 33833386 ↗ — Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia
- T6 27044938 ↗ — Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer
- T6INDIRECT 19417117 ↗ — Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiolog
- T6INDIRECT 31130732 ↗ — Surgery of the lateral skull base: a 50-year endeavour
- T6INDIRECT 28800865 ↗ — Anaphylaxis
- T6INDIRECT 25124015 ↗ — Noninvasive imaging of cardiovascular injury related to the treatment of cancer
- T6INDIRECT 32421085 ↗ — Hypersensitivity reactions to biologics (part I): allergy as an important differential diagnosis in
- T6 35159802 ↗ — Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue
- T6 29950872 ↗ — Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers
- T6 28730291 ↗ — Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
Cognitive Multisensory Rehabilitation
T6
T6 — Mechanistic / preclinical
POTS
Conservative Measures for Orthostatic Hypotension
T6
T6 — Mechanistic / preclinical
POTS
Continuous Positive Airway Pressure
T6
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 34969689 ↗ — Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 d
- T6INDIRECT 26671213 ↗ — Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched
- T6INDIRECT 31570638 ↗ — Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment
- T6INDIRECT 31129916 ↗ — Interventions for improving sleep quality in people with chronic kidney disease
- T6INDIRECT 30584530 ↗ — Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine
- T6INDIRECT 28489279 ↗ — Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention o
- T6INDIRECT 21745374 ↗ — Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated
- T6INDIRECT 31685792 ↗ — Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary s
- T6INDIRECT 23116538 ↗ — Treatment of multiple system atrophy using intravenous immunoglobulin
- T6INDIRECT 24703753 ↗ — A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder assoc
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 29101940 ↗ — REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions
- T6INDIRECT 36782262 ↗ — Circadian disruption and sleep disorders in neurodegeneration
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 26595642 ↗ — Lewy body dementias
- T6 28298428 ↗ — Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of th
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Continuous positive airway pressure
T6
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 34969689 ↗ — Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 d
- T6INDIRECT 26671213 ↗ — Systematic Differences between Cochrane and Non-Cochrane Meta-Analyses on the Same Topic: A Matched
- T6INDIRECT 31570638 ↗ — Stridor in multiple system atrophy: Consensus statement on diagnosis, prognosis, and treatment
- T6INDIRECT 31129916 ↗ — Interventions for improving sleep quality in people with chronic kidney disease
- T6INDIRECT 30584530 ↗ — Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neuroendocrine
- T6INDIRECT 28489279 ↗ — Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention o
- T6INDIRECT 21745374 ↗ — Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated
- T6INDIRECT 31685792 ↗ — Effect of dapagliflozin on obstructive sleep apnea in patients with type 2 diabetes: a preliminary s
- T6INDIRECT 23116538 ↗ — Treatment of multiple system atrophy using intravenous immunoglobulin
- T6INDIRECT 24703753 ↗ — A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder assoc
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 29101940 ↗ — REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions
- T6INDIRECT 36782262 ↗ — Circadian disruption and sleep disorders in neurodegeneration
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 26595642 ↗ — Lewy body dementias
- T6 28298428 ↗ — Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of th
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
Contrast Compression Therapy
T6
T6 — Mechanistic / preclinical
POTS
Conventional rehabilitation, the Erigo®Pro table, motor imagery
T6
T6 — Mechanistic / preclinical
POTS
Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait parameters.
T6
T6 — Mechanistic / preclinical
POTS
Conventional rehabilitation, the Erigo®Pro table, motor imagery on gait.
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
11 sources
- T6 28273839 ↗ — Parkinson's Disease: From Pathogenesis to Pharmacogenomics
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 23241069 ↗ — A review of the efficacy and safety of oral antidiabetic drugs
- T6 27505015 ↗ — Side effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharma
- T6 17592632 ↗ — A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatm
- T6INDIRECT 23792716 ↗ — Clinical Diabetes/Therapeutics
- T6 31442412 ↗ — Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults
- T6 27994440 ↗ — Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations
- T6 20523873 ↗ — Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes
- T6 36012132 ↗ — Bromocriptine-QR Therapy Reduces Sympathetic Tone and Ameliorates a Pro-Oxidative/Pro-Inflammatory P
- T6 21847449 ↗ — Bromocriptine in type 2 diabetes mellitus
DRG stimulation 20 Hz 30/90
T6
T6 — Mechanistic / preclinical
POTS
DRG stimulation 5 Hz 30/90
T6
T6 — Mechanistic / preclinical
POTS
DaTSCAN™ Ioflupane Injection
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 25432016 ↗ — Exercise for reducing fear of falling in older people living in the community
- T6INDIRECT 24018704 ↗ — Physiotherapy versus placebo or no intervention in Parkinson's disease
- T6INDIRECT 32449203 ↗ — Interventions for increasing fruit and vegetable consumption in children aged five years and under
- T6INDIRECT 29770960 ↗ — Interventions for increasing fruit and vegetable consumption in children aged five years and under
- T6INDIRECT 34318929 ↗ — Interventions for preventing falls and fall-related fractures in community-dwelling older adults: A
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 35665915 ↗ — Interventions for preventing falls in Parkinson's disease
- T6INDIRECT 29143692 ↗ — Non-pharmacological interventions for Lewy body dementia: a systematic review
- T6INDIRECT 38588457 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
- T6INDIRECT 2940082 ↗ — Metabolism and possible health effects of aluminum
- T6INDIRECT 17227286 ↗ — Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cess
- T6INDIRECT 18286801 ↗ — Cannabinoids in health and disease
- T6INDIRECT 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6INDIRECT 25332912 ↗ — Effects of physical activity in Parkinson's disease: A new tool for rehabilitation
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 27366343 ↗ — Pathophysiology of Motor Dysfunction in Parkinson's Disease as the Rationale for Drug Treatment and
- T6 39743381 ↗ — Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 35705848 ↗ — Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Impli
- T6 27770207 ↗ — Gait disorders in adults and the elderly : A clinical guide
T6 — Mechanistic / preclinical
POTS
2 sources
Dorsal Root Ganglion Stimulation Cessation
T6
T6 — Mechanistic / preclinical
POTS
Dose-attenuated IST and Hetrombopag
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
15 sources
- T6INDIRECT 32290577 ↗ — Comparative Effectiveness of Botulinum Toxin Injection for Chronic Shoulder Pain: A Meta-Analysis of
- T6INDIRECT 38900335 ↗ — Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of
- T6 32629534 ↗ — Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understoo
- T6 32279713 ↗ — Medical and Surgical Treatments for Dystonia
- T6 35095742 ↗ — Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management Through Clinica
- T6 35526973 ↗ — Trigger Point Injections
- T6 24579044 ↗ — Effect of Platelet-Rich Plasma (PRP) versus Autologous Whole Blood on Pain and Function Improvement
- T6INDIRECT 33467373 ↗ — TMJ Dysfunctions Systemic Implications and Postural Assessments: A Review of Recent Literature
- T6INDIRECT 37830088 ↗ — Breaking the cycle: unraveling the diagnostic, pathophysiological and treatment challenges of refrac
- T6INDIRECT 20820780 ↗ — Long-term safety and effectiveness of the "OptEase" vena cava filter
- T6INDIRECT 37089610 ↗ — "Long COVID-19" and viral "fibromyalgia-ness": Suggesting a mechanistic role for fascial myofibrobla
- T6 41221343 ↗ — Exploring fascia in myofascial pain syndrome: an integrative model of mechanisms
- T6 42080121 ↗ — Myofascial pain in older adults: a geroscience-informed framework integrating precision geriatrics a
- T6 32725471 ↗ — Abstracts from the 2020 Annual Meeting of the Society of General Internal Medicine
- T6 35195724 ↗ — Association of Chiropractic Colleges Research Agenda Conference 2022: Wellness and Health Promotion:
Dual chamber pacemeker
T6
T6 — Mechanistic / preclinical
POTS
EEG/HRV/RSA Monitoring using Infiniti System
T6
T6 — Mechanistic / preclinical
POTS
ETX-636 dose escalation
T6
T6 — Mechanistic / preclinical
POTS
ETX-636 dose escalation in combination with fulvestrant
T6
T6 — Mechanistic / preclinical
POTS
ETX-636 dose expansion in combination with fulvestrant
T6
T6 — Mechanistic / preclinical
POTS
Elastic abdominal binder
T6
T6 — Mechanistic / preclinical
POTS
8 sources
- T6INDIRECT 25448247 ↗ — Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults wi
- T6 20439562 ↗ — Preventing and treating orthostatic hypotension: As easy as A, B, C
- T6 35293295 ↗ — Advances in the Pharmacological and Non-pharmacological Management of Non-motor Symptoms in Parkinso
- T6 32938788 ↗ — Association of transient orthostatic hypotension with falls and syncope in patients with Parkinson d
- T6 30363559 ↗ — Elastic Abdominal Binders Attenuate Orthostatic Hypotension in Parkinson's Disease
- T6INDIRECT 39751950 ↗ — Diagnosis and treatment of autonomic failure, pain and sleep disturbances in Parkinson's disease: gu
- T6INDIRECT 40192452 ↗ — Evaluation and management of autonomic functions in patients with spinal cord injury: A scoping revi
- T6 33392545 ↗ — Initial assessment and management of respiratory infections in persons with spinal cord injuries and
T6 — Mechanistic / preclinical
POTS
3 sources
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 33107592 ↗ — Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progr
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 31554937 ↗ — Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive dr
- T6INDIRECT 36266539 ↗ — Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the p
- T6INDIRECT 26644241 ↗ — Mineralocorticoid Receptor Activation Contributes to the Supine Hypertension of Autonomic Failure
- T6INDIRECT 20368505 ↗ — Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system
- T6INDIRECT 33739123 ↗ — Local Passive Heat for the Treatment of Hypertension in Autonomic Failure
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 26760044 ↗ — Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Gui
- T6 24423978 ↗ — Adrenocortical carcinoma
- T6INDIRECT 38441582 ↗ — Cardiac Amyloidosis Due to Transthyretin Protein: A Review
- T6INDIRECT 23184849 ↗ — Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
- T6INDIRECT 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
- T6INDIRECT 27406184 ↗ — Interventional procedures and future drug therapy for hypertension
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 36507632 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 39651970 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2025
- T6 27471550 ↗ — Interactions between kidney disease and diabetes: dangerous liaisons
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T6 — Mechanistic / preclinical
POTS
16 sources
- T6INDIRECT 36005278 ↗ — Hypoxia-inducible factor stabilisers for the anaemia of chronic kidney disease
- T6INDIRECT 38299639 ↗ — Non-immunosuppressive treatment for IgA nephropathy
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 26366058 ↗ — Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors
- T6INDIRECT 31407088 ↗ — Autonomic cardiovascular control changes in recent heart transplant recipients lead to physiological
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 24423978 ↗ — Adrenocortical carcinoma
- T6INDIRECT 23184849 ↗ — Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
- T6INDIRECT 24636754 ↗ — Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment
- T6INDIRECT 31130732 ↗ — Surgery of the lateral skull base: a 50-year endeavour
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 28174091 ↗ — Inhibitors of cyclin-dependent kinases as cancer therapeutics
- T6 21092758 ↗ — CYP17 inhibitors for prostate cancer therapy
Exenatide Pen Injector [Bydureon]
T6
T6 — Mechanistic / preclinical
POTS
Exercise Self-Monitoring
T6
T6 — Mechanistic / preclinical
POTS
3 sources
- T6 34295408 ↗ — Treatment burden and ability to work
- T6 34632375 ↗ — Self-Monitoring of Balance Performance can Reduce the Rate of Falls Among Older Adults
- T6 23949610 ↗ — Abstracts of the 49th EASD (European Association for the Study of Diabetes) Annual Meeting. Septembe
Expectation-Enhancing Informational Framing
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
20 sources
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 28655357 ↗ — Drug-related problems and medication reviews among old people with dementia
- T6 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6 23186897 ↗ — Transverse myelitis
- T6 23184849 ↗ — Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
- T6 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6 37465527 ↗ — Research on prescribing cascades: a scoping review
- T6 34769943 ↗ — Evaluation of Silodosin and Pelvic Floor Muscle Training in Men with Benign Prostatic Hyperplasia an
- T6INDIRECT 25125424 ↗ — Lower urinary tract symptoms in men
- T6INDIRECT 32767032 ↗ — Current Management and Emerging Therapies in Multiple System Atrophy
- T6INDIRECT 40507996 ↗ — Hazardous Interactions Between Food, Herbs, and Drugs in the First Stage of Biotransformation: Case
- T6INDIRECT 28503229 ↗ — CUA guideline on adult overactive bladder
- T6 33137942 ↗ — Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
- T6 34885733 ↗ — Treatment of Benign Prostatic Hyperplasia by Natural Drugs
- T6 36051157 ↗ — Evolving Role of Silodosin for the Treatment of Urological Disorders - A Narrative Review
- T6 27629059 ↗ — New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and futu
- T6 34991304 ↗ — A Review of Aging and the Lower Urinary Tract: The Future of Urology
- T6 36533160 ↗ — Subjective cognitive decline, mild cognitive impairment, and dementia - syndromic approach: recommen
- T6 33065745 ↗ — Neurogenic Bladder: Epidemiology, Diagnosis, and Management
- T6 34276544 ↗ — Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrom
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
20 sources
- T6INDIRECT 37756687 ↗ — Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta
- T6INDIRECT 36482103 ↗ — Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 24423978 ↗ — Adrenocortical carcinoma
- T6 24323045 ↗ — Autophagy and human diseases
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 33895845 ↗ — 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral A
- T6 26561559 ↗ — Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924)
- T6 27044938 ↗ — Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer
- T6 26377597 ↗ — Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 year
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 24672257 ↗ — Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 23594434 ↗ — A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival
- T6INDIRECT 32117030 ↗ — Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome
- T6INDIRECT 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6 37919282 ↗ — Smart nanoparticles for cancer therapy
- T6 30130469 ↗ — Iron and Cancer
- T6 23095830 ↗ — Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and preven
- T6 26391778 ↗ — Cancer-treatment-induced neurotoxicity--focus on newer treatments
Gonadotropin Releasing Hormone Agonists
T6
T6 — Mechanistic / preclinical
POTS
11 sources
- T6 28293453 ↗ — An overview and management of osteoporosis
- T6 23470964 ↗ — Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer
- T6INDIRECT 16223449 ↗ — Familial clustering of Leiomyomatosis peritonealis disseminata: an unknown genetic syndrome?
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
- T6INDIRECT 32028907 ↗ — Computed tomography evaluation of extensive intravenous angioleiomyoma: a case report
- T6INDIRECT 40575073 ↗ — Primary hyperhidrosis: an updated review
- T6INDIRECT 41438256 ↗ — Peritoneal Inclusion Cyst Mimicking Adrenal Pathology in a Young Man: A Rare Case Report
- T6INDIRECT 19350330 ↗ — Abstracts of the Society of General Internal Medicine 32nd Annual Meeting. Miami Beach, Florida, USA
- T6 38939420 ↗ — A Comprehensive Review of the Efficacy and Safety of Dopamine Agonists for Women with Endometriosis-
- T6 40566700 ↗ — A Pragmatic Approach to Sexual Health in Movement Disorders
T6 — Mechanistic / preclinical
POTS
17 sources
- T6INDIRECT 24595586 ↗ — Non-surgical interventions for the management of chronic pelvic pain
- T6INDIRECT 31727154 ↗ — Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outco
- T6INDIRECT 9810943 ↗ — Subcutaneous apomorphine in late stage Parkinson's disease: a long term follow up
- T6INDIRECT 30580266 ↗ — Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasi
- T6 34451161 ↗ — Critical Review of Biodegradable and Bioactive Polymer Composites for Bone Tissue Engineering and Dr
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6INDIRECT 31960741 ↗ — Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies
- T6INDIRECT 36811119 ↗ — Clozapine is the approved option in treatment-resistant schizophrenia and requires careful managemen
- T6INDIRECT 34745786 ↗ — Treatment and Management of Sexual Disinhibition in Elderly Patients With Neurocognitive Disorders
- T6INDIRECT 37685769 ↗ — Primary Hemostasis Disorders as a Cause of Heavy Menstrual Bleeding in Women of Reproductive Age
- T6INDIRECT 32276665 ↗ — The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recom
- T6INDIRECT 37968732 ↗ — Symptomatic treatment options for Huntington's disease (guidelines of the German Neurological Societ
- T6 41461581 ↗ — The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors
- T6 25928806 ↗ — Proceedings of the fourth international conference on central hypoventilation
- T6 33948343 ↗ — Prostate cancer racial, socioeconomic, geographic disparities: targeting the genomic landscape and s
T6 — Mechanistic / preclinical
POTS
16 sources
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 41683658 ↗ — Beyond the Pain: Rethinking Chronic Pain Management Through Integrated Therapeutic Approaches-A Syst
- T6 31871494 ↗ — Therapeutic Approaches for Peripheral and Central Neuropathic Pain
- T6 27973405 ↗ — Chronic Pain in Children and Adolescents: Diagnosis and Treatment of Primary Pain Disorders in Head,
- T6 35295500 ↗ — Complex Regional Pain Syndrome. A Comprehensive Review on Neuroplastic Changes Supporting the Use of
- T6 32802594 ↗ — Immersive Virtual Reality for Pain Relief in Upper Limb Complex Regional Pain Syndrome: A Pilot Stud
- T6INDIRECT 35005361 ↗ — Evidence of motor system reorganization in complex regional pain syndrome type 1: A case report
- T6INDIRECT 27582958 ↗ — The clinical physiotherapy assessment of non-traumatic shoulder instability
- T6INDIRECT 36466621 ↗ — Altered bodily perceptions in chronic neuropathic pain conditions and implications for treatment usi
- T6INDIRECT 41743427 ↗ — Current status and future prospects of brain-computer interfaces in the field of neurological diseas
- T6 35195724 ↗ — Association of Chiropractic Colleges Research Agenda Conference 2022: Wellness and Health Promotion:
- T6 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
- T6 PMC11235737 ↗ — ePresentations
- T6 PMC10795779 ↗ — Book of Posters
- T6 PMC9377251 ↗ — Symposia Abstracts
- T6 33490941 ↗ — Complex regional pain syndrome - Autoimmune or functional neurologic syndrome
T6 — Mechanistic / preclinical
POTS
Home sleep study device
T6
T6 — Mechanistic / preclinical
POTS
Horse Anti-Thymocyte Globulin
T6
T6 — Mechanistic / preclinical
POTS
Hybrid Cardiac Rehabilitation Program
T6
T6 — Mechanistic / preclinical
POTS
1 source
- T6 40869705 ↗ — Implementation of a Hybrid Cardiac Rehabilitation and Symptom Scoring System in Patients with Inappr
T6 — Mechanistic / preclinical
POTS
23 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 24158454 ↗ — Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data a
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T6INDIRECT 26906034 ↗ — Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-C
- T6INDIRECT 2337713 ↗ — Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy
- T6INDIRECT 28655357 ↗ — Drug-related problems and medication reviews among old people with dementia
- T6INDIRECT 24650926 ↗ — A randomized pilot study of aortic waveform guided therapy in chronic heart failure
- T6INDIRECT 24229653 ↗ — What are the causes of late-life depression?
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 28862947 ↗ — Role of Volume Redistribution in the Congestion of Heart Failure
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 36507632 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 25767284 ↗ — The sympathetic nervous system alterations in human hypertension
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
T6 — Mechanistic / preclinical
POTS
25 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 19821318 ↗ — Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitiv
- T6INDIRECT 33107592 ↗ — Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progr
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T6INDIRECT 18398080 ↗ — Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the S
- T6INDIRECT 34739197 ↗ — Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- T6INDIRECT 26936519 ↗ — Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiote
- T6INDIRECT 18326958 ↗ — Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled w
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 23094876 ↗ — Brugada phenocopy: new terminology and proposed classification
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 20396637 ↗ — Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tool
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 29565029 ↗ — Hypertension
- T6 26111766 ↗ — SLC transporters as therapeutic targets: emerging opportunities
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 18266020 ↗ — European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- T6 32792490 ↗ — Podocytopathies
- T6 32213941 ↗ — Chemical Constituents and Pharmacological Activities of Garlic (<i>Allium sativum</i> L.): A Review
- T6 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
T6 — Mechanistic / preclinical
POTS
1 source
- T6INDIRECT 31073926 ↗ — Safety of Opioids in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis
T6 — Mechanistic / preclinical
POTS
23 sources
- T6INDIRECT 24018704 ↗ — Physiotherapy versus placebo or no intervention in Parkinson's disease
- T6INDIRECT 30578633 ↗ — Psychological therapies for anxiety and depression in children and adolescents with long-term physic
- T6INDIRECT 36515150 ↗ — Management of REM sleep behavior disorder: an American Academy of Sleep Medicine systematic review,
- T6INDIRECT 39607990 ↗ — Systematic review and meta-analysis of the effect of psychological interventions on anxiety in child
- T6INDIRECT 31129916 ↗ — Interventions for improving sleep quality in people with chronic kidney disease
- T6INDIRECT 34844288 ↗ — Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease
- T6INDIRECT 34291816 ↗ — Interventions for the management of abdominal pain in ulcerative colitis
- T6INDIRECT 37751413 ↗ — Experiences of people with long COVID: Symptoms, support strategies and the Long COVID Optimal Healt
- T6 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6 35430029 ↗ — Functional neurological disorder: new subtypes and shared mechanisms
- T6INDIRECT 30789419 ↗ — Diagnosis and Treatment of Rumination Syndrome: A Critical Review
- T6INDIRECT 37496529 ↗ — Efficacy of Stellate Ganglion Block in Treating Long-Term COVID-19-Related Olfactory and Gustatory D
- T6INDIRECT 28368365 ↗ — Mind-Body Interventions for Pediatric Inflammatory Bowel Disease
- T6INDIRECT 27582958 ↗ — The clinical physiotherapy assessment of non-traumatic shoulder instability
- T6INDIRECT 20726290 ↗ — Best practice guide for the treatment of nightmare disorder in adults
- T6 29163522 ↗ — The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Trac
- T6 37629273 ↗ — The Impact of Microbiota on the Gut-Brain Axis: Examining the Complex Interplay and Implications
- T6 39319312 ↗ — Role of stress and early-life stress in the pathogeny of inflammatory bowel disease
- T6 32213001 ↗ — UEG Week 2019 Poster Presentations
- T6 39754724 ↗ — European Guideline on Chronic Nausea and Vomiting-A UEG and ESNM Consensus for Clinical Management
- T6 PMC6643206 ↗ — E-Poster Viewing
- T6 25973272 ↗ — Central sensitization syndrome and the initial evaluation of a patient with fibromyalgia: a review
- T6 36467081 ↗ — Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as
T6 — Mechanistic / preclinical
POTS
1 source
- T6 26259941 ↗ — Urban Malaria: Understanding its Epidemiology, Ecology, and Transmission Across Seven Diverse ICEMR
T6 — Mechanistic / preclinical
POTS
1 source
- T6 34064288 ↗ — Discrimination of Genetically Very Close Accessions of Sweet Orange (<i>Citrus sinensis</i> L. Osbec
IV saline / fluid loading
T6
T6 — Mechanistic / preclinical
POTS
Immunoabsorption/plasmapheresis procedure
T6
T6 — Mechanistic / preclinical
POTS
In clinic VRpain reduction exercises + VR homeworks
T6
T6 — Mechanistic / preclinical
POTS
Inflatable abdominal binder
T6
T6 — Mechanistic / preclinical
POTS
9 sources
- T6INDIRECT 27271310 ↗ — Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotensi
- T6INDIRECT 32673517 ↗ — Splanchnic Venous Compression Enhances the Effects of ß-Blockade in the Treatment of Postural Tachyc
- T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
- T6 35230654 ↗ — Advances in the Pathophysiology and Management of Supine Hypertension in Patients with Neurogenic Or
- T6 32943966 ↗ — Neurogenic Orthostatic Hypotension: State of the Art and Therapeutic Strategies
- T6INDIRECT 32906173 ↗ — Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfall
- T6 35591450 ↗ — Assessment of Abdominal Constrictor's Forces for Informing Computational Models of Orthostatic Hypot
- T6 32038283 ↗ — Intermittent Calf Compression Delays the Onset of Presyncope in Young Healthy Individuals
- T6 41404536 ↗ — Update on the Treatment of Autonomic Disorders
T6 — Mechanistic / preclinical
POTS
24 sources
- T6INDIRECT 32541925 ↗ — Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million p
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 20566676 ↗ — Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and e
- T6INDIRECT 19114612 ↗ — Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes
- T6INDIRECT 23279307 ↗ — Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequat
- T6INDIRECT 24067431 ↗ — Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflo
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 24026211 ↗ — Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 d
- T6INDIRECT 21816980 ↗ — Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequat
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 28585944 ↗ — Cellular uptake of nanoparticles: journey inside the cell
- T6 23968694 ↗ — Sugar for the brain: the role of glucose in physiological and pathological brain function
- T6 36148880 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes As
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
T6 — Mechanistic / preclinical
POTS
18 sources
- T6INDIRECT 27115217 ↗ — Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
- T6INDIRECT 27115215 ↗ — Different types of intranasal steroids for chronic rhinosinusitis
- T6INDIRECT 23740736 ↗ — Metered dose inhalers versus nebulizers for aerosol bronchodilator delivery for adult patients recei
- T6INDIRECT 35355450 ↗ — The impact of identifying laryngeal obstruction syndromes on reducing treatment of pediatric asthma:
- T6INDIRECT 7742148 ↗ — The reproducibility and effect on non-specific airway responsiveness of inhaled prostaglandin D2 and
- T6INDIRECT 29234869 ↗ — A Controlled Trial of Inhaled Bronchodilators in Familial Dysautonomia
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6 24699931 ↗ — Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
- T6 25200111 ↗ — Drooling in Parkinson's disease: a review
- T6INDIRECT 28050310 ↗ — Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments
- T6INDIRECT 32397615 ↗ — Future Trends in Nebulized Therapies for Pulmonary Disease
- T6INDIRECT 36927875 ↗ — Multiple system atrophy
- T6INDIRECT 36994117 ↗ — Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 35453749 ↗ — Inflammation and Oxidative Stress as Common Mechanisms of Pulmonary, Autonomic and Musculoskeletal D
- T6 31277288 ↗ — Effects of Water Availability in the Soil on Tropane Alkaloid Production in Cultivated <i>Datura str
- T6 27433087 ↗ — Gut dysfunction in Parkinson's disease
T6 — Mechanistic / preclinical
POTS
18 sources
- T6INDIRECT 27070085 ↗ — Wait-and-see treatment strategies for rectal cancer patients with clinical complete response after n
- T6INDIRECT 37756687 ↗ — Toxicity profiles of antibody-drug conjugates for anticancer treatment: a systematic review and meta
- T6INDIRECT 38478773 ↗ — Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
- T6INDIRECT 16940980 ↗ — CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 24423978 ↗ — Adrenocortical carcinoma
- T6 37919282 ↗ — Smart nanoparticles for cancer therapy
- T6 23095830 ↗ — Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and preven
- T6 35648703 ↗ — Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- T6 27044938 ↗ — Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer
- T6INDIRECT 24672257 ↗ — Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature
- T6INDIRECT 32880078 ↗ — Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to
- T6INDIRECT 38087070 ↗ — Gut Microbiota Modulation and Its Implications on Neuropathic Pain: A Comprehensive Literature Revie
- T6INDIRECT 34094953 ↗ — The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
- T6INDIRECT 35510137 ↗ — International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines
- T6 35159802 ↗ — Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue
- T6 37124134 ↗ — Immunotherapy in glioblastoma treatment: Current state and future prospects
- T6 34948113 ↗ — Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
Isometric Exercise Training
T6
T6 — Mechanistic / preclinical
POTS
4 sources
- T6 38762832 ↗ — Isometric Exercise Training and Arterial Hypertension: An Updated Review
- T6 37581135 ↗ — Evaluation of Cardiovascular Response to Isometric Handgrip Exercise in Obese Individuals
- T6 39831301 ↗ — Physical function estimates change in pain following IIPT among children with chronic pain
- T6 PMC8148279 ↗ — Neural Hormonal Mechanisms (Renin; Neural Control; Vasoactive Autacoids)
T6 — Mechanistic / preclinical
POTS
1 source
- T6 36345396 ↗ — Clinical Evaluation of Dapagliflozin in the Management of CKD: Focus on Patient Selection and Clinic
T6 — Mechanistic / preclinical
POTS
25 sources
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 26355598 ↗ — Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualit
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 15846598 ↗ — Electroconvulsive therapy for schizophrenia
- T6INDIRECT 27419911 ↗ — Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestina
- T6INDIRECT 25866139 ↗ — Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia
- T6INDIRECT 23076930 ↗ — Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 24126931 ↗ — Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with mini
- T6INDIRECT 34743319 ↗ — Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 31663402 ↗ — Consensus statement for perioperative care in total hip replacement and total knee replacement surge
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 23094876 ↗ — Brugada phenocopy: new terminology and proposed classification
- T6INDIRECT 31871494 ↗ — Therapeutic Approaches for Peripheral and Central Neuropathic Pain
- T6INDIRECT 23184849 ↗ — Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
- T6 22160349 ↗ — The novel object recognition memory: neurobiology, test procedure, and its modifications
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 30909387 ↗ — Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
- T6 28298428 ↗ — Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of th
- T6 30127324 ↗ — Current Concepts and Treatments of Schizophrenia
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 20511282 ↗ — N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observ
- T6 33907312 ↗ — The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
T6 — Mechanistic / preclinical
POTS
12 sources
- T6INDIRECT 41683658 ↗ — Beyond the Pain: Rethinking Chronic Pain Management Through Integrated Therapeutic Approaches-A Syst
- T6INDIRECT 30407326 ↗ — Management of chronic pain in Ehlers-Danlos syndrome: Two case reports and a review of literature
- T6 36534007 ↗ — Dysphagia, dysphonia and olfactory disease: a map of Cochrane evidence relevant to rehabilitation fo
- T6 34462917 ↗ — Research priorities for children with neurological impairment and medical complexity in high-income
- T6 37653505 ↗ — Psychological interventions for individuals with Ehlers-Danlos syndrome and hypermobility spectrum d
- T6 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
- T6INDIRECT 41287699 ↗ — Knee Osteoarthritis: Current Insights Into Pathophysiology and Non-surgical Management Options
- T6INDIRECT 32119569 ↗ — Platform and poster presentation abstracts
- T6INDIRECT 28277786 ↗ — Platform and poster presentation abstracts
- T6INDIRECT 32218879 ↗ — Abstracts of the 14th International Congress of the European Geriatric Medicine Society: 10-12 Octob
- T6 PMC12075107 ↗ — ESPGHAN 57th Annual Meeting Abstracts
- T6 PMC8853075 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Po
T6 — Mechanistic / preclinical
POTS
3 sources
- T6 21321035 ↗ — Health effects of energy drinks on children, adolescents, and young adults
- T6 32676851 ↗ — Four-Repeat Tauopathies: Current Management and Future Treatments
- T6 34512258 ↗ — Novel Therapies for Parkinsonian Syndromes-Recent Progress and Future Perspectives
T6 — Mechanistic / preclinical
POTS
26 sources
- T6INDIRECT 25924806 ↗ — Clinical symptoms, signs and tests for identification of impending and current water-loss dehydratio
- T6INDIRECT 30701543 ↗ — Phosphodiesterase 5 inhibitors for pulmonary hypertension
- T6INDIRECT 26774659 ↗ — Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 26607938 ↗ — Dietary nitrate improves vascular function in patients with hypercholesterolemia: a randomized, doub
- T6INDIRECT 22561596 ↗ — Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrom
- T6INDIRECT 3089519 ↗ — The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypote
- T6INDIRECT 14670816 ↗ — Mechanisms of postspaceflight orthostatic hypotension: low alpha1-adrenergic receptor responses befo
- T6INDIRECT 24473484 ↗ — Regional neurovascular coupling and cognitive performance in those with low blood pressure secondary
- T6 21092187 ↗ — Fabry disease
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 19337156 ↗ — The IC3D classification of the corneal dystrophies
- T6INDIRECT 30039193 ↗ — Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
- T6INDIRECT 11179008 ↗ — Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia
- T6INDIRECT 11179021 ↗ — Familial dysautonomia is caused by mutations of the IKAP gene
- T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 31866818 ↗ — ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 33907312 ↗ — The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets
- T6 32287334 ↗ — Free radicals, oxidative stress, and antioxidants in human health and disease
- T6 31196984 ↗ — Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
- T6 20646222 ↗ — Water, hydration, and health
- T6 20534464 ↗ — Resting-state functional MRI in depression unmasks increased connectivity between networks via the d
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
Lesion-Specific Surgical Correction
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
16 sources
- T6INDIRECT 32382043 ↗ — Pregnancy rates after slow-release insemination (SRI) and standard bolus intrauterine insemination (
- T6 24423978 ↗ — Adrenocortical carcinoma
- T6 28174091 ↗ — Inhibitors of cyclin-dependent kinases as cancer therapeutics
- T6 31277273 ↗ — Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence
- T6 33295608 ↗ — Male infertility due to testicular disorders
- T6 24131779 ↗ — A first-in-human, phase 1, dose-escalation study of dinaciclib, a novel cyclin-dependent kinase inhi
- T6INDIRECT 32576952 ↗ — Diphthamide-deficiency syndrome: a novel human developmental disorder and ribosomopathy
- T6INDIRECT 25232325 ↗ — Cyclophosphamide-induced severe acute hyponatremic encephalopathy in patients with breast cancer: re
- T6INDIRECT 31818306 ↗ — Idiopathic mast cell activation syndrome and radiation therapy: a case study, literature review, and
- T6INDIRECT 31960741 ↗ — Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies
- T6INDIRECT 36835974 ↗ — The Role of Aromatase Inhibitors in Male Prolactinoma
- T6INDIRECT 32881895 ↗ — COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinica
- T6INDIRECT 32086342 ↗ — RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tum
- T6 28173850 ↗ — New horizons in treatment of osteoporosis
- T6 32452701 ↗ — An up-to-date overview of computational polypharmacology in modern drug discovery
- T6 29607374 ↗ — Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
T6 — Mechanistic / preclinical
POTS
16 sources
- T6INDIRECT 18509106 ↗ — Pharmacotherapy for inappropriate sexual behaviors in dementia: a systematic review of literature
- T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6INDIRECT 30789419 ↗ — Diagnosis and Treatment of Rumination Syndrome: A Critical Review
- T6INDIRECT 31960741 ↗ — Multimodality Cardiac Imaging in the Era of Emerging Cancer Therapies
- T6INDIRECT 23486794 ↗ — Approach to inappropriate sexual behaviour in people with dementia
- T6INDIRECT 31341757 ↗ — Pharmacologic Management of Agitation in Patients with Dementia
- T6INDIRECT 20820780 ↗ — Long-term safety and effectiveness of the "OptEase" vena cava filter
- T6INDIRECT 39762640 ↗ — Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
- T6INDIRECT 32725471 ↗ — Abstracts from the 2020 Annual Meeting of the Society of General Internal Medicine
- T6 41461581 ↗ — The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors
- T6 24054763 ↗ — Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cance
- T6 18580296 ↗ — Sex hormone effects on body fluid regulation
T6 — Mechanistic / preclinical
POTS
27 sources
- T6 NCT01210430 ↗ — Local Vasoconstriction in Postural Tachycardia Syndrome
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 33624299 ↗ — Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 33107592 ↗ — Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progr
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 21993710 ↗ — Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy
- T6INDIRECT 34739197 ↗ — Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease
- T6INDIRECT 22034636 ↗ — Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy
- T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
- T6INDIRECT 23594434 ↗ — A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival
- T6INDIRECT 36787743 ↗ — Angiotensin-converting enzyme 2-at the heart of the COVID-19 pandemic
- T6INDIRECT 31031694 ↗ — Autonomic Dysfunction in α-Synucleinopathies
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 34589395 ↗ — Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic n
- T6 20978471 ↗ — The relationship between blood pressure and cognitive function
- T6 23588782 ↗ — Applications of CYP450 testing in the clinical setting
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 25514304 ↗ — The diagnosis and management of mild cognitive impairment: a clinical review
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
- T6 31210940 ↗ — European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gl
- T6 16365341 ↗ — JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical pract
Low-Dose Total Body Irradiation
T6
T6 — Mechanistic / preclinical
POTS
3 sources
- T6 36323940 ↗ — The 48<sup>th</sup> Annual Meeting of the European Society for Blood and Marrow Transplantation: Phy
- T6 PMC11177578 ↗ — EHA2024 Hybrid Congress
- T6 PMC4894295 ↗ — 21st Congress of the European Hematology Association Copenhagen, Denmark, June 9–12, 2016
T6 — Mechanistic / preclinical
POTS
Maintenance:BEVACIZUMAB
T6
T6 — Mechanistic / preclinical
POTS
Maintenance:BEVACIZUMAB+CAPECITABINE+CYCLOPHOSPHAMIDE
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
28 sources
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 33091160 ↗ — Electromechanical-assisted training for walking after stroke
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 20537128 ↗ — Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine lon
- T6INDIRECT 36602886 ↗ — Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis
- T6INDIRECT 36282618 ↗ — Support for healthy breastfeeding mothers with healthy term babies
- T6INDIRECT 12521968 ↗ — Multifactorial intervention after a fall in older people with cognitive impairment and dementia pres
- T6INDIRECT 20946990 ↗ — A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalg
- T6INDIRECT 30635141 ↗ — Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial
- T6INDIRECT 25304766 ↗ — The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 34741573 ↗ — Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considera
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 31871494 ↗ — Therapeutic Approaches for Peripheral and Central Neuropathic Pain
- T6INDIRECT 32698400 ↗ — Current State of Knowledge on Primary Sjögren's Syndrome, an Autoimmune Exocrinopathy
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 38748847 ↗ — Clinical practice guidelines for the care of girls and women with Turner syndrome
- T6 26062169 ↗ — Fear and the Defense Cascade: Clinical Implications and Management
- T6 26959131 ↗ — Understanding Neuropathic Corneal Pain--Gaps and Current Therapeutic Approaches
- T6 33586685 ↗ — Gastrointestinal motility disorders in neurologic disease
- T6 21620994 ↗ — Acute retinal arterial occlusive disorders
- T6 22229124 ↗ — The history of Parkinson's disease: early clinical descriptions and neurological therapies
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 25621208 ↗ — Chronic complications of spinal cord injury
- T6 36178003 ↗ — World guidelines for falls prevention and management for older adults: a global initiative
- T6 16678566 ↗ — Childhood functional gastrointestinal disorders: child/adolescent
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
Matched Unrelated Donor Hematopoetic Stem Cell Transplant
T6
T6 — Mechanistic / preclinical
POTS
Median Nerve Decompression
T6
T6 — Mechanistic / preclinical
POTS
5 sources
- T6 1848299 ↗ — Inherited amyloidosis
- T6 36387914 ↗ — New horizons of biomaterials in treatment of nerve damage in diabetes mellitus: A translational pros
- T6 33203445 ↗ — Epigenetic profiling of Italian patients identified methylation sites associated with hereditary tra
- T6 20676282 ↗ — Cardiac amyloidosis responding to bortezomib: case report and review of literature
- T6 26087075 ↗ — Supplement
T6 — Mechanistic / preclinical
POTS
24 sources
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 22419314 ↗ — Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 30556597 ↗ — Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people
- T6INDIRECT 21649634 ↗ — Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of random
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 19700947 ↗ — Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation
- T6INDIRECT 28604926 ↗ — ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease
- T6INDIRECT 28833562 ↗ — Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa
- T6INDIRECT 31853557 ↗ — Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 23225012 ↗ — Parkinson's disease
- T6INDIRECT 28106066 ↗ — The psychosis spectrum in Parkinson disease
- T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
- T6INDIRECT 28781611 ↗ — Best practice in the management of behavioural and psychological symptoms of dementia
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6 20194146 ↗ — Recommendations for the pharmacological management of neuropathic pain: an overview and literature u
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 31866818 ↗ — ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 26595642 ↗ — Lewy body dementias
- T6 21875407 ↗ — N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, va
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
T6 — Mechanistic / preclinical
POTS
1 source
Motor Representation Techniques
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
1 source
National Institutes of Health Expert Consensus Meeting
T6
T6 — Mechanistic / preclinical
POTS
4 sources
- T6 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6 34246578 ↗ — Postural orthostatic tachycardia syndrome (POTS): Priorities for POTS care and research from a 2019
- T6 36169159 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of pos
- T6 35753858 ↗ — 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complication
Nebivolol Hydrochloride
T6
T6 — Mechanistic / preclinical
POTS
1 source
- T6 36013259 ↗ — The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patie
T6 — Mechanistic / preclinical
POTS
20 sources
- T6INDIRECT 31076938 ↗ — Physical activity and dietary interventions in diabetic neuropathy: a systematic review
- T6INDIRECT 40808332 ↗ — Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Fut
- T6 27491830 ↗ — Diabetes and Cognitive Impairment
- T6 34400495 ↗ — Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
- T6 27797810 ↗ — Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
- T6 28351347 ↗ — Sporobolus stapfianus: Insights into desiccation tolerance in the resurrection grasses from linking
- T6INDIRECT 39334239 ↗ — Cardiovascular adaptations and pathological changes induced by spaceflight: from cellular mechanisms
- T6INDIRECT 41303689 ↗ — Neurodegeneration as Ecosystem Failure: A New Paradigm for Prevention and Treatment
- T6INDIRECT 40598239 ↗ — Current strategies in the management of dementia with lewy bodies and future directions based on dis
- T6INDIRECT 40498265 ↗ — Chronic Fatigue in Cancer Survivorship: Psychiatry Versus Oncology or Psychiatry with Oncology?
- T6INDIRECT 39996855 ↗ — Mitochondrial Dysfunction and Its Potential Molecular Interplay in Hypermobile Ehlers-Danlos Syndrom
- T6INDIRECT 30480150 ↗ — Program Abstracts from the GSA 2018 Annual Scientific Meeting "The Purposes of Longer Lives"
- T6INDIRECT 32150216 ↗ — Abstract: Symposia, Conferences, Oral communications: 10th International Conference on Frailty, Sarc
- T6INDIRECT 29032633 ↗ — 2017 Annual Meetings
- T6 38673885 ↗ — Emerging Therapeutic Strategies in Sarcopenia: An Updated Review on Pathogenesis and Treatment Advan
- T6 35578945 ↗ — Physiological Systems in Promoting Frailty
- T6 34944054 ↗ — Autophagy-Lysosomal Pathway as Potential Therapeutic Target in Parkinson's Disease
- T6 33129841 ↗ — Vincristine- and bortezomib-induced neuropathies - from bedside to bench and back
- T6 34695606 ↗ — Role of senescence in the chronic health consequences of COVID-19
- T6 38555403 ↗ — Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in
T6 — Mechanistic / preclinical
POTS
26 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 30701543 ↗ — Phosphodiesterase 5 inhibitors for pulmonary hypertension
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 1540729 ↗ — Renal protective effect of enalapril in diabetic nephropathy
- T6INDIRECT 8198938 ↗ — Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients wit
- T6INDIRECT 2337713 ↗ — Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy
- T6INDIRECT 9890307 ↗ — Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of auto
- T6 22258608 ↗ — The promise of induced pluripotent stem cells in research and therapy
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 24090418 ↗ — Life-threatening outcomes associated with autonomic dysreflexia: a clinical review
- T6INDIRECT 23184849 ↗ — Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
- T6INDIRECT 20396637 ↗ — Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tool
- T6INDIRECT 22126626 ↗ — Adverse interactions between antifungal azoles and vincristine: review and analysis of cases
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 26401246 ↗ — Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 9723817 ↗ — Grapefruit juice-drug interactions
- T6 36507632 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 23850704 ↗ — Phenotypic screens as a renewed approach for drug discovery
- T6 25621208 ↗ — Chronic complications of spinal cord injury
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T6 — Mechanistic / preclinical
POTS
Nitroglycerin transdermal
T6
T6 — Mechanistic / preclinical
POTS
5 sources
- T6INDIRECT 16391172 ↗ — Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure
- T6 37109736 ↗ — Recent Advancement of Medical Patch for Transdermal Drug Delivery
- T6 34631214 ↗ — The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson's Disease: What
- T6 40006555 ↗ — AI-Driven Innovation in Skin Kinetics for Transdermal Drug Delivery: Overcoming Barriers and Enhanci
- T6 29076058 ↗ — Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease
T6 — Mechanistic / preclinical
POTS
28 sources
- T6INDIRECT 15846598 ↗ — Electroconvulsive therapy for schizophrenia
- T6INDIRECT 27419911 ↗ — Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestina
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 26222246 ↗ — Interventions for pain with intrauterine device insertion
- T6INDIRECT 29694674 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 34671311 ↗ — Visual Snow Syndrome as a Network Disorder: A Systematic Review
- T6INDIRECT 34743319 ↗ — Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind
- T6INDIRECT 14705689 ↗ — Effect of postoperative skin-surface warming on oxygen consumption and the shivering threshold
- T6INDIRECT 16732081 ↗ — Fructose administration increases intraoperative core temperature by augmenting both metabolic rate
- T6INDIRECT 22189652 ↗ — Core temperatures during major abdominal surgery in patients warmed with new circulating-water garme
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 35782167 ↗ — Biological nitrogen fixation and prospects for ecological intensification in cereal-based cropping s
- T6INDIRECT 25053156 ↗ — Recommendations for anesthesia and perioperative management in patients with Ehlers-Danlos syndrome(
- T6INDIRECT 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6INDIRECT 24032030 ↗ — Controls on soil microbial community stability under climate change
- T6INDIRECT 26401246 ↗ — Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute
- T6 33769101 ↗ — Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation
- T6 27671918 ↗ — Anxiety Disorders and Cardiovascular Disease
- T6 24248213 ↗ — Cobalamin deficiency: clinical picture and radiological findings
- T6 31555890 ↗ — Doubled haploid technology for line development in maize: technical advances and prospects
- T6 31141884 ↗ — Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Fo
- T6 27403447 ↗ — Cerebral blood flow and autoregulation: current measurement techniques and prospects for noninvasive
- T6 29429934 ↗ — Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary
- T6 34386109 ↗ — JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias
- T6 14726459 ↗ — Global change and human vulnerability to vector-borne diseases
- T6 30072764 ↗ — Soil bacterial networks are less stable under drought than fungal networks
- T6 30587246 ↗ — Rhizosphere microorganisms can influence the timing of plant flowering
T6 — Mechanistic / preclinical
POTS
21 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 35739136 ↗ — Long-COVID in children and adolescents: a systematic review and meta-analyses
- T6INDIRECT 32690803 ↗ — Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observa
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 20427088 ↗ — Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt l
- T6INDIRECT 27195814 ↗ — Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75
- T6INDIRECT 22492586 ↗ — Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metf
- T6INDIRECT 22446170 ↗ — Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in pati
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 36148880 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes As
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
T6 — Mechanistic / preclinical
POTS
14 sources
- T6 32404379 ↗ — Clinical trials in REM sleep behavioural disorder: challenges and opportunities
- T6 29607374 ↗ — Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
- T6 32452701 ↗ — An up-to-date overview of computational polypharmacology in modern drug discovery
- T6 33959901 ↗ — Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochr
- T6 31189100 ↗ — Poly(ADP-Ribose) Links the DNA Damage Response and Biomineralization
- T6INDIRECT 40317194 ↗ — Approach to the Patient With Metastatic Pheochromocytoma and Paraganglioma
- T6INDIRECT 38652045 ↗ — Approach to the Patient: Concept and Application of Targeted Radiotherapy in the Paraganglioma Patie
- T6INDIRECT 32862332 ↗ — Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
- T6INDIRECT 35903274 ↗ — Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Geneti
- T6INDIRECT 37916027 ↗ — Pheochromocytoma: a changing perspective and current concepts
- T6INDIRECT 38944505 ↗ — Management of Pheochromocytomas and Paragangliomas
- T6INDIRECT 31564906 ↗ — Therapies targeting the signal pathways of pheochromocytoma and paraganglioma
- T6 35158955 ↗ — Existing Evidence for the Repurposing of PARP-1 Inhibitors in Rare Demyelinating Diseases
- T6 33810219 ↗ — MicroRNAs, Long Non-Coding RNAs, and Circular RNAs: Potential Biomarkers and Therapeutic Targets in
Optional lumbar puncture + blood sample
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
24 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 33925784 ↗ — Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Com
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 36915214 ↗ — Roles of neuropathology-associated reactive astrocytes: a systematic review
- T6INDIRECT 25233067 ↗ — Systematic review of potential health risks posed by pharmaceutical, occupational and consumer expos
- T6INDIRECT 32409561 ↗ — Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, ra
- T6INDIRECT 20484178 ↗ — A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis
- T6INDIRECT 33180097 ↗ — Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Random
- T6INDIRECT 8828642 ↗ — Orthostatic intolerance after spaceflight
- T6INDIRECT 33831043 ↗ — Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6 6326753 ↗ — Oxygen toxicity, oxygen radicals, transition metals and disease
- T6 23968694 ↗ — Sugar for the brain: the role of glucose in physiological and pathological brain function
- T6 21092187 ↗ — Fabry disease
- T6 29565029 ↗ — Hypertension
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
Oxymetazoline 0.05% nasal solution
T6
T6 — Mechanistic / preclinical
POTS
Pacemaker treatment, pacemaker programmed as active = CLS
T6
T6 — Mechanistic / preclinical
POTS
Pacemaker, programmed as passive = VVI 30 beats per minute
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
19 sources
- T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
- T6INDIRECT 29271481 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 31917873 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- T6INDIRECT 20427088 ↗ — Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt l
- T6INDIRECT 27048170 ↗ — Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selec
- T6INDIRECT 31727154 ↗ — Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outco
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 34988090 ↗ — Treatment of Inflammatory Bowel Disease: A Comprehensive Review
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 33856918 ↗ — COVID-19 and Cardiovascular Disease: From Bench to Bedside
- T6INDIRECT 31954495 ↗ — Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- T6INDIRECT 29222231 ↗ — AL amyloidosis: from molecular mechanisms to targeted therapies
- T6INDIRECT 33416999 ↗ — Rituximab for the treatment of multiple sclerosis: a review
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6 28174091 ↗ — Inhibitors of cyclin-dependent kinases as cancer therapeutics
- T6 32114384 ↗ — Resistance to Checkpoint Inhibition in Cancer Immunotherapy
- T6 33807303 ↗ — Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis
Precompression Defibrillation
T6
T6 — Mechanistic / preclinical
POTS
Prism Adaptation Therapy Group
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
24 sources
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 20927745 ↗ — Finasteride for benign prostatic hyperplasia
- T6INDIRECT 29932206 ↗ — Saline irrigation for allergic rhinitis
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 37818791 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 36971690 ↗ — Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- T6INDIRECT 26306400 ↗ — Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the tr
- T6INDIRECT 15089807 ↗ — Modelling the cardiovascular effects of ephedrine
- T6INDIRECT 23116538 ↗ — Treatment of multiple system atrophy using intravenous immunoglobulin
- T6INDIRECT 15066944 ↗ — Water potentiates the pressor effect of ephedra alkaloids
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 20396637 ↗ — Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tool
- T6INDIRECT 32117030 ↗ — Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome
- T6INDIRECT 29058089 ↗ — Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms
- T6INDIRECT 24385718 ↗ — Pharmacotherapy of essential tremor
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 34414219 ↗ — Antidepressant Drugs Effects on Blood Pressure
- T6 18500382 ↗ — Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)
- T6 23472781 ↗ — Medical therapy and physical maneuvers in the treatment of the vasovagal syncope and orthostatic hyp
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 22110357 ↗ — MAO-inhibitors in Parkinson's Disease
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
T6 — Mechanistic / preclinical
POTS
26 sources
- T6INDIRECT 33107592 ↗ — Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progr
- T6INDIRECT 24869750 ↗ — Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 35886227 ↗ — Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-
- T6INDIRECT 30480768 ↗ — First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive dr
- T6INDIRECT 31167038 ↗ — Pharmacotherapy for hypertension in adults 60 years or older
- T6INDIRECT 30832759 ↗ — The Pharmacological Treatment of Arterial Hypertension in Frail, Older Patients—a Systematic Review
- T6INDIRECT 24650926 ↗ — A randomized pilot study of aortic waveform guided therapy in chronic heart failure
- T6INDIRECT 28373993 ↗ — Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic
- T6INDIRECT 31841279 ↗ — Central blood pressure for the management of hypertension: Is it a practical clinical tool in curren
- T6INDIRECT 27388039 ↗ — Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy
- T6INDIRECT 40162571 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 29943271 ↗ — Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejec
- T6INDIRECT 19222671 ↗ — Pheochromocytoma presenting with myocardial infarction, cardiomyopathy, renal failure, pulmonary hem
- T6INDIRECT 33832606 ↗ — Management of Women With Acquired Cardiovascular Disease From Pre-Conception Through Pregnancy and P
- T6INDIRECT 34094953 ↗ — The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
- T6INDIRECT 8364814 ↗ — Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of esse
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 31141884 ↗ — Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Fo
- T6 34948113 ↗ — Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions
- T6 36552014 ↗ — Diabetes-Induced Cardiac Autonomic Neuropathy: Impact on Heart Function and Prognosis
- T6 19475778 ↗ — Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after rec
- T6 29062239 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives
- T6 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 32699774 ↗ — RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
T6 — Mechanistic / preclinical
POTS
Rapid Pulse Confirmation Device
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 35739136 ↗ — Long-COVID in children and adolescents: a systematic review and meta-analyses
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 33925784 ↗ — Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Com
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 20484178 ↗ — A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis
- T6INDIRECT 16505299 ↗ — Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI
- T6INDIRECT 23128427 ↗ — Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease
- T6INDIRECT 33831043 ↗ — Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary
- T6INDIRECT 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 22187469 ↗ — Standards of medical care in diabetes--2012
- T6INDIRECT 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6INDIRECT 23264422 ↗ — Standards of medical care in diabetes--2013
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 33753937 ↗ — Post-acute COVID-19 syndrome
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
T6 — Mechanistic / preclinical
POTS
2 sources
- T6 38617189 ↗ — Structure and function of therapeutic antibodies approved by the US FDA in 2023
- T6 41097798 ↗ — Immune Checkpoint Inhibitors in Merkel Cell Carcinoma of the Skin: A 2025 Comprehensive Review
T6 — Mechanistic / preclinical
POTS
3 sources
- T6 32357528 ↗ — Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
- T6 36830034 ↗ — Effect-Directed, Chemical and Taxonomic Profiling of Peppermint Proprietary Varieties and Correspond
- T6 37396659 ↗ — Identifying potential drug-target interactions based on ensemble deep learning
T6 — Mechanistic / preclinical
POTS
25 sources
- T6INDIRECT 31794067 ↗ — Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in pe
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 31167038 ↗ — Pharmacotherapy for hypertension in adults 60 years or older
- T6INDIRECT 22895968 ↗ — Momordica charantia for type 2 diabetes mellitus
- T6INDIRECT 28333365 ↗ — Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
- T6INDIRECT 39464183 ↗ — Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor a
- T6INDIRECT 22446170 ↗ — Effects of dapagliflozin, an SGLT2 inhibitor, on HbA(1c), body weight, and hypoglycemia risk in pati
- T6INDIRECT 19921145 ↗ — The gait and balance of patients with diabetes can be improved: a randomised controlled trial
- T6INDIRECT 31501226 ↗ — Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship
- T6INDIRECT 21722580 ↗ — The effect of type-2-diabetes-related vascular endothelial dysfunction on skin physiology and activi
- T6INDIRECT 32039382 ↗ — From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
- T6INDIRECT 35033161 ↗ — Adherence and persistence rates of major antidiabetic medications: a review
- T6INDIRECT 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 21193625 ↗ — Standards of medical care in diabetes--2011
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 32699774 ↗ — RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
- T6 27491830 ↗ — Diabetes and Cognitive Impairment
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
Routine physical therapy and exercise program
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
19 sources
- T6INDIRECT 30191554 ↗ — Interventions for preventing falls in older people in care facilities and hospitals
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 31755549 ↗ — Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention o
- T6INDIRECT 37818791 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 20427088 ↗ — Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt l
- T6INDIRECT 24902920 ↗ — The design and rationale of a multicenter clinical trial comparing two strategies for control of sys
- T6INDIRECT 30200910 ↗ — CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery
- T6INDIRECT 9285463 ↗ — Autonomic effects of selegiline: possible cardiovascular toxicity in Parkinson's disease
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 17227286 ↗ — Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cess
- T6 25834232 ↗ — Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 8177173 ↗ — Gas vesicles
- T6 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
T6 — Mechanistic / preclinical
POTS
22 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 38580972 ↗ — A systematic review and meta-analysis on sodium tanshinone IIA sulfonate injection for the adjunctiv
- T6INDIRECT 25757188 ↗ — Equivalent Lung Dose and Systemic Exposure of Budesonide/Formoterol Combination via Easyhaler and Tu
- T6INDIRECT 23179472 ↗ — Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compare
- T6INDIRECT 8098220 ↗ — Beta adrenoreceptor subtype cross regulation in the human heart
- T6INDIRECT 20565455 ↗ — Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in health
- T6INDIRECT 7742148 ↗ — The reproducibility and effect on non-specific airway responsiveness of inhaled prostaglandin D2 and
- T6INDIRECT 23589685 ↗ — Evaluation of effects of shoulder girdle training on strength and performance of activities of daily
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
- T6INDIRECT 24093037 ↗ — Reducing pill burden and helping with medication awareness to improve adherence
- T6INDIRECT 18286801 ↗ — Cannabinoids in health and disease
- T6INDIRECT 27712641 ↗ — Anorectal and Pelvic Pain
- T6INDIRECT 36868923 ↗ — Cutaneous lupus erythematosus: a review of etiopathogenic, clinical, diagnostic and therapeutic aspe
- T6INDIRECT 22143168 ↗ — Dysautonomia: perioperative implications
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 10379421 ↗ — Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines an
- T6 33573164 ↗ — Magnesium in Aging, Health and Diseases
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 18308299 ↗ — Sympathetic modulation of immunity: relevance to disease
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
Sequential Gas Delivery
T6
T6 — Mechanistic / preclinical
POTS
1 source
- T6 39297140 ↗ — Reduced Stroke Volume and Brain Perfusion Drive Postural Hyperventilation in Postural Orthostatic Ta
T6 — Mechanistic / preclinical
POTS
1 source
- T6 34584412 ↗ — Nanomaterials-Upconverted Hydroxyapatite for Bone Tissue Engineering and a Platform for Drug Deliver
Single agent, adjuvant anti-PD1 therapy
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
4 sources
- T6 35483386 ↗ — CDKL5 deficiency disorder: clinical features, diagnosis, and management
- T6 38203200 ↗ — Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine
- T6 36923331 ↗ — Dravet Syndrome as an Example of Precision Medicine in Epilepsy
- T6 39196806 ↗ — Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment H
T6 — Mechanistic / preclinical
POTS
4 sources
- T6 37285026 ↗ — A review of the current state of single-cell proteomics and future perspective
- T6 39042344 ↗ — Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer
- T6 41048472 ↗ — Assessing the Impact of Antidepressants on Cancer Treatment: A Retrospective Analysis of 14 Antineop
- T6 40498965 ↗ — EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025
T6 — Mechanistic / preclinical
POTS
State of the science and clinical care from a
T6
T6 — Mechanistic / preclinical
POTS
3 sources
- T6 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
- T6 36169159 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of pos
- T6 35753858 ↗ — 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complication
Structured Combined Exercise Program
T6
T6 — Mechanistic / preclinical
POTS
Supine/Standing Postural Change Test
T6
T6 — Mechanistic / preclinical
POTS
Suprascapular and median nerve blocks
T6
T6 — Mechanistic / preclinical
POTS
Sural Nerve Graft to the Substantia Nigra
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
16 sources
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 41057811 ↗ — Depressive disorders: systematic review of approved psychiatric medications (2009-April 2025) and pi
- T6INDIRECT 38747749 ↗ — Effects of Vitamin D Supplementation on Central Hemodynamic Parameters and Autonomic Nervous System
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6INDIRECT 6758355 ↗ — Fasting: the history, pathophysiology and complications
- T6INDIRECT 32925078 ↗ — COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
- T6INDIRECT 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 36810524 ↗ — Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
- T6 32708302 ↗ — Small Molecule NF-κB Pathway Inhibitors in Clinic
T6 — Mechanistic / preclinical
POTS
12 sources
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6INDIRECT 32925078 ↗ — COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
- T6INDIRECT 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6INDIRECT 37147404 ↗ — Parkinson's disease therapy: what lies ahead?
- T6INDIRECT 10490564 ↗ — Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial isch
- T6INDIRECT 27770180 ↗ — 40<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Munich,
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 36810524 ↗ — Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions
T6 — Mechanistic / preclinical
POTS
11 sources
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6INDIRECT 6758355 ↗ — Fasting: the history, pathophysiology and complications
- T6INDIRECT 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6INDIRECT 27770180 ↗ — 40<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Munich,
- T6INDIRECT 20820780 ↗ — Long-term safety and effectiveness of the "OptEase" vena cava filter
- T6INDIRECT 28795195 ↗ — 53 <sup>rd</sup> EASD Annual Meeting of the European Association for the Study of Diabet
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
T6 — Mechanistic / preclinical
POTS
3 sources
- T6 41440056 ↗ — Alpha-Synuclein Neurobiology in Parkinson's Disease: A Comprehensive Review of Its Role, Mechanisms,
- T6 42293144 ↗ — Multiple system atrophy: integrating clinical phenotypes and multimodal biomarkers for early diagnos
- T6 41387161 ↗ — Treatment of primary adult-onset neurodegenerative cerebellar ataxias
T6 — Mechanistic / preclinical
POTS
25 sources
- T6INDIRECT 9935002 ↗ — The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing f
- T6INDIRECT 10899092 ↗ — Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : p
- T6INDIRECT 15451153 ↗ — A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment o
- T6INDIRECT 10193720 ↗ — Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovag
- T6INDIRECT 16505178 ↗ — Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prev
- T6INDIRECT 11194602 ↗ — 'The Italian Protocol': a simplified head-up tilt testing potentiated with oral nitroglycerin to ass
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 12270863 ↗ — Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing
- T6INDIRECT 8941538 ↗ — Subnormal norepinephrine release relates to presyncope in astronauts after spaceflight
- T6 33243837 ↗ — Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
- T6INDIRECT 28106066 ↗ — The psychosis spectrum in Parkinson disease
- T6INDIRECT 9214258 ↗ — Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the America
- T6INDIRECT 35841911 ↗ — Diagnosis and treatment of orthostatic hypotension
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6INDIRECT 27749843 ↗ — Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 cop
- T6INDIRECT 11842064 ↗ — Computational modeling of cardiovascular response to orthostatic stress
- T6 20668263 ↗ — REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century
- T6 19639282 ↗ — Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophys
- T6 19962493 ↗ — Pathophysiology of fibromyalgia
- T6 17626613 ↗ — Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia
- T6 30007465 ↗ — Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features
- T6 29523389 ↗ — Postural tachycardia syndrome - Diagnosis, physiology, and prognosis
- T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T6 — Mechanistic / preclinical
POTS
9 sources
- T6 24423978 ↗ — Adrenocortical carcinoma
- T6 32862332 ↗ — Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
- T6 35559257 ↗ — Selinexor and COVID-19: The Neglected Warden
- T6 26890144 ↗ — Drug screening on Hutchinson Gilford progeria pluripotent stem cells reveals aminopyrimidines as new
- T6 39735644 ↗ — Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment
- T6INDIRECT 35903274 ↗ — Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Geneti
- T6INDIRECT 23788859 ↗ — Chemotherapy-induced polyneuropathy. Part I. Pathophysiology
- T6 23738080 ↗ — Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Ref
- T6 30761065 ↗ — Role of Sonification and Rhythmic Auditory Cueing for Enhancing Gait Associated Deficits Induced by
Transcutaneous electrical nerve stimulation
T6
T6 — Mechanistic / preclinical
POTS
27 sources
- T6INDIRECT 17943857 ↗ — Antidepressants for neuropathic pain
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 22336858 ↗ — Whole-body vibration training for patients with neurodegenerative disease
- T6INDIRECT 30050569 ↗ — Noninvasive Brain Stimulations for Unilateral Spatial Neglect after Stroke: A Systematic Review and
- T6INDIRECT 36282618 ↗ — Support for healthy breastfeeding mothers with healthy term babies
- T6INDIRECT 34844288 ↗ — Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease
- T6INDIRECT 21418678 ↗ — Low back pain (chronic)
- T6INDIRECT 34291816 ↗ — Interventions for the management of abdominal pain in ulcerative colitis
- T6INDIRECT 30560316 ↗ — Autonomic Neuromodulation Acutely Ameliorates Left Ventricular Strain in Humans
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6INDIRECT 23186897 ↗ — Transverse myelitis
- T6INDIRECT 31871494 ↗ — Therapeutic Approaches for Peripheral and Central Neuropathic Pain
- T6INDIRECT 25584767 ↗ — Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy
- T6INDIRECT 27130211 ↗ — Pediatric complex regional pain syndrome: a review
- T6INDIRECT 24142590 ↗ — Treatment of dystonia
- T6INDIRECT 36211804 ↗ — Tremor in Parkinson's Disease: From Pathophysiology to Advanced Therapies
- T6INDIRECT 23227356 ↗ — Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder
- T6 40274830 ↗ — Diabetic neuropathy: cutting-edge research and future directions
- T6 26676662 ↗ — Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions
- T6 34671261 ↗ — Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy
- T6 34179101 ↗ — Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy
- T6 37670573 ↗ — Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
- T6 32856490 ↗ — Current Strategies for the Management of Painful Diabetic Neuropathy
- T6 28085085 ↗ — Wearable Sensors for Remote Health Monitoring
- T6 25621208 ↗ — Chronic complications of spinal cord injury
- T6 16320031 ↗ — Outcome of non-invasive treatment modalities on back pain: an evidence-based review
- T6 28674681 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Prime
Transcutaneous electrical nerve stimulation and hypnosis
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
24 sources
- T6INDIRECT 17943857 ↗ — Antidepressants for neuropathic pain
- T6INDIRECT 22071859 ↗ — Antidepressants for pain management in rheumatoid arthritis
- T6INDIRECT 32315333 ↗ — Pharmacological treatment of depression: A systematic review comparing clinical practice guideline r
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 32402075 ↗ — Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
- T6INDIRECT 36375174 ↗ — Pharmacological interventions for people with borderline personality disorder
- T6INDIRECT 36971690 ↗ — Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- T6INDIRECT 2915441 ↗ — Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache
- T6INDIRECT 1705137 ↗ — Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine
- T6 31871779 ↗ — Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 28100251 ↗ — Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) de
- T6INDIRECT 32456656 ↗ — Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH<sub>4</sub&g
- T6INDIRECT 34151765 ↗ — Depression and Pain: Use of Antidepressants
- T6INDIRECT 31075831 ↗ — The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice
- T6INDIRECT 16511612 ↗ — The pharmacotherapy of chronic pain: a review
- T6 27222667 ↗ — Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
- T6 22407614 ↗ — Serotonin and blood pressure regulation
- T6 27803666 ↗ — Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 37841347 ↗ — Depletion of dopamine in Parkinson's disease and relevant therapeutic options: A review of the liter
- T6 24905879 ↗ — Induced pluripotent stem cells for regenerative medicine
- T6 17608249 ↗ — Risks of combined alcohol/medication use in older adults
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
T6 — Mechanistic / preclinical
POTS
Upstroke Compression Defibrillation
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
13 sources
- T6INDIRECT 28922704 ↗ — Direct-acting antivirals for chronic hepatitis C
- T6INDIRECT 28585310 ↗ — Direct-acting antivirals for chronic hepatitis C
- T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
- T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
- T6 27065172 ↗ — Hemodynamics
- T6 31633216 ↗ — Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
- T6INDIRECT 36696027 ↗ — Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndr
- T6INDIRECT 32767032 ↗ — Current Management and Emerging Therapies in Multiple System Atrophy
- T6INDIRECT 25465548 ↗ — Effect of blending Jersey and Holstein-Friesian milk on Cheddar cheese processing, composition, and
- T6 37035422 ↗ — Advanced surface engineering of titanium materials for biomedical applications: From static modifica
- T6 40274830 ↗ — Diabetic neuropathy: cutting-edge research and future directions
- T6 20526857 ↗ — RNAi-mediated suppression of isoprene emission in poplar transiently impacts phenolic metabolism und
T6 — Mechanistic / preclinical
POTS
20 sources
- T6INDIRECT 34352984 ↗ — 2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
- T6INDIRECT 28489279 ↗ — Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention o
- T6INDIRECT 39464183 ↗ — Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor a
- T6INDIRECT 31349678 ↗ — Acute Effects of Nutritive and Non-Nutritive Sweeteners on Postprandial Blood Pressure
- T6INDIRECT 25336915 ↗ — Multiple-dose pharmacokinetics and pharmacodynamics of evogliptin (DA-1229), a novel dipeptidyl pept
- T6INDIRECT 28109295 ↗ — A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term
- T6 36148880 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes As
- T6 29565029 ↗ — Hypertension
- T6 36151309 ↗ — Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes A
- T6 27491830 ↗ — Diabetes and Cognitive Impairment
- T6INDIRECT 29934758 ↗ — Diabetic Gastroparesis: Principles and Current Trends in Management
- T6INDIRECT 35033161 ↗ — Adherence and persistence rates of major antidiabetic medications: a review
- T6INDIRECT 29021829 ↗ — Review article: effects of type 2 diabetes therapies on bone metabolism
- T6INDIRECT 23147521 ↗ — Clinical guideline: management of gastroparesis
- T6INDIRECT 32699774 ↗ — RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020
- T6INDIRECT 39091005 ↗ — 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of t
- T6 27660695 ↗ — Update on the treatment of type 2 diabetes mellitus
- T6 23241069 ↗ — A review of the efficacy and safety of oral antidiabetic drugs
- T6 29748368 ↗ — Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors
- T6 38645427 ↗ — Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms
Whey protein powder and L-carnitine
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
4 sources
- T6 35295500 ↗ — Complex Regional Pain Syndrome. A Comprehensive Review on Neuroplastic Changes Supporting the Use of
- T6 32010039 ↗ — Effects of Exoskeleton Gait Training on Balance, Load Distribution, and Functional Status in Stroke:
- T6 1571875 ↗ — New Brunswick's remarkable Dr. Roberts
- T6 PMC7122588 ↗ — Abkürzungen
T6 — Mechanistic / preclinical
POTS
17 sources
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30019766 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30521670 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 30556597 ↗ — Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people
- T6INDIRECT 34564844 ↗ — Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: a
- T6 28585944 ↗ — Cellular uptake of nanoparticles: journey inside the cell
- T6 35682631 ↗ — Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous
- T6 29075626 ↗ — Impact of Metal and Metal Oxide Nanoparticles on Plant: A Critical Review
- T6 22229124 ↗ — The history of Parkinson's disease: early clinical descriptions and neurological therapies
- T6 22908279 ↗ — Soybean susceptibility to manufactured nanomaterials with evidence for food quality and soil fertili
- T6INDIRECT 29387043 ↗ — Strategies to Combat Antibiotic Resistance in the Wastewater Treatment Plants
- T6INDIRECT 10931787 ↗ — Inorganic dust pneumonias: the metal-related parenchymal disorders
- T6INDIRECT 25323828 ↗ — Current treatments in familial dysautonomia
- T6INDIRECT 26387020 ↗ — Invited review: Recommendations for reporting intervention studies on reproductive performance in da
- T6INDIRECT 36836486 ↗ — The Rationale for Vitamin, Mineral, and Cofactor Treatment in the Precision Medical Care of Autism S
- T6INDIRECT 35480890 ↗ — Applications of Alginate-Based Nanomaterials in Enhancing the Therapeutic Effects of Bee Products
- T6 35159802 ↗ — Review on Nanoparticles and Nanostructured Materials: Bioimaging, Biosensing, Drug Delivery, Tissue
carvedilol (beta-blocker)
T6
T6 — Mechanistic / preclinical
POTS
23 sources
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 24158454 ↗ — Blood pressure control and primary prevention of stroke: summary of the recent clinical trial data a
- T6INDIRECT 32519776 ↗ — Withdrawal of antihypertensive drugs in older people
- T6INDIRECT 30480768 ↗ — First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive dr
- T6INDIRECT 23796325 ↗ — Systematic review of genuine versus spurious side-effects of beta-blockers in heart failure using pl
- T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
- T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
- T6INDIRECT 31167038 ↗ — Pharmacotherapy for hypertension in adults 60 years or older
- T6INDIRECT 24650926 ↗ — A randomized pilot study of aortic waveform guided therapy in chronic heart failure
- T6INDIRECT 17094780 ↗ — The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential h
- T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
- T6INDIRECT 28862947 ↗ — Role of Volume Redistribution in the Congestion of Heart Failure
- T6INDIRECT 38441582 ↗ — Cardiac Amyloidosis Due to Transthyretin Protein: A Review
- T6INDIRECT 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 29565029 ↗ — Hypertension
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
- T6 38078592 ↗ — 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2024
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
T6 — Mechanistic / preclinical
MCASPOTS
51 sources
- T6 NCT00006251 ↗ — Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by C
- T6 NCT00014235 ↗ — Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transpla
- T6 NCT00118352 ↗ — Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophen
- T6 NCT00112593 ↗ — Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and M
- T6INDIRECT 21497847 ↗ — AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome
- T6INDIRECT 37056675 ↗ — The crucial role and mechanism of insulin resistance in metabolic disease
- T6INDIRECT 30968949 ↗ — Home use of interdental cleaning devices, in addition to toothbrushing, for preventing and controlli
- T6INDIRECT 26110030 ↗ — Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid:
a systematic review
- T6INDIRECT 10951147 ↗ — Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria
- T6INDIRECT 25046337 ↗ — Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who rema
- T6INDIRECT 20431041 ↗ — Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and l
- T6INDIRECT 29652551 ↗ — n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease
- T6INDIRECT 30943337 ↗ — Benralizumab for <i>PDGFRA</i>-Negative Hypereosinophilic Syndrome
- T6 22878108 ↗ — Cell biology of ischemia/reperfusion injury
- T6INDIRECT 32114706 ↗ — Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
- T6INDIRECT 24554461 ↗ — Echinacea for preventing and treating the common cold
- T6INDIRECT 25919144 ↗ — Interventions for rosacea
- T6INDIRECT 29271481 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 35603936 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 31917873 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 22251436 ↗ — Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of pati
- T6 28293453 ↗ — An overview and management of osteoporosis
- T6 33243615 ↗ — Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on
- T6 37436070 ↗ — Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
- T6INDIRECT 17655751 ↗ — Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis
- T6INDIRECT 25686388 ↗ — The pathophysiology, diagnosis, and treatment of dry eye disease
- T6INDIRECT 24275598 ↗ — Treating inflammation by blocking interleukin-1 in humans
- T6INDIRECT 28242845 ↗ — Focal Segmental Glomerulosclerosis
- T6INDIRECT 30558872 ↗ — Antibiotic allergy
- T6INDIRECT 32106302 ↗ — Overview of Castleman disease
- T6 26228647 ↗ — Colchicine--Update on mechanisms of action and therapeutic uses
- T6 25861976 ↗ — Ion channels in innate and adaptive immunity
- T6 28736339 ↗ — TFOS DEWS II pain and sensation report
- T6 32376392 ↗ — Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventio
- T6 30774631 ↗ — The Immunology of Macrophage Activation Syndrome
- T6INDIRECT 31485575 ↗ — Clinical Manifestations, Diagnosis, and Treatment of Sarcoidosis
- T6INDIRECT 29399043 ↗ — Treatment strategies for autoimmune encephalitis
- T6INDIRECT 23184849 ↗ — Grapefruit-medication interactions: forbidden fruit or avoidable consequences?
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 23147521 ↗ — Clinical guideline: management of gastroparesis
- T6INDIRECT 31210940 ↗ — European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gl
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6 29565029 ↗ — Hypertension
- T6 34988090 ↗ — Treatment of Inflammatory Bowel Disease: A Comprehensive Review
- T6 19165601 ↗ — Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps
- T6 23241069 ↗ — A review of the efficacy and safety of oral antidiabetic drugs
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
- T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
diphenhydramine (H1 antihistamine)
T6
T6 — Mechanistic / preclinical
MCASPOTS
43 sources
- T6INDIRECT 25046337 ↗ — Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who rema
- T6INDIRECT 29650949 ↗ — Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement
- T6INDIRECT 20226302 ↗ — The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficu
- T6INDIRECT 25200415 ↗ — Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-Ig
- T6INDIRECT 12867500 ↗ — Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin
- T6INDIRECT 10377184 ↗ — Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-indu
- T6INDIRECT 24176117 ↗ — A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic pa
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 18774392 ↗ — Treatment of chronic autoimmune urticaria with omalizumab
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 30175841 ↗ — Interventions to improve the appropriate use of polypharmacy for older people
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 18787227 ↗ — Antipsychotic therapy during early and late pregnancy. A systematic review
- T6INDIRECT 28893208 ↗ — Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients
- T6 37160297 ↗ — Antidepressants for pain management in adults with chronic pain: a network meta-analysis
- T6 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 15577865 ↗ — Rhinosinusitis: establishing definitions for clinical research and patient care
- T6INDIRECT 15577816 ↗ — Rhinosinusitis: Establishing definitions for clinical research and patient care
- T6INDIRECT 32436290 ↗ — EAACI Allergen Immunotherapy User's Guide
- T6INDIRECT 24813302 ↗ — Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of a
- T6INDIRECT 32128023 ↗ — IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position p
- T6INDIRECT 26525001 ↗ — 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines
- T6 27795547 ↗ — Food allergy: immune mechanisms, diagnosis and immunotherapy
- T6 26869768 ↗ — Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chit
- T6 37230968 ↗ — Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
- T6 33204386 ↗ — World allergy organization anaphylaxis guidance 2020
- T6 21460831 ↗ — TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch
- T6 21134576 ↗ — Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAI
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 23147521 ↗ — Clinical guideline: management of gastroparesis
- T6 21034217 ↗ — Orexin receptors: pharmacology and therapeutic opportunities
- T6 30018614 ↗ — Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration
- T6 34589395 ↗ — Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic n
- T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
- T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
- T6 29852897 ↗ — Insomnia in the Elderly: A Review
- T6 10457047 ↗ — Childhood functional gastrointestinal disorders
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T6 — Mechanistic / preclinical
POTS
25 sources
- T6INDIRECT 19406310 ↗ — A systematic review of the management of orthostatic hypotension after spinal cord injury
- T6INDIRECT 9091692 ↗ — Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind m
- T6INDIRECT 12521968 ↗ — Multifactorial intervention after a fall in older people with cognitive impairment and dementia pres
- T6INDIRECT 19687359 ↗ — Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less i
- T6INDIRECT 28893208 ↗ — Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients
- T6INDIRECT 9505918 ↗ — Midodrine: a role in the management of neurocardiogenic syncope
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 9244228 ↗ — Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia
- T6INDIRECT 12933939 ↗ — Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypoten
- T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 24423978 ↗ — Adrenocortical carcinoma
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 29565029 ↗ — Hypertension
- T6 28716886 ↗ — Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 26595642 ↗ — Lewy body dementias
- T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
- T6 35648703 ↗ — Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer
- T6 6811067 ↗ — Diagnosis and management of diabetic autonomic neuropathy
- T6 36178003 ↗ — World guidelines for falls prevention and management for older adults: a global initiative
T6 — Mechanistic / preclinical
POTS
26 sources
- T6INDIRECT 17943857 ↗ — Antidepressants for neuropathic pain
- T6INDIRECT 30673120 ↗ — Pregabalin for neuropathic pain in adults
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
- T6INDIRECT 24920437 ↗ — Central changes associated with chronic pelvic pain and endometriosis
- T6INDIRECT 19029129 ↗ — Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study
- T6INDIRECT 18281407 ↗ — Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with bord
- T6INDIRECT 22281448 ↗ — Placebo-controlled comparison of prazosin and cognitive-behavioral treatments for sleep disturbances
- T6INDIRECT 26902950 ↗ — Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A
- T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
- T6INDIRECT 27999003 ↗ — Diabetic Neuropathy: A Position Statement by the American Diabetes Association
- T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
- T6INDIRECT 31663402 ↗ — Consensus statement for perioperative care in total hip replacement and total knee replacement surge
- T6INDIRECT 26514824 ↗ — Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 20042772 ↗ — Standards of medical care in diabetes--2010
- T6INDIRECT 19118286 ↗ — Standards of medical care in diabetes--2009
- T6 21092187 ↗ — Fabry disease
- T6 20194146 ↗ — Recommendations for the pharmacological management of neuropathic pain: an overview and literature u
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 28620280 ↗ — Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
- T6 39353925 ↗ — Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6 23425518 ↗ — Guideline of transthyretin-related hereditary amyloidosis for clinicians
- T6 36178003 ↗ — World guidelines for falls prevention and management for older adults: a global initiative
T6 — Mechanistic / preclinical
POTS
1 source
- T6 38828714 ↗ — An update on multiple system atrophy
T6 — Mechanistic / preclinical
MCASPOTS
51 sources
- T6INDIRECT 30327483 ↗ — Phenome-wide association studies across large population cohorts support drug target validation
- T6INDIRECT 29861802 ↗ — Low-Level Laser Therapy for Temporomandibular Disorders: A Systematic Review with Meta-Analysis
- T6INDIRECT 35361131 ↗ — Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysi
- T6INDIRECT 32176310 ↗ — A Systematic Review of Drug-Induced Pemphigoid
- T6INDIRECT 31117264 ↗ — Herpes Virus, Oral Clinical Signs and QoL: Systematic Review of Recent Data
- T6INDIRECT 28709457 ↗ — Tubulointerstitial nephritis and uveitis (TINU) syndrome: a systematic review of its epidemiology, d
- T6INDIRECT 28779491 ↗ — Antiepileptic drugs for chronic non-cancer pain in children and adolescents
- T6INDIRECT 24085261 ↗ — Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers
- T6INDIRECT 29856741 ↗ — Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with maj
- T6INDIRECT 21834936 ↗ — Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroida
- T6INDIRECT 24554461 ↗ — Echinacea for preventing and treating the common cold
- T6INDIRECT 23076930 ↗ — Local anaesthetics and regional anaesthesia for preventing chronic pain after surgery
- T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
- T6INDIRECT 24595586 ↗ — Non-surgical interventions for the management of chronic pelvic pain
- T6INDIRECT 22376048 ↗ — American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in o
- T6INDIRECT 31132795 ↗ — Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migr
- T6INDIRECT 31207169 ↗ — The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Do
- T6INDIRECT 15345500 ↗ — A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of A
- T6INDIRECT 28655357 ↗ — Drug-related problems and medication reviews among old people with dementia
- T6INDIRECT 9727818 ↗ — Contrasting actions of pressor agents in severe autonomic failure
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 32689643 ↗ — Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights
- T6INDIRECT 29844705 ↗ — Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies
- T6INDIRECT 27866580 ↗ — Eosinophilia
- T6INDIRECT 24792340 ↗ — Migraine and estrogen
- T6INDIRECT 26525001 ↗ — 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines
- T6INDIRECT 29438602 ↗ — International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
- T6INDIRECT 23452057 ↗ — Characterization of different courses of atopic dermatitis in adolescent and adult patients
- T6 25287861 ↗ — Calcitonin gene-related peptide: physiology and pathophysiology
- T6 39174535 ↗ — Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strateg
- T6 32376392 ↗ — Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventio
- T6 30874629 ↗ — Pain and immunity: implications for host defence
- T6 31275462 ↗ — PEGylated liposomes: immunological responses
- T6 19099185 ↗ — Mcl-1 is a potential therapeutic target in multiple types of cancer
- T6 9092596 ↗ — Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage
- T6INDIRECT 23094876 ↗ — Brugada phenocopy: new terminology and proposed classification
- T6INDIRECT 17915006 ↗ — Hereditary sensory and autonomic neuropathies: types II, III, and IV
- T6INDIRECT 24433463 ↗ — Review of pharmacological therapies in fibromyalgia syndrome
- T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
- T6INDIRECT 28541649 ↗ — Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulati
- T6INDIRECT 19730409 ↗ — Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-in
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 23588782 ↗ — Applications of CYP450 testing in the clinical setting
- T6 16461471 ↗ — Diabetic neuropathy
- T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
- T6 30033869 ↗ — A Summary of Electrospun Nanofibers as Drug Delivery System: Drugs Loaded and Biopolymers Used as Ma
- T6 30712918 ↗ — Type 2 diabetes mellitus and osteoarthritis
- T6 10457047 ↗ — Childhood functional gastrointestinal disorders
- T6 26834959 ↗ — Predicting risk of adverse drug reactions in older adults
- T6 31394725 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
in clinic pain VR reduction exercises
T6
T6 — Mechanistic / preclinical
POTS
increased dietary salt / fluid (POTS)
T6
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
POTS
24 sources
- T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
- T6INDIRECT 26447539 ↗ — Interventions for fatigue in Parkinson's disease
- T6INDIRECT 36190739 ↗ — Pharmacological interventions for prevention of weight gain in people with schizophrenia
- T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
- T6INDIRECT 32402075 ↗ — Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
- T6INDIRECT 36138129 ↗ — The impact of pharmacological and non-pharmacological interventions on physical health outcomes in p
- T6INDIRECT 36971690 ↗ — Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- T6INDIRECT 20679638 ↗ — Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
- T6INDIRECT 17134849 ↗ — Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double
- T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
- T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
- T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
- T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
- T6INDIRECT 25200111 ↗ — Drooling in Parkinson's disease: a review
- T6INDIRECT 29101940 ↗ — REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions
- T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
- T6 26595642 ↗ — Lewy body dementias
- T6 28837986 ↗ — Sleep Disturbance, Cognitive Decline, and Dementia: A Review
- T6 24699931 ↗ — Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
- T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
- T6 19603170 ↗ — Primary biliary cirrhosis
- T6 23065655 ↗ — A practical guide to the therapy of narcolepsy and hypersomnia syndromes
- T6 20815187 ↗ — Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment
T6 — Mechanistic / preclinical
POTS
T6 — Mechanistic / preclinical
RegisteredPOTS
25 sources
- T6REGISTERED-ONLY NCT06597682 ↗ — Evaluating Immunomodulatory Interventions in Post-Acute Sequelae of SARS-CoV-2 InfEction
- T6INDIRECT 26343551 ↗ — Interactive telemedicine: effects on professional practice and health care outcomes
- T6INDIRECT 26561338 ↗ — Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
- T6INDIRECT 24067431 ↗ — Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflo
- T6INDIRECT 33180097 ↗ — Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Random
- T6INDIRECT 31782181 ↗ — Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
- T6INDIRECT 27382171 ↗ — Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid a
- T6INDIRECT 17965121 ↗ — Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of respo
- T6 28293453 ↗ — An overview and management of osteoporosis
- T6 26760044 ↗ — Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Gui
- T6 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
- T6INDIRECT 24462240 ↗ — Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a c
- T6INDIRECT 33649022 ↗ — Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management
- T6INDIRECT 30184160 ↗ — Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
- T6INDIRECT 30218025 ↗ — Mechanisms, biomarkers and targets for adult-onset Still's disease
- T6INDIRECT 24682347 ↗ — 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the
- T6INDIRECT 37748514 ↗ — Distinguishing features of long COVID identified through immune profiling
- T6 17223625 ↗ — Histoplasmosis: a clinical and laboratory update
- T6 32231332 ↗ — Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- T6 32792490 ↗ — Podocytopathies
- T6 9723817 ↗ — Grapefruit juice-drug interactions
- T6 34988090 ↗ — Treatment of Inflammatory Bowel Disease: A Comprehensive Review
- T6 25182228 ↗ — Clinician's Guide to Prevention and Treatment of Osteoporosis
- T6 35478046 ↗ — The clinician's guide to prevention and treatment of osteoporosis
- T6 31080465 ↗ — 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Commit
T6 — Mechanistic / preclinical
POTS
19 sources
- T6INDIRECT 27869661 ↗ — An Exploratory Investigation of Endotoxin Levels in Novice Long Distance Triathletes, and the Effect
- T6INDIRECT 33652910 ↗ — The Impact of Decaffeinated Green Tea Extract on Fat Oxidation, Body Composition and Cardio-Metaboli
- T6 20876709 ↗ — Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treat
- T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
- T6 23970715 ↗ — Mechanisms and management of diabetic painful distal symmetrical polyneuropathy
- T6 28824446 ↗ — Human Pathophysiological Adaptations to the Space Environment
- T6 23550085 ↗ — Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease
- T6INDIRECT 34655433 ↗ — Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
- T6INDIRECT 24567799 ↗ — Cardiac autonomic neuropathy in patients with diabetes mellitus
- T6INDIRECT 30039193 ↗ — Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder
- T6INDIRECT 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
- T6INDIRECT 30248938 ↗ — Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization
- T6INDIRECT 32950543 ↗ — Pain management in hidradenitis suppurativa and a proposed treatment algorithm
- T6INDIRECT 32906684 ↗ — Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adv
- T6INDIRECT 32676851 ↗ — Four-Repeat Tauopathies: Current Management and Future Treatments
- T6 16461471 ↗ — Diabetic neuropathy
- T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
- T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
- T6 24954624 ↗ — Diabetic neuropathy: mechanisms, emerging treatments, and subtypes
No agents match this search.